
<html lang="en"     class="pb-page"  data-request-id="5c63ed8f-ecb7-487f-9409-1a6dfd3fcac0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2018.61.issue-10;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.8b00389;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Furoxans (Oxadiazole-4N-oxides) with Attenuated Reactivity are Neuroprotective, Cross the Blood Brain Barrier, and Improve Passive Avoidance Memory" /></meta><meta name="dc.Creator" content="Austin  Horton" /></meta><meta name="dc.Creator" content="Kevin  Nash" /></meta><meta name="dc.Creator" content="Ethel  Tackie-Yarboi" /></meta><meta name="dc.Creator" content="Alexander  Kostrevski" /></meta><meta name="dc.Creator" content="Adam  Novak" /></meta><meta name="dc.Creator" content="Aparna  Raghavan" /></meta><meta name="dc.Creator" content="Jatin  Tulsulkar" /></meta><meta name="dc.Creator" content="Qasim  Alhadidi" /></meta><meta name="dc.Creator" content="Nathan  Wamer" /></meta><meta name="dc.Creator" content="Bryn  Langenderfer" /></meta><meta name="dc.Creator" content="Kalee  Royster" /></meta><meta name="dc.Creator" content="Maxwell  Ducharme" /></meta><meta name="dc.Creator" content="Katelyn  Hagood" /></meta><meta name="dc.Creator" content="Megan  Post" /></meta><meta name="dc.Creator" content="Zahoor A.  Shah" /></meta><meta name="dc.Creator" content="Isaac T.  Schiefer" /></meta><meta name="dc.Description" content="Nitric oxide (NO) mimetics and other agents capable of enhancing NO/cGMP signaling have demonstrated efficacy as potential therapies for Alzheimer’s disease. A group of thiol-dependent NO mimetics ..." /></meta><meta name="Description" content="Nitric oxide (NO) mimetics and other agents capable of enhancing NO/cGMP signaling have demonstrated efficacy as potential therapies for Alzheimer’s disease. A group of thiol-dependent NO mimetics ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 23, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00389" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00389" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00389" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00389" /></link>
        
    
    

<title>Furoxans (Oxadiazole-4N-oxides) with Attenuated Reactivity are Neuroprotective, Cross the Blood Brain Barrier, and Improve Passive Avoidance Memory | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00389" /></meta><meta property="og:title" content="Furoxans (Oxadiazole-4N-oxides) with Attenuated Reactivity are Neuroprotective, Cross the Blood Brain Barrier, and Improve Passive Avoidance Memory" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0010.jpeg" /></meta><meta property="og:description" content="Nitric oxide (NO) mimetics and other agents capable of enhancing NO/cGMP signaling have demonstrated efficacy as potential therapies for Alzheimer’s disease. A group of thiol-dependent NO mimetics known as furoxans may be designed to exhibit attenuated reactivity to provide slow onset NO effects. The present study describes the design, synthesis, and evaluation of a furoxan library resulting in the identification of a prototype furoxan, 5a, which was profiled for use in the central nervous system. Furoxan 5a demonstrated negligible reactivity toward generic cellular thiols under physiological conditions. Nonetheless, cGMP-dependent neuroprotection was observed, and 5a (20 mg/kg) reversed cholinergic memory deficits in a mouse model of passive avoidance fear memory. Importantly, 5a can be prepared as a pharmaceutically acceptable salt and is observed in the brain 12 h after oral administration, suggesting potential for daily dosing and excellent metabolic stability. Continued investigation into furoxans as attenuated NO mimetics for the CNS is warranted." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00389"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00389">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00389&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00389&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00389&amp;href=/doi/10.1021/acs.jmedchem.8b00389" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 4593-4607</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00330" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00441" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.8b00891"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Furoxans (Oxadiazole-4<i>N</i>-oxides) with Attenuated Reactivity are Neuroprotective, Cross the Blood Brain Barrier, and Improve Passive Avoidance Memory</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Austin Horton</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Austin Horton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal and Biological Chemistry, University of Toledo, Toledo, Ohio 43614, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Austin++Horton">Austin Horton</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kevin Nash</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kevin Nash</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, Ohio 43614, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Nash">Kevin Nash</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ethel Tackie-Yarboi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ethel Tackie-Yarboi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal and Biological Chemistry, University of Toledo, Toledo, Ohio 43614, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ethel++Tackie-Yarboi">Ethel Tackie-Yarboi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alexander Kostrevski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alexander Kostrevski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal and Biological Chemistry, University of Toledo, Toledo, Ohio 43614, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alexander++Kostrevski">Alexander Kostrevski</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Adam Novak</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adam Novak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal and Biological Chemistry, University of Toledo, Toledo, Ohio 43614, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adam++Novak">Adam Novak</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Aparna Raghavan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aparna Raghavan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal and Biological Chemistry, University of Toledo, Toledo, Ohio 43614, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aparna++Raghavan">Aparna Raghavan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jatin Tulsulkar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jatin Tulsulkar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal and Biological Chemistry, University of Toledo, Toledo, Ohio 43614, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jatin++Tulsulkar">Jatin Tulsulkar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qasim Alhadidi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qasim Alhadidi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal and Biological Chemistry, University of Toledo, Toledo, Ohio 43614, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qasim++Alhadidi">Qasim Alhadidi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nathan Wamer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nathan Wamer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal and Biological Chemistry, University of Toledo, Toledo, Ohio 43614, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nathan++Wamer">Nathan Wamer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bryn Langenderfer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bryn Langenderfer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal and Biological Chemistry, University of Toledo, Toledo, Ohio 43614, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bryn++Langenderfer">Bryn Langenderfer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kalee Royster</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kalee Royster</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal and Biological Chemistry, University of Toledo, Toledo, Ohio 43614, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kalee++Royster">Kalee Royster</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maxwell Ducharme</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maxwell Ducharme</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal and Biological Chemistry, University of Toledo, Toledo, Ohio 43614, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maxwell++Ducharme">Maxwell Ducharme</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Katelyn Hagood</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Katelyn Hagood</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal and Biological Chemistry, University of Toledo, Toledo, Ohio 43614, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Katelyn++Hagood">Katelyn Hagood</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Megan Post</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Megan Post</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal and Biological Chemistry, University of Toledo, Toledo, Ohio 43614, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Megan++Post">Megan Post</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zahoor A. Shah</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zahoor A. Shah</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal and Biological Chemistry, University of Toledo, Toledo, Ohio 43614, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zahoor+A.++Shah">Zahoor A. Shah</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Isaac T. Schiefer</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Isaac T. Schiefer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal and Biological Chemistry, University of Toledo, Toledo, Ohio 43614, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: (419) 383-1935; e-mail: <a href="/cdn-cgi/l/email-protection#8be2f8eaeae8a5f8e8e3e2eeedeef9cbfeffe4e7eeefe4a5eeeffe"><span class="__cf_email__" data-cfemail="472e342626246934242f2e22212235073233282b22232869222332">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Isaac+T.++Schiefer">Isaac T. Schiefer</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4749-408X" title="Orcid link">http://orcid.org/0000-0003-4749-408X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00389&amp;href=/doi/10.1021%2Facs.jmedchem.8b00389" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 4593–4607</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 23, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 March 2018</li><li><span class="item_label"><b>Published</b> online</span>23 April 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 May 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00389" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00389</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4593%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAustin%2BHorton%252C%2BKevin%2BNash%252C%2BEthel%2BTackie-Yarboi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D10%26contentID%3Dacs.jmedchem.8b00389%26title%3DFuroxans%2B%2528Oxadiazole-4N-oxides%2529%2Bwith%2BAttenuated%2BReactivity%2Bare%2BNeuroprotective%252C%2BCross%2Bthe%2BBlood%2BBrain%2BBarrier%252C%2Band%2BImprove%2BPassive%2BAvoidance%2BMemory%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4607%26publicationDate%3DMay%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00389"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1793</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00389" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Furoxans (Oxadiazole-4N-oxides) with Attenuated Reactivity are Neuroprotective, Cross the Blood Brain Barrier, and Improve Passive Avoidance Memory&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Austin&quot;,&quot;last_name&quot;:&quot;Horton&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Nash&quot;},{&quot;first_name&quot;:&quot;Ethel&quot;,&quot;last_name&quot;:&quot;Tackie-Yarboi&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;Kostrevski&quot;},{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;Novak&quot;},{&quot;first_name&quot;:&quot;Aparna&quot;,&quot;last_name&quot;:&quot;Raghavan&quot;},{&quot;first_name&quot;:&quot;Jatin&quot;,&quot;last_name&quot;:&quot;Tulsulkar&quot;},{&quot;first_name&quot;:&quot;Qasim&quot;,&quot;last_name&quot;:&quot;Alhadidi&quot;},{&quot;first_name&quot;:&quot;Nathan&quot;,&quot;last_name&quot;:&quot;Wamer&quot;},{&quot;first_name&quot;:&quot;Bryn&quot;,&quot;last_name&quot;:&quot;Langenderfer&quot;},{&quot;first_name&quot;:&quot;Kalee&quot;,&quot;last_name&quot;:&quot;Royster&quot;},{&quot;first_name&quot;:&quot;Maxwell&quot;,&quot;last_name&quot;:&quot;Ducharme&quot;},{&quot;first_name&quot;:&quot;Katelyn&quot;,&quot;last_name&quot;:&quot;Hagood&quot;},{&quot;first_name&quot;:&quot;Megan&quot;,&quot;last_name&quot;:&quot;Post&quot;},{&quot;first_name&quot;:&quot;Zahoor&quot;,&quot;last_name&quot;:&quot;A. Shah&quot;},{&quot;first_name&quot;:&quot;Isaac&quot;,&quot;last_name&quot;:&quot;T. Schiefer&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;4593-4607&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00389&quot;},&quot;abstract&quot;:&quot;Nitric oxide (NO) mimetics and other agents capable of enhancing NO/cGMP signaling have demonstrated efficacy as potential therapies for Alzheimer’s disease. A group of thiol-dependent NO mimetics known as furoxans may be designed to exhibit attenuated reactivity to provide slow onset NO effects. The present study describes the design, synthesis, and evaluation of a furoxan library resulting in the identification of a prototype furoxan, 5a, which was profiled for use in the central nervous system. Furoxan 5a demonstrated negligible reactivity toward generic cellular thiols under physiological conditions. Nonetheless, cGMP-dependent neuroprotection was observed, and 5a (20 mg/kg) reversed cholinergic memory deficits in a mouse model of passive avoidance fear memory. Importantly, 5a can be prepared as a pharmaceutically acceptable salt and is observed in the brain 12 h after oral administration, suggesting potential for daily dosing and excellent metabolic stability. Continued investigation into furoxans as att&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00389&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00389" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00389&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00389" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00389&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00389" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00389&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00389&amp;href=/doi/10.1021/acs.jmedchem.8b00389" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00389" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00389" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00389%26sid%3Dliteratum%253Aachs%26pmid%3D29683322%26genre%3Darticle%26aulast%3DHorton%26date%3D2018%26atitle%3DFuroxans%2B%2528Oxadiazole-4N-oxides%2529%2Bwith%2BAttenuated%2BReactivity%2Bare%2BNeuroprotective%252C%2BCross%2Bthe%2BBlood%2BBrain%2BBarrier%252C%2Band%2BImprove%2BPassive%2BAvoidance%2BMemory%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D10%26spage%3D4593%26epage%3D4607%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (5)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=290792" title="Circuits">Circuits</a>,</li><li><a href="/action/doSearch?ConceptID=291368" title="Liquid chromatography-tandem mass spectrometry">Liquid chromatography-tandem mass spectrometry</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291452" title="Reactivity">Reactivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/jmcmar.2018.61.issue-10/20180524/jmcmar.2018.61.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/medium/jm-2018-00389a_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00389&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Nitric oxide (NO) mimetics and other agents capable of enhancing NO/cGMP signaling have demonstrated efficacy as potential therapies for Alzheimer’s disease. A group of thiol-dependent NO mimetics known as furoxans may be designed to exhibit attenuated reactivity to provide slow onset NO effects. The present study describes the design, synthesis, and evaluation of a furoxan library resulting in the identification of a prototype furoxan, <b>5a</b>, which was profiled for use in the central nervous system. Furoxan <b>5a</b> demonstrated negligible reactivity toward generic cellular thiols under physiological conditions. Nonetheless, cGMP-dependent neuroprotection was observed, and <b>5a</b> (20 mg/kg) reversed cholinergic memory deficits in a mouse model of passive avoidance fear memory. Importantly, <b>5a</b> can be prepared as a pharmaceutically acceptable salt and is observed in the brain 12 h after oral administration, suggesting potential for daily dosing and excellent metabolic stability. Continued investigation into furoxans as attenuated NO mimetics for the CNS is warranted.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56116" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56116" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nitric oxide (NO) is a fundamental regulator of synaptic function. The ability of NO to enhance synaptic plasticity is chiefly attributed to activation of NO-sensitive soluble guanylyl cyclase (NO-sGC), resulting in increased production of cyclic guanosine monophosphate (cGMP) and kinase signal transduction, primarily via protein kinase G (PKG), leading to phosphorylation of cAMP response element binding protein (CREB) at Ser-133.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> CREB phosphorylation is required for synaptic plasticity and memory consolidation. Prolonged transcriptional activation of CREB results in the production of neurogenic gene products, such as brain-derived neurotrophic factor (BDNF), and the formation of new dendritic spines, ensuring the capacity for morphological flexibility in synaptic networks.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Regulation of CREB was first identified as being controlled by cAMP/PKA kinase signaling but actually involves numerous coregulators. Importantly, inhibition of any component of the NO/cGMP/PKG system suppresses synaptic signal. This pathway is directly inhibited by amyloid beta (Aβ) in Alzheimer’s disease (AD).<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5−8)</a> Reversal of Aβ-induced deficits via agents that activate NO/cGMP signaling results in improved cognitive function, as demonstrated for nitrates, sGC activators, and phosphodiesterase inhibitors (PDEi).<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13">(9−13)</a></div><div class="NLM_p">NO-related biological chemistry is complex, and the term “NO donor” is often used to describe multiple chemical classes, some of which do not directly yield molecular NO<sup>•</sup>. Multiple “NO donor” classes exhibit NO mimetic activity through one of several NO species (such as NO<sup>•</sup>, HNO, NO<sup>–</sup>, NO<sup>+</sup>, NO<sub>2</sub><sup>–</sup>, or HONOO<sup>–</sup>). Here, we describe a class of synthetic, thiol-dependent NO mimetics known as furoxans. Furoxans have been investigated as potential therapeutics for a plethora of disease states.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18 ref19">(14−19)</a> The majority of furoxan development has focused on relatively reactive furoxans that harness the potent vasodilatory or cytotoxic effects associated with large transient fluxes of NO. Indeed, of approximately 158 “furoxan”-themed original research articles in medicinal chemistry journals in the past 20 years, only two instances focused on the use of furoxans for the central nervous system (CNS) (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_001.csv" class="ext-link">Supplemental Table 1</a>). The pioneering effort by Schiefer et al. used the furoxan moiety with a putative peptidomimetic motif (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A) and demonstrated that (1) reactivity and propensity for NO mimetic activity can be modulated via a predictable structure–activity relationship (SAR), (2) furoxans protect against oxygen glucose deprivation (OGD) in primary cortical cell culture via a NO/cGMP-dependent mechanism, and (3) furoxans rescue oligomeric Aβ-induced deficits in long-term potentiation (LTP) (i.e., sustained strengthening of synaptic signal).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Additionally, Chegaeve et al. reported restored LTP and disruption of Tau and Aβ aggregation using thiacarbocyanine-furoxan hybrids (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Each of these studies incorporated the furoxan moiety within hybrid scaffolds and confirmed efficacy with in vitro cell cultures and ex vivo hippocampal slices. Furoxans have not hitherto been investigated in vivo for CNS applications.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/medium/jm-2018-00389a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Overview of furoxan development for the CNS. The furoxans described here have more favorable physiochemical properties as potential CNS drugs than previously described furoxans. Furoxans have not been studied in the brain previously. *Abbreviations: MW = molecular weight; tPSA = total polar surface area; cLogP = calculated partition coefficient; Aβ = oligomeric amyloid beta; LTP = long-term potentiation; STPA = step-through passive avoidance.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00389&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In this paper, a focused furoxan library was designed with rigorous consideration of physiochemical properties for CNS penetration. Incorporating varying electron-donating or -withdrawing groups probed electronic sensitivity of the thiophilic furoxan ring with the goal of fine-tuning reactivity toward endogenous thiols and thus the rate of NO release. The furoxan <b>5a</b> demonstrated negligible reactivity toward generic cellular thiols under physiological conditions. Nonetheless, NO/cGMP-dependent neuroprotection was observed with a hyperbolic concentration response curve, and <b>5a</b> was shown to penetrate the blood brain barrier via multiple administration routes and was capable of reversing cholinergic memory blockade in a mouse model of passive avoidance memory.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88045" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88045" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Library Design</h3><div class="NLM_p">The design motif for novel furoxans is summarized in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A. Groups at GlaxoSmithKline, Eli Lilly, and others have described favorable CNS penetration as resulting from several inter-related properties including (1) membrane permeability and solubility, (2) low propensity for efflux by P-glycoproteins (Pgp), and (3) adequate brain partitioning to provide a sufficient level of unbound drug at the site of action.<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22−24)</a> Behavior with regard to these properties is highly dependent upon the physiochemical properties of the molecule being studied (i.e., molecular weight [MW], partition coefficient [logP], and total polar surface area [tPSA]). On the basis of these considerations, all of our compounds obey the following design criteria: (1) MW < 400 g/mol, (2) clogP = 2.5–4.5, and (3) tPSA = 45–85. A <i>para</i>-substituted aryl system was used to modulate furoxan reactivity while blocking potential metabolic <i>para</i>-hydroxylation, the main route of metabolism of phenyl-containing drugs.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> 4-Methylpiperdine was incorporated as a cap group because it is small, relatively hydrophobic, and contains a tertiary amine (related 4-alkylpiperdine reported p<i>K</i><sub>a</sub> ∼ 9.0),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> which allows preparation of pharmaceutically acceptable salts that possess excellent water solubility. Importantly, despite predominantly existing as a charged species at physiological pH, similar 4-alkylpiperidines are present in several orally bioavailable CNS drugs, including haloperidol, risperidone, and the AD standard of care donepezil.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/medium/jm-2018-00389a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Design justification for furoxan library. (B) Review of furoxan designation nomenclature. Furoxans tautomerize when heated sufficiently (at least 100 °C for a sustained period of time depending upon substitution pattern) but do not interconvert at physiologically relevant temperatures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00389&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Synthesis</h3><div class="NLM_p">Novel furoxans were synthesized from readily available cinnamic acids (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) beginning with anhydride formation and reduction with sodium borohydride to produce the corresponding cinnamyl alcohols (<b>1a</b>–<b>h</b>). The cinnamyl alcohols were cyclized using an optimized cyclization reaction with excess sodium nitrite performed in a 1:1 mixture of acetic acid:dimethylformamide with gradual heating to yield <b>2a</b>–<b>h</b>. A traditional Appel reaction afforded the alkyl bromides <b>3a</b>–<b>h</b>, and subsequent substitution with 4-methylpiperidine yielded the oxadiazole-2<i>N</i>-oxides (ODZ-2N) <b>4a</b>–<b>h</b>. The final step of the synthesis involved tautomerization of the furoxan in refluxing toluene to yield oxadiazole-4<i>N</i>-oxides (ODZ-4N). Separation of the ODZ-2N/ODZ-4N tautomers was realized via reverse-phase flash chromatography to yield the ODZ-4N compounds <b>5a</b>–<b>h</b>. Initial in vitro testing nominated <b>5a</b> for in vivo evaluation (vide infra). Accordingly, substitution of <b>3a</b> with isotope-labeled 4-methylpiperidine-2,2,6,6-<i>d</i><sup>4</sup> followed by tautomerization provided <b>7a</b> as an appropriate internal standard for LC-MS/MS studies (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Additionally, treatment of <b>5a</b> with HCl in diethyl ether provided the water-soluble HCl salt for in vivo investigations.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/medium/jm-2018-00389a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Library Synthesis<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00389&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(i) Ethyl chloroformate, triethylamine, sodium borohydride, 0 °C to r.t.; (ii) acetic acid:dimethylformamide (1:1), sodium nitrite, 0 to 60 °C; (iii) triphenylphosphine, carbon tetrabromide, 0 °C to r.t.; (iv) 4-methylpiperidine, triethylamine, r.t. to 60 °C; (v) toluene, reflux, 7 d.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/medium/jm-2018-00389a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the LC-MS/MS Internal Standard<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00389&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(i) 4-Methylpiperidine-2,2,6,6-<i>d</i><sup>4</sup>, triethylamine, r.t. to 60 °C; (ii) toluene, reflux, 7 d.</p></p></figure><div class="NLM_p">Crystallographic examination of <b>5a</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A) confirmed the presence of the ODZ-4N structure (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_005.pdf" class="ext-link">Supplemental Crystallographic Report</a>). HPLC purity analysis using a photodiode array detector (PDA) showed a noticeable shift in the λ<sub>max</sub> of absorption for ODZ-2N analogues (∼246–261 nm) versus that of ODZ-4N analogues (279–293 nm) with a representative example shown for <b>4a</b> and <b>5a</b> in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_003.pdf" class="ext-link">Supplemental Characterization</a> for PDA data for all compounds). This phenomenon may be used to easily distinguish furoxan tautomeric forms. In all instances, retention time (<i>R</i><sub>t</sub>) comparisons indicated that, despite possessing greater aromaticity based on λ<sub>max</sub>, the ODZ-4N analogues are more polar than the corresponding ODZ-2N analogues. Furoxan <b>5a</b> was also profiled by 2D-NMR (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_002.pdf" class="ext-link">Supporting Information</a> for homonuclear correlation spectroscopy [COSY] and heteronuclear multiple quantum coherence [HMQC]).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/medium/jm-2018-00389a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Crystal structure of <b>5a</b> confirming the oxadiazole-4<i>N</i>-oxide ring configuration. (B) HPLC-PDA analysis demonstrating differences in relative polarity and UV absorption properties for ODZ-2N and ODZ-4N furoxans <b>4a</b> and <b>5a</b>, respectively. Chromatograms represent overlay of UV signal at 254 nm with PDA analysis of the representative portion of the chromatogram shown above each peak.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00389&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Neuroprotection</h3><div class="NLM_p">Oxygen glucose deprivation (OGD) provides a cellular model of oxidative stress resulting in apoptotic cell death, which provides a model of neuronal death across neurodegenerative diseases, including AD.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Expert perspectives suggest that experimental paradigms in drug discovery should model well-understood target pathways rather than specific disease state.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> NO mimetics have been benchmarked as being protective against oxidative stress induced by OGD via multiple proposed mechanisms including (1) antioxidant effects, (2) mediating phosphorylation of prosurvival kinase signaling, and (3) <i>S</i>-nitrosylation of pro-apoptotic caspases.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> Neuroprotection was evaluated by 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl-tetrazolium bromide (MTT) assays of cell viability in nondifferentiated PC-12 cell cultures subjected to OGD for 90 min followed by reoxygenation and replacement with nutrient-rich media containing furoxans screened at three concentrations (1, 10, and 25 μM) for 24 h. Neuroprotection is reported as percent change relative to vehicle (DMSO)-treated controls.</div><div class="NLM_p">The ODZ-2N compounds (except <b>4d</b>) showed negligible neuroprotection (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). A few ODZ-4N analogues provided noticeable neuroprotective activity, including compounds <b>5a</b> (4-F), <b>5c</b> (4-Br), and <b>5d</b> (4-OCHF<sub>2</sub>). The 4-OCHF<sub>2</sub> tautomers (<b>4d</b> and <b>5d</b>) showed robust potency with significant efficacy at 1 μM. Furoxans <b>4d</b> and <b>5d</b> are considered to exhibit “outlier-like” behavior compared to the rest of the library based upon (1) <b>4d</b> being the only active ODZ-2N from our series and (2) the potency of these compounds being an order of magnitude lower than any other compound. Antioxidant effects, such as those traditionally seen for NO mimetics, result in potent in vitro neuroprotection against oxidative stress associated with OGD. In NO-related drug discovery, the most potent compounds in primary assays may not survive hit-to-lead optimization due to deleterious effects in animals. Furoxans <b>4d</b> and <b>5d</b> warrant additional investigation; however, they were not considered for proof-of-concept  in vivo investigation of attenuated furoxans because the impetus for this work was to produce NO mimetics that activate NO/cGMP signaling without producing significant fluxes of NO, thereby reducing the potential for side effects. Furoxans <b>5a</b> and <b>5c</b> demonstrate statistically equivalent efficacy and potency. Furoxan <b>5a</b>, rather than <b>5c</b>, was chosen for in vivo evaluation for multiple reasons, including the smaller molecular weight (a critical factor in brain penetration and ligand efficiency)<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and future potential for incorporation of <sup>18</sup>F for radioimaging. Furoxan <b>7a</b> was synthesized for use as an LC-MS/MS internal standard and was also tested in the primary assay. Similar activity was expected compared to nondeuterated <b>5a</b>; however, <b>7a</b> possessed no neuroprotective effects. UPLC separation suggests <b>7a</b> is slightly more polar than <b>5a</b> based on <i>R</i><sub>t</sub> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_002.pdf" class="ext-link">Supplemental Figure S3</a>). LC-MS/MS was used to measure membrane permeability in the primary assay (i.e., extracellular concentration versus intracellular concentration) of <b>5a</b> and <b>7a</b> in the media (supernatant) and cytosol of control (no OGD) and OGD-treated PC12 cells following 24 h incubation via subcellular fractionation. Each compound was found in greatest amounts in the cytosol, and submitting to OGD insult did not significantly effect distribution (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_002.pdf" class="ext-link">Supplemental Figure S4</a>). These data demonstrate (1) furoxans readily cross cell membranes in the primary assay and (2) significant amounts of furoxan after 24 h incubation with PC12 cells, providing further evidence for the relatively unreactive nature of this furoxan library.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Protection against Oxygen Glucose Deprivation (OGD)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char=" " /></col><col align="char" char="%" /></col><col align="char" char="%" /></col><col align="char" char="%" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=" "> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="%">% change in viability relative to vehicle mean</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">structure</th><th class="colsep0 rowsep0" align="center" char=" ">tautomer</th><th class="colsep0 rowsep0" align="center" char="%">1 μM</th><th class="colsep0 rowsep0" align="center" char="%">10 μM</th><th class="colsep0 rowsep0" align="center" char="%">25 μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R<sub>1</sub> = F</td><td class="colsep0 rowsep0" align="char" char=" "><b>4a</b> (2N)</td><td class="colsep0 rowsep0" align="char" char="%">11% ± 2</td><td class="colsep0 rowsep0" align="char" char="%">11% ± 3</td><td class="colsep0 rowsep0" align="char" char="%">5% ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" "><b>5a</b> (4N)</td><td class="colsep0 rowsep0" align="char" char="%">–3% ± 4</td><td class="colsep0 rowsep0" align="char" char="%">46%*** ± 7</td><td class="colsep0 rowsep0" align="char" char="%">41%*** ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R<sub>1</sub> = CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=" "><b>4b</b> (2N)</td><td class="colsep0 rowsep0" align="char" char="%">–9% ± 7</td><td class="colsep0 rowsep0" align="char" char="%">10% ± 7</td><td class="colsep0 rowsep0" align="char" char="%">0% ± 14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" "><b>5b</b> (4N)</td><td class="colsep0 rowsep0" align="char" char="%">2% ± 23%</td><td class="colsep0 rowsep0" align="char" char="%">–16% ± 7</td><td class="colsep0 rowsep0" align="char" char="%">–22% ± 10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R<sub>1</sub> = Br</td><td class="colsep0 rowsep0" align="char" char=" "><b>4c</b> (2N)</td><td class="colsep0 rowsep0" align="char" char="%">–7% ± 2</td><td class="colsep0 rowsep0" align="char" char="%">–2% ± 1</td><td class="colsep0 rowsep0" align="char" char="%">19% ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" "><b>5c</b> (4N)</td><td class="colsep0 rowsep0" align="char" char="%">25% ± 6</td><td class="colsep0 rowsep0" align="char" char="%">77%*** ± 5</td><td class="colsep0 rowsep0" align="char" char="%">96%*** ± 19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R<sub>1</sub> = OCHF<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=" "><b>4d</b> (2N)</td><td class="colsep0 rowsep0" align="char" char="%">54%** ± 11</td><td class="colsep0 rowsep0" align="char" char="%">86%*** ± 15</td><td class="colsep0 rowsep0" align="char" char="%">108%*** ± 24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" "><b>5d</b> (4N)</td><td class="colsep0 rowsep0" align="char" char="%">67%*** ± 7</td><td class="colsep0 rowsep0" align="char" char="%">61%*** ± 7</td><td class="colsep0 rowsep0" align="char" char="%">53%** ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R<sub>1</sub> = OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=" "><b>4e</b> (2N)</td><td class="colsep0 rowsep0" align="char" char="%">14% ± 6</td><td class="colsep0 rowsep0" align="char" char="%">10% ± 6</td><td class="colsep0 rowsep0" align="char" char="%">–1% ± 9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" "><b>5e</b> (4N)</td><td class="colsep0 rowsep0" align="char" char="%">11% ± 6</td><td class="colsep0 rowsep0" align="char" char="%">12% ± 14</td><td class="colsep0 rowsep0" align="char" char="%">5% ± 17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R<sub>1</sub> = CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=" "><b>4f</b> (2N)</td><td class="colsep0 rowsep0" align="char" char="%">7% ± 12</td><td class="colsep0 rowsep0" align="char" char="%">12% ± 15</td><td class="colsep0 rowsep0" align="char" char="%">10% ± 11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" "><b>5f</b> (4N)</td><td class="colsep0 rowsep0" align="char" char="%">22% ± 20</td><td class="colsep0 rowsep0" align="char" char="%">13% ± 18</td><td class="colsep0 rowsep0" align="char" char="%">8% ± 18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R<sub>1</sub> = Cl</td><td class="colsep0 rowsep0" align="char" char=" "><b>4g</b> (2N)</td><td class="colsep0 rowsep0" align="char" char="%">35% ± 16</td><td class="colsep0 rowsep0" align="char" char="%">7% ± 8</td><td class="colsep0 rowsep0" align="char" char="%">25% ± 16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" "><b>5g</b> (4N)</td><td class="colsep0 rowsep0" align="char" char="%">–10% ± 12</td><td class="colsep0 rowsep0" align="char" char="%">19% ± 19</td><td class="colsep0 rowsep0" align="char" char="%">4% ± 18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R<sub>1</sub> = H</td><td class="colsep0 rowsep0" align="char" char=" "><b>4h</b> (2N)</td><td class="colsep0 rowsep0" align="char" char="%">9% ± 11</td><td class="colsep0 rowsep0" align="char" char="%">19% ± 6</td><td class="colsep0 rowsep0" align="char" char="%">16% ± 15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" "><b>5h</b> (4N)</td><td class="colsep0 rowsep0" align="char" char="%">–21% ± 7</td><td class="colsep0 rowsep0" align="char" char="%">6% ± 23</td><td class="colsep0 rowsep0" align="char" char="%">–11% ± 6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R<sub>1</sub> = F <i>d</i><sup>4</sup> analogue</td><td class="colsep0 rowsep0" align="char" char=" "><b>6a</b> (2N)</td><td class="colsep0 rowsep0" align="char" char="%">11% ± 8</td><td class="colsep0 rowsep0" align="char" char="%">6% ± 7</td><td class="colsep0 rowsep0" align="char" char="%">–1% ± 12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=" "><b>7a</b> (4N)</td><td class="colsep0 rowsep0" align="char" char="%">8% ± 11</td><td class="colsep0 rowsep0" align="char" char="%">20% ± 13</td><td class="colsep0 rowsep0" align="char" char="%">7% ± 9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Assay workflow: expose PC12 cells to OGD for 90 min → reoxygenate and add furoxan (1, 10, or 25 μM) → incubate for 24 h → MTT readout. Data represented as mean ± SEM (<i>n</i> = 3) of triplicate experiments. *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 compared to vehicle control using one-way ANOVA analysis with Dunnett’s posthoc test. The viability of the OGD vehicle group is 51.4 ± 4.1% compared to vehicle group. This number is based on <i>N</i> = 20 OGD/vehicle trials, reported as mean ± SEM.</p></div></div></div><div class="NLM_p">An expanded dose–response assay of OGD-exposed PC12 cells treated with <b>5a</b> revealed a bell-shaped (i.e., hyperbolic) efficacy curve from which an EC<sub>50</sub> = 1.9 μM was calculated (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). For concentration response studies a resorufin based dye was used as the viability read-out due to a significantly shorter incubation time before colorimetric measurement, which allows more direct observation and increased throughput compared to MTT. The hyperbolic response curve is in agreement with previous studies that identified a correlation between production of NO<sub>2</sub><sup>–</sup> by furoxans in the presence of cysteine (i.e., reactivity) with protection against OGD. Notably, although protective effects of <b>5a</b> are lost at higher concentrations, no toxicity was observed at the highest concentration tested (50 μM). Co-incubation with ODQ (1<i>H</i>-[1,2,4]oxadiazolo-[4,3-<i>a</i>]quinoxalin-1-one), a selective sGC inhibitor, completely blocked the neuroprotective effects of <b>5a</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B), providing evidence for enhanced NO/cGMP signaling as being responsible for neuroprotective efficacy of <b>5a</b>. This result is in agreement with previous reports of ODQ blocking the ability of furoxans or nitrates to protect against oxidative stress in cell culture.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The presence of a basic nitrogen in the structure of the furoxan may lead to the interaction with a number of different targets in CNS. Hence, <b>5a</b> (active) and <b>7a</b> (inactive) were sent to the Psychoactive Drug Screening Program for binding studies to assess off-target effects as described previously.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> As shown in <a class="ref internalNav" href="#notes-2" aria-label="Supplementary Table 2">Supplementary Table 2</a>, <b>5a</b> does not interfere with binding of any radioligands for all receptors screened, including GABA<sub>A</sub>, serotonin receptors, dopamine receptors, and muscarinic and nicotinic acetylcholine receptors. No hERG binding was observed. For the most part <b>7a</b> demonstrated a similar profile but significantly inhibited binding at the delta opioid receptor and benzodiazepine (BZP) rat brain site.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/medium/jm-2018-00389a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Neuroprotection concentration response curve for <b>5a</b>. PC12 cells were submitted to OGD for 90 min followed by addition of <b>5a</b> (0.1, 1, 5, 10, 25, or 50 μM) and incubated under normoxic conditions for 24 h. Data represent percent change in viability relative to vehicle-treated control mean = 1, Prestoblue readout. Vehicle control viability range (assay baseline [blue]) and viability range control plates not submitted to OGD are shown in yellow. (B) Neuroprotection of <b>5a</b> is dependent on sGC signaling. ODQ (10 μM) abolished neuroprotective activity of <b>5a</b> in a PC12-OGD assay using MTT as a viability readout. Data represented as mean ± SEM (<i>n</i> = 3) of duplicate experiments. *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 compared to vehicle control using one-way ANOVA analysis with Dunnett’s posthoc test. Average viability of the OGD vehicle cells was 51.4% (±4.1) that of vehicle cells based on 20 OGD/vehicle trials, represented as mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00389&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Reactivity</h3><div class="NLM_p last">Furoxan <b>5a</b> was incubated with <i>N</i>-acetyl cysteine (5 mM) in PBS (50 mM, pH 7.4) to examine the stability of the furoxan ring in the presence of excess free thiols (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_002.pdf" class="ext-link">Supplemental Figures S10 and S11</a>). We hypothesized reactivity with excess thiol would correlate with neuroprotection in the primary assay. However, no reaction was observed by HPLC-PDA analysis of all compounds, whereas control incubations using the electrophile <i>N</i>-ethylmaleimide (NEM) showed complete reaction of NEM after 2 and 12 h. In agreement with the observed attenuated reactivity, negligible NO production was observed from <b>5a</b> in the form of NO<sub>2</sub><sup>–</sup> in the primary assay (<a class="ref internalNav" href="#notes-2" aria-label="Supplemental Figure S11">Supplemental Figure S11</a>).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Improved Memory in Step-Through Passive Avoidance (STPA)</h3><div class="NLM_p">Pilot behavioral studies evaluated the ability of <b>5a</b> to reverse scopolamine-induced deficits in STPA, which assesses the ability of drugs to reverse hippocampal-dependent aversive memory deficits.<a onclick="showRef(event, 'ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38">(36−38)</a> Scopolamine is a well-characterized pan-muscarinic antagonist that produces significant amnesic effects when administered 30 min prior to training in STPA.<a onclick="showRef(event, 'ref36 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref36 ref39 ref40">(36,39,40)</a> Reversal of scopolamine-induced amnesia is not a sophisticated model, but it is well understood and remains useful as a resource-efficient screen for procognitive agents.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Importantly, reversal of scopolamine-induced cholinergic deficits in STPA via NO/cGMP enhancement is well characterized and has been benchmarked for nitrates, sGC activators, PKG activators, and several phosphodiesterase inhibitors (PDEi).<a onclick="showRef(event, 'ref42 ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44 ref45 ref46">(42−46)</a> The STPA apparatus consists of an acrylic box with an illuminated compartment connected to a darkened compartment by a small guillotine door. Mice are placed in the illuminated side and trained against their natural tendency to translocate to the dark side using an aversive stimulus during double trial acquisition. Memory consolidation is measured as the latency to enter the dark compartment 24 h after training (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Testing latency 24 h after treatment avoids potential convolution from lethargy caused by drug exposure, and lethargy is not reported for agents acting via cGMP signaling as shown for sildenafil in the open field test.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/medium/jm-2018-00389a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Reversal of cholinergic memory deficits in STPA by <b>5a</b>. Male C57BL/6 mice administered either vehicle or <b>5a</b> (0.1, 1, 10, or 20 mg/kg) via ip injection at 1 or 2 h prior to training. Scopolamine (1 mg/kg) was administered 30 min prior to training. Memory was measured as latency to enter a dark chamber 24 h after training. Data represented as mean and SEM (<i>n</i> = 8–9) for <i>n</i> = 8, see exclusion criteria in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. **<i>p</i> < 0.01 and ***<i>p</i> < 0.001 compared to negative scopolamine-treated control using one-way ANOVA analysis with Dunnett’s posthoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00389&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Furoxans have never been studied in the CNS. Hence, choices for dosing and administration timing were not evident at the onset. A NO-chimeric nitrate reversed scopolamine-induced deficits in STPA when administered 20 min prior to training but had no effect when given 60 min prior to training, demonstrating the short biological half-life of nitrates resulting in rapid onset of neuromodulatory efficacy at a low dose (1 mg/kg).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> On the basis of the knowledge that attenuated furoxans likely have greater metabolic stability, we anticipated that a longer pretraining treatment duration would be required to allow sufficient time for slow-onset NO mimetic effects. With these considerations in mind, we examined varying doses at two pretraining time points (1 or 2 h). Scopolamine-treated mice showed significantly less latency to enter the dark compartment compared to that of wild-type mice (scopolamine-treated: 63.5 ± 30 s [SEM] versus vehicle-treated: 270 ± 29 s [SEM], <i>p</i> < 0.001). Furoxan <b>5a</b> was capable of reversing scopolamine-induced amnesia with a statistically significant effect observed when administered 2 h prior to training at 20 mg/kg (latency = 237 ± 22 s [SEM], <i>p</i> < 0.01). These data demonstrate, for the first time, the ability of a furoxan to improve memory in mice by reversing cholinergic memory blockade.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> In Vivo Drug Stability, Brain Penetration, and Effect on Protein Phosphorylation</h3><div class="NLM_p">To understand the STPA behavioral results, we attempted to correlate the amount of <b>5a</b> in the forebrain with modulation of a hypothesized marker of efficacy, CREB phosphorylation. The forebrain contains the primary neurocircuitry responsible for learning and memory, particularly the hippocampus. Pilot studies analyzed the entire forebrain to ensure enough tissue was available for both ELISA and LC-MS/MS analysis from the same animal (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). Furoxan <b>5a</b> was measured by LC-MS/MS analysis of plasma and forebrain samples after intraperitoneal (ip) and oral (po) administration at varying time points (1, 2, or 12 h [<i>n</i> = 4]). CREB phosphorylation was also analyzed in the forebrain samples as the pCREB:tCREB ratio. Selected sacrifice times were intended to provide a preliminary assessment of the in vivo <i>t</i><sub>1/2</sub> while providing a pharmacodynamic measurement in a system mimicking behavioral studies in which <b>5a</b> (20 mg/kg) reversed scopolamine-induced memory deficits when administered 2 h prior to behavioral training.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/medium/jm-2018-00389a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Male C57BL/6 mice (<i>N</i> = 4 per cohort) were treated with vehicle or <b>5a</b> (20 mg/kg), and at the specified time, plasma and forebrain were collected and processed as indicated. (B) At the specified time (1, 2, or 12 h), plasma (triangles) and forebrain (circles) were collected, spiked with <b>7a</b>, and extracted. Oral gavage (po) is indicated by solid lines and yellow symbols. Intraperitoneal injection (ip) is indicated by dotted lines and red symbols. Quantitation based on the ratio of the AUC of the MRM transitions for <b>5a</b> versus <b>7a</b> relative to a calibration curve. Concentrations (μM) were calculated after normalizing for tissue weight (assuming tissue/plasma density = 1). Data shown as mean ± SEM (<i>n</i> = 4) for all cohorts except 1 h ip (<i>n</i> = 3), see exclusion criteria in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. (C) Forebrains were homogenized, normalized by bradford, and analyzed for pCREB and tCREB by ELISA (V = veh, D = drug [<b>5a</b>]). The ratio of absorbance values was normalized to Veh mean = 1 for each treatment group. Data represent mean ± SEM (<i>n</i> = 4), analysis by one-way ANOVA with Tukey’s test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00389&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Assessment of brain:plasma ratio was carried out via MRM (multiple reaction monitoring) using LC-MS/MS. The forebrain and plasma samples were processed using solid-phase extraction (SPE). Furoxan <b>5a</b> was observed in all drug-treated animals, including detectable levels after 12 h (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Deuterated internal standards are desirable for absolute quantitation via LC-MS/MS because they have similar physiochemical properties to their nondeuterated analogue but may be distinguished based on molecular weight. Inclusion of <b>7a</b> allowed for absolute quantitation of <b>5a</b> in the forebrain of treated mice. Extraction methodology and tandem LC-MS/MS parameters (triple quadrupole utilizing optimized MRM transitions) were developed and validated via extraction of untreated brain tissue spiked with varying concentrations of <b>5a</b> and a fixed concentration of <b>7a</b> to develop a calibration curve. Systemic <i>t</i><sub>1/2</sub> for brain and plasma measurements was between 50 and 110 min depending on the administration route. There were no significant differences in levels of <b>5a</b> in the brain (B) versus plasma (P). Furthermore, there were no significant differences in levels in the brain for po versus ip administration, suggesting a consistent and favorable biodistribution profile with either administration route. Differences in B:P based on administration route trended toward but did not reach significance (<i>p</i> = 0.16 using unpaired <i>t</i> test) with an average oral administration B:P ratio of 1.49 (±0.52, SEM) and intraperitoneal administration average B:P ratio of 0.68 (±0.03, SEM). We anticipate <b>5a</b> accesses the brain via passive diffusion based on a low molecular weight (291.1 g/mol) and a clogP of ∼3.1, both of which are predicted to allow passive membrane permeability.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> These findings are novel for several reasons, including being the first report (1) demonstrating a furoxan crossing the blood brain barrier, (2) to our knowledge, demonstrating the first NO mimetic observed in the brain 12 h after administration (ip or po), and (3) establishing a B:P ratio for a furoxan.</div><div class="NLM_p">Given the knowledge that <b>5a</b> reverses scopolamine-induced deficits in STPA, we expected <b>5a</b> to elicit a change in CREB phosphorylation (pCREB). However, no effect on pCREB was observed for any cohorts treated with <b>5a</b> alone based on analysis by ELISA (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C). A more rigorous evaluation was performed in follow-up investigations studying hippocampal protein phosphorylation by Western blotting. Mice were treated in an identical manner to STPA studies except the animals were sacrificed at the time-point previously used for training in STPA (i.e., at the time of memory acquisition). These studies included four cohorts (<i>N</i> = 8 per cohort [with experimenters blinded to treatment]) with each receiving one ip injection 2 h prior to sacrifice (either <b>5a</b> [20 mg/kg] or vehicle) and one ip injection 30 min prior to sacrifice (either scopolamine [1 mg/kg] or vehicle). Blots for either phosphorylated protein [pProtein] or total protein [tProtein] were normalized to GAPDH loading controls prior to calculating the phosphorylation ratio as pProtein:tProtein analyzed by one-way ANOVA. Despite these efforts, statistically significant changes in hippocampal protein phosphorylation were not observed in any cohorts for pCREB:tCREB or pErk:tErk (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_002.pdf" class="ext-link">Supplementary Figure S16</a>). Importantly, we did not observe significant changes in protein phosphorylation for mice administered only scopolamine, the negative control group. Most articles utilizing acute scopolamine-induced memory deficits do not report measurements of protein phosphorylation, and those that do, agree with our findings. Indeed, acute scopolamine induces impaired learning and memory but has no effect on protein phosphorylation in normal mice (C57BL/6).<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49,50)</a> Furthermore, neither acute nor long-term administration of PDEi’s affects hippocampal pCREB in normal mice.<a onclick="showRef(event, 'ref39 ref51'); return false;" href="javascript:void(0);" class="ref ref39 ref51">(39,51)</a> Hence, our findings for furoxans are in line with literature precedent for agents acting via NO/cGMP signaling. Long-term administration (>3 weeks) of nitrates or PDEi’s to AD transgenic (AD-Tg) mice results in increases in hippocampal pCREB relative to vehicle-treated controls.<a onclick="showRef(event, 'ref10 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref12 ref13">(10,12,13)</a> Hippocampal pCREB is most appropriate as a marker of efficacy when studying long-term administration of these agents in AD transgenic mice (such as APP/PS1, 5xFAD, 3xTg).</div><div class="NLM_p last">We provide evidence for furoxan effects associated with activation of NO/cGMP signaling including (1) protection against oxidative stress, which is abolished upon blocking cGMP production with a selective sGC inhibitor, and 2) reversal of scopolamine-induced memory impairment reliably shown for NO mimetics, PDEI’s, and sGC activators. Furoxans have been extensively described as thiol-dependent NO mimetics. Our pursuit of furoxans with attenuated reactivity has resulted in the identification of efficacious furoxans that lack reactivity with generic thiols. Characterizing the reaction of an attenuated furoxan with thiol is difficult due to the lack of reactivity. The specific thiol(s) responsible for and mechanism of bioactivation is not known at present. On the basis of our data, we present two proposed scenarios: (A) a subset of yet to be identified sufficiently reactive cellular thiols attack the furoxan ring to activate NO release, or (B) efficacious furoxans described here are metabolized in a CYP-independent manner (based on activity in PC12 cells) to a yet to be identified active metabolite. In scenario B, the active metabolite would contain the intact furoxan but would have greater thiophilic reactivity. In medicinal chemistry, it is well-known that instances in which a deuterated derivative lacks efficacy of an equivalent nondeuterated molecule may be explained by a requirement for metabolic activation for efficacy (i.e., an active metabolite is responsible for efficacy). Hence, the lack of activity of the deuterated (<i>d</i><sup>4</sup><i>)</i> analogue, <b>7a</b>, provides support for the notion of an active metabolite. Additional supportive data are provided by the STPA behavioral model in which activity was observed when <b>5a</b> was administered 2 h prior to training but not 1 h. The foundational efforts described here provide a reasonable starting point for exploration of these scenarios going forward.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68754" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68754" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The neuroprotective properties of novel attenuated furoxans have been explored. The furoxan <b>5a</b> elicits a hyperbolic concentration response curve for protection against oxidative stress that is completely blocked by coincubation with ODQ, a selective sGC inhibitor, thus implicating neuroprotection resulting from a cGMP-dependent mechanism. The incorporation of a tertiary amine into the cap group provides access to pharmaceutically acceptable salts. Fortunately, the presence of the tertiary amine [calculated p<i>K</i><sub>a</sub> ∼9], which is likely charged at physiologic pH, does not hinder the ability to cross biological membranes based on levels of <b>5a</b> in the cytosolic fractions of PC12 cells and brain penetration following administration by oral gavage. Memory improvement was observed for <b>5a</b> when administered 2 h prior to training in STPA, showing statistically significant recovery of cognitive function after an induced deficit by scopolamine. Cumulatively, our data indicates that <b>5a</b> is a relatively stable attenuated (i.e, weakly reactive) NO mimetic based on (1) negligible reactivity with generic thiols at physiological pH and temperature, (2) the presence of <b>5a</b> in PC12 cells 24 h after treatment, and (3) the presence of <b>5a</b> in the brain and plasma 12 h after po and ip administration. Furthermore, we hypothesize <b>5a</b> works via a NO/cGMP/CREB-dependent mechanism based upon (1) eliminated neuroprotection upon sGC blockage, (2) a hyperbolic concentration response curve, and (3) reversal of cholinergic memory deficits in STPA. Our data suggest that free thiols alone are not capable of activating release of NO from attenuated furoxans. Identification of the protein target(s) or microenvironment(s) that facilitate bioactivation would allow for the development of a quantitative structure–activity relationship (QSAR) for analogue refinement leading to candidate nomination for IND enabling studies. Further investigation is warranted to elucidate the exact mechanism of furoxan bioactivation leading to NO release.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25701" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25701" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All chemicals and reagents were purchased from Sigma-Aldrich (St. Louis, MO) or Fisher Scientific unless stated otherwise. All protocols and procedures involving the use of animals were approved by the Institutional Animal Care and Use Committee at the University of Toledo.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> General Methods</h3><div class="NLM_p last">Reagents and solvents were purchased from common commercial suppliers (Fisher Scientific or Sigma-Aldrich) and used as received. Isotope labeled starting materials were purchased from Cambridge Isotope Laboratories. All reactions were carried out under atmospheric conditions at room temperature unless otherwise indicated. Reactions were monitored by thin-layer chromatography (TLC, LuxPlate silica gel 60 F<sub>254</sub> plates) and revealed by UV light (254 nm). Column chromatography was performed using Teledyne Combiflash R<sub>f</sub> with RediSepR<sub>f</sub> Gold columns and RediSep Rf C18 columns for tautomerization purification. HPLC analysis was performed using a Shimadzu Prominence HPLC (LCD-20AD) with temperature-controlled autosampler (SIL-20AC), refractive index (RID-20A), and PDA (SPD-M20A) detectors. LC-MS/MS analysis was carried out with a Nexera XR UPLC coupled with a Shimadzu 8050 triple quadrupole mass spectrometer (ESI, positive mode). Separations utilized a Phenomenex Kinetix core column (2.6 μm, C18, 100 Å, 100 × 4.6 mm column). HPLC conditions: mobile phase A = water (0.1% formic acid [FA]) and mobile phase B = acetonitrile (0.1% FA); 1.0 mL/min at 30% B for 1 min followed by gradient increase to 95% B over 5 min followed by 1 min at 95% B and re-equilibration at 30% B for 4 min resulting in a total run time = 10 min. UPLC-MS/MS utilized the same conditions substituting aqueous ammonium formate (25 mM, 0.1% FA) as mobile phase A and a flow rate of 0.4 mL/min. Purity of tested compounds was found to be >95% pure at two wavelengths, 254 and 282 nm, unless otherwise indicated. NMR (<sup>1</sup>H, <sup>13</sup>C) was taken using a Bruker Avance 600 MHz spectrometer (cryoprobe). High-resolution mass spectra (HRMS) were recorded using a Waters Synapt high-definition mass spectrometer (HDMS) equipped with nano-ESI source in positive mode.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Crystallography</h3><div class="NLM_p last">Furoxan <b>5a</b> was chosen for crystallographic examination. A clear, colorless, irregular prism-like specimen of C<sub>15</sub>H<sub>18</sub>FN<sub>3</sub>O<sub>2</sub>, with approximate dimensions 0.058 mm × 0.156 mm × 0.270 mm, was used for the X-ray crystallographic analysis. The X-ray intensity data were measured. The integration of the data using a monoclinic unit cell yielded a total of 26380 reflections to a maximum θ angle of 33.11° (0.65 Å resolution) of which 5531 were independent (average redundancy 4.769, completeness = 95.1%, <i>R</i><sub>int</sub> = 4.72%, <i>R</i><sub>sig</sub> = 4.02%) and 4041 (73.06%) were greater than 2σ(F2). The final cell constants of a = 11.3374(14) Å, b = 7.2234(9) Å, c = 18.825(2) Å, β = 97.601(2)°, volume = 1528.1(3) Å<sup>3</sup> are based upon the refinement of the XYZ-centroids of reflections above 20 σ(I). The final anisotropic full-matrix least-squares refinement on F2 with 255 variables converged at R1 = 5.17% for the observed data and wR2 = 14.18% for all data. The methyl group (C15) is disordered. The occupancy of the C15 atoms was refined to be 50% and then fixed. Data were refined with isotropic atomic displacement parameters; the bonded hydrogen atoms were calculated on idealized hydrogens and refined as riding atoms. The goodness-of-fit was 1.012. The largest peak in the final difference electron density synthesis was 0.487 e–/Å<sup>3</sup>, and the largest hole was −0.540 e–/Å<sup>3</sup> with an RMS deviation of 0.058 e–/Å<sup>3</sup>. On the basis of the final model, the calculated density was 1.266 g/cm<sup>3</sup> and <i>F</i>(000) of 616 e–.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Oxygen Glucose Deprivation (OGD) Neuroprotection Assay</h3><div class="NLM_p last">Viability is reported as % change relative to vehicle-treated control over at least three separate trials. Undifferentiated PC12 cells (passage 12–14) were exposed to OGD as described previously.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Briefly, 1 × 10<sup>6</sup> PC12 cells were plated overnight in growth medium (DMEM/F12 1:1 containing 5% FBS, 5% HS, penicillin/streptomycin). The medium was replaced with glucose-free buffered salt solution (HBSS phenol red medium), and the plate was placed in an anaerobic chamber under inert atmosphere (argon) for 1.5 h in a 37 °C incubator. After OGD, the glucose-free medium was removed, and fresh growth medium was added along with drug or vehicle (DMSO) treatment for 24 h at 37 °C. Cell viability was assessed by MTT dye or PrestoBlue cell viability reagent (ThermoFisher) according to the manufacturer instructions. MTT (0.5 mg/mL) was added to each well for 4 h; the medium was aspirated, and then the dye was resuspended in DMSO and read by microplate reader (absorbance, 540 nm). Alternatively, PrestoBlue (10%) was added to each well for 30 min and then read by a microplate reader (fluorescence, excitation/emission 560/590 nm).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Reactivity Analysis</h3><div class="NLM_p last">The appropriate furoxan (250 μM) or <i>N</i>-ethylmaleimide (250 μM) was incubated ±<i>N</i>-acetylcysteine (5 mM) in PBS (50 mM, pH 7.4) at 37 °C and aliquots taken at 2 and 12 h. The mixtures were analyzed by HPLC-PDA analysis according to general methods. Peak integration determined the area under the curve (AUC) from UV absorbance spectra at the λ-max of each analyte provided the relative abundance of each starting material. The results can be found in <a class="ref internalNav" href="#notes-2" aria-label="Supplemental Figures S10 and S11">Supplemental Figures S10 and S11</a>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> LC-MS/MS Study of Cell Permeability</h3><div class="NLM_p last">Because of the different in vitro activities between <b>5a</b> and its <i>d</i><sup>4</sup>-counterpart <b>7a</b>, the cellular permeability of each compound was investigated by LC-MS/MS. Briefly, 1 × 10<sup>6</sup> PC12 cells were exposed to OGD as described in the <a class="ref internalNav" href="#sec4_3" aria-label="Neuroprotection Assay">Neuroprotection Assay</a> section and treated with each analyte (25 μM) or vehicle control for 24 h. A control plate, which was not submitted to OGD, was also studied. The supernatant (1 mL) fractions were collected and stored at −80 °C until further analysis. Cells were lysed using fractionation buffers for the cytosolic fraction. To each sample was added 150 μL of buffer A (HEPES [10 mM], MgCl<sub>2</sub> [1.5 mM], KCl [10 mM], 1% NP-40, dithiothreitol [0.5 mM], phenylmethylsulfonyl fluoride [0.2 mM], sodium orthovanadate [1 mM], NaF [50 mM], sodium pyrophosphate [10 mM], protease inhibitor cocktail [Thermo]), which was then vortexed and maintained at 0 °C for 15 min. The resulting solution was centrifuged, and the supernatant was collected as cytosolic fraction. Fractions were stored at −80 °C until further analysis. Supernatant (extracellular) and cytosolic (intracellular) samples (100 μL) were diluted with 200 μL of 2% formic acid (FA) in dH<sub>2</sub>O and spiked with a corresponding internal standard (<b>7a</b> for vehicle and <b>5a</b>-treated samples; <b>5a</b> for <b>7a</b>-treated samples). Analysis was carried out as described in the UPLC-MS/MS method described in the <a class="ref internalNav" href="#sec4_1" aria-label="General Methods">General Methods</a> section. The AUCs for the MRM transitions of the analytes were integrated and normalized to their respective internal standards. The result can be found in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_002.pdf" class="ext-link">Supplemental Figure S4</a>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Step-Through Passive Avoidance</h3><div class="NLM_p last">In the early morning (within 1 h of the light “on” cycle beginning), male C57BL/6 mice were habituated in the STPA apparatus to confirm the photophobic phenotype. Translocation in <30 s was considered normal. All mice exhibited normal photophobic behavior. Mice were weighed and administered either vehicle (0.9% NaCl with 1% DMSO) or the HCl salt of <b>5a</b> (0.1, 1, 10, or 20 mg/kg) via ip injection at 60 or 120 min prior to training in STPA. Scopolamine (1 mg/kg) or vehicle (0.9% NaCl) was administered 30 min prior to training via ip injection. Mice were placed in the illuminated side of the passive avoidance apparatus (Ugo Basile), and entry into the dark chamber (monitored by sensors in the STPA apparatus) resulted in automatic closing of a vertical door and administration of a mild aversive electrical shock (0.5 mA, 3 s in duration) via electrical floor grid. The mouse was kept in the dark chamber for 30 s and then returned to the holding cage for 120 s before the second training session. In the second training, in instances when the mice did not translocate in 300 s, they were gently pushed into the dark compartment. Latency to enter the dark compartment was measured 24 h (±30 min) after initial training to determine memory retention. No shock was administered during the retention trial. Animals that did not translocate during the retention trial were assigned a retention latency of 300 s. Mice were euthenized by carbon dioxide poisoning and cervical dislocation within 24 h of retention testing completion. Notes: (1) Double trial acquisition increases the statistical power of data from STPA and decreases the requisite sample sizes from <i>n</i> = 12–14 to 7–9.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (2) In four treatment cohorts (60 min [10 mg/kg], 60 min [20 mg/kg], 120 min [1 mg/kg], and 120 min [10 mg/kg]), upon opening the dark compartment following the second training, a mouse jumped from the apparatus and landed on the floor; these mice were excluded from further analysis, hence the <i>n</i> = 8 for these groups. An oversight in experimental setup resulted in the use of vehicle containing 1% DMSO; however, it should be noted that the HCl salt of <b>5a</b> readily dissolves in saline at the concentration of these studies used.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> LC-MS/MS Method Development</h3><div class="NLM_p last">Synthesized standards of <b>5a</b> and <b>7a</b> were used to study LC-MS/MS fragmentation to provide parent to daughter ion transitions for MRM analysis as follows: <b>5a</b> (292.2 → 112.1, 292.2 → 99.1, 292.2 → 154.1) and <b>7a</b> (296.2→ 158.1, 296.2 → 116.2, 296.2 → 102.2). MRM transitions are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_002.pdf" class="ext-link">Supplemental Figures S10 and S11</a>. During method development, blank brain homogenate (100 μL each) was added to 200 μL of 2% aqueous FA spiked with a fixed concentration of <b>7a</b> (0.5 μM, final concentration based on reconstitution in 100 μL of LC-MS load solvent) and varying amounts of <b>5a</b> (0.0001, 0.001, 0.01, 0.1, 1, or 10 μM, final concentration based on reconstitution in 100 μL of LC-MS load solvent). Each mixture was vortexed briefly and applied to a solid-phase extraction resin (Evolute Express ABN cartridge; size = 30 mg/mL [Biotage]) using a Vacmaster manifold (Biotage). Cartridges were washed with dH<sub>2</sub>O (1 mL), and analytes were eluted with MeOH (1 mL) and evaporated to dryness via high flow air purge. Samples were reconstituted in 100 μL of ACN:dH<sub>2</sub>O (1:1) for LC-MS/MS analysis (injection volume of 20 μL). All samples were run in one batch, and then the entire batch was repeated. The internal standard AUC deviation was <10% for all samples. For each sample, the AUC for <b>5a</b> was divided by the intrarun TIC <b>7a</b> to provide <b>5a</b>:<b>7a</b> ratios that were averaged between the two runs and plotted against the corresponding concentrations, demonstrating appropriate linearity of <i>R</i><sup>2</sup> = 0.99. The lower limit of quantitation (LLOQ) for <b>5a</b> was <0.1 nM (signal-to-noise [S/N] to be >10:1). Determination of the exact limit of detection (LOD) and LLOQ was not required based on the presence of <b>5a</b> at high concentrations.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Bioavailability Study</h3><div class="NLM_p">C57BL/6 mice were weighed and administered the HCl salt of <b>5a</b> (20 mg/kg) via oral gavage (vehicle = sesame oil) or intraperitoneal injection (vehicle = 0.9% NaCl with 1% DMSO). Mice were returned to holding cages and monitored prior to euthenisia by carbon dioxide poisoning and cervical dislocation after 1, 2, or 12 h. No signs of lethargy or distress were noted during monitoring. Blood was collected into K<sub>2</sub>EDTA coated tubes (BD Microtainer) by cardiac puncture, flash frozen in liquid N<sub>2</sub>, and stored at −80 °C for further analysis. Each brain was removed and immediately placed on a metal dissection surface that lay atop a bed of dry ice to minimize protein degradation and two portions dissected out: (1) the forebrain (containing cerebral cortex and hippocampus) and (2) the cerebellum. Dissected out tissue was placed in a preweighed 5 mL eppendorf tube and flash frozen with liquid N<sub>2</sub> and stored at −80 °C for further analysis.</div><div class="NLM_p last">Each forebrain was placed in a 1.5 mL RINO tube (Next Advance Inc.) followed by addition of tissue extraction reagent (1 mL [Invitrogen], containing a protease/phosphatase inhibitor cocktail). The mixture was homogenized with The Bullet Blender Storm (Next Advance Inc.) for 1 min at 4 °C (speed 8) followed by centrifugation at 13000 rpm for 2 min at 4 °C. A homogenate aliquot of 100 μL was extracted, and the rest of the homogenate was stored at −80 °C for further analysis. Homogenate (100 μL) or plasma (50 μL) was added to 2% FA (200 μL, containing <b>7a</b> [0.5 μM, final concentration upon reconstitution in 100 μL] and applied to a solid-phase extraction resin (Evolute Express ABN cartridge; size = 30 mg/mL [Biotage]) using a Vacmaster manifold (Biotage). Cartridges were washed with dH<sub>2</sub>O (1 mL); analytes were eluted with MeOH (1 mL) and evaporated to dryness via high flow air purge. Samples were reconstituted in 100 μL of load solvent for LC-MS/MS analysis (injection volume of 10 μL). All samples were run in one batch, and then the entire LC batch was repeated. For each sample, the AUC for <b>5a</b> was divided by the intrarun AUC of <b>7a</b> to provide <b>5a</b>:<b>7a</b> ratios, which were averaged between the two runs. Forebrain homogenate extraction was repeated a second time, and comparison of analyte concentration from both extractions provided a strong correlation (<i>R</i><sup>2</sup> = 0.99), suggesting remarkable consistency for the solid-phase extraction method. Plasma extraction was only performed once due to the limited amount of material and the reliability shown for forebrain extractions; <i>n</i> = 4 for all PK data except the 1 h ip group. Note, for the 1 h ip group, we measured <b>5a</b> at levels 50–100× greater than any other mouse (in plasma and brain). Experimenters hypothesized potentially mistaken bladder injection. We have not investigated this outlier further. It is possible that the alkaline pH of the bladder deprotonated the piperidine ring allowing increased membrane permeability and greater distribution.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Measuring pCREB:tCREB Ratio by ELISA</h3><div class="NLM_p last">pCREB and tCREB were measured using ELISA kits purchased from Invitrogen according to the provided protocol. Briefly, protein concentrations for forebrain homogenates from the bioavailability study were analyzed by Bradford assay. Each homogenate (4 μL) was added to standard diluent buffer (96 μL) and incubated for 2 h alongside calibration curve standard solutions. Wells were washed with wash buffer (4 × 300 μL) followed by 1 h incubation with appropriate primary antibodies (CREB [pS133] detection antibody or CREB (total) detection antibody). Wells were washed with wash buffer (4 × 300 μL) followed by 30 min incubation with secondary antibody (anti-rabbit IgG HRP). Wells were washed with wash buffer (4 × 300 μL) followed by 30 min incubation with the chromogen (100 μL) and subsequent addition of the stop solution (100 μL). Absorbance was measured at 450 nm using a Biotek Synergy H2 plate reader. Levels of pCREB and tCREB were normalized to total protein concentration to provide reported pCREB:tCREB ratios. Data represent SEM with analysis by one-way ANOVA with Tukey’s test; <i>n</i> = 4.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> In Vivo Study of Protein Phosphorylation by Western Blotting</h3><div class="NLM_p last">Protein phosphorylation was measured according to previously described procedures.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> C57BL/6 mice were weighed and administered the HCl salt of <b>5a</b> (20 mg/kg) via ip injection (vehicle = 0.9% NaCl [1% DMSO]) 2 h prior to sacrifice. Scopolamine (1 mg/kg) or vehicle (0.9% NaCl) was administered 30 min prior to sacrifice via ip injection. Mice were returned to holding cages and monitored prior to euthanasia by carbon dioxide poisoning and cervical dislocation. No signs of lethargy or distress were noted during monitoring. Hippocampal tissue was dissected out and flash frozen in liquid nitrogen until transfer to −80 °C for storage. Hippocampi were homogenized with cell extraction reagent (Thermofisher) containing protease/phosphatase inhibitor cocktail and centrifuged at 13000 rpm for 5 min, and the supernatant was collected and frozen at −80 °C. Protein concentration was determined by Bradford assay, and the samples were analyzed by loading equivalent amounts of protein onto 10–20% Tris-Glycine Mini gels (Novex WedgeWell, ThermoFisher). Proteins were transferred to PVDF membranes and blocked with 5% BSA for 1 h at room temperature followed by overnight incubation at 4 °C with the following antibodies: rabbit anti-pCREB (Ser133) (1:1000, Cell Signaling), rabbit anti-CREB (1:1000, Cell Signaling), rabbit anti-p-p44/42 MAPK (ERK1/2) (Thr202/Tyr204) (1:2000, Cell Signaling), rabbit anti-p44/42 MAPK (ERK1/2) (1:1000, Cell Signaling), and rabbit anti-GAPDH (1:2000, Millipore). After washing three times with TBST (5 min/wash), membranes were incubated with secondary antibody, goat antirabbit (1:10000 in 5% milk, Jackson ImmunoResearch). Blots were imaged using Bio-Rad ChemiDoc XRS. The images were analyzed using NIH ImageJ, and the values were normalized with respect to GAPDH and expressed as the ratio of phosphorylated protein to total protein. See <a href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_002.pdf" class="ext-link">Supporting Information</a> for the detailed experimental procedure.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Synthetic Chemistry</h3><div id="sec4_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> General Reduction Procedure</h4><div class="NLM_p">The appropriate cinnamic acid (1 equiv) was dissolved in anhydrous tetrahydrofuran (THF, 20 mL) and brought to 0 °C under argon. Triethylamine (TEA, 1 equiv) was added dropwise over 2 min. After an additional 5 min, ethyl chloroformate (1 equiv) was added dropwise over 5 min to yield a white precipitate. The solution was filtered through a glass frit, and NaBH<sub>4</sub> (3.8 equiv) was added portionwise to the filtrate at 0 °C with stirring (in some instances, additional equivalents of NaBH<sub>4</sub> were added as indicated for each analogue below). Thirty min after the final NaBH<sub>4</sub> addition, the reaction was quenched with MeOH (20 mL) added over 30 min using a syringe pump, and the reaction was stirred overnight. HCl (1 N) was added dropwise over 30 min until the solution became acidic (∼30 mL). The reaction was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 50 mL), and the combined organic extracts were washed with brine (1 × 100 mL). The combined organic layers were concentrated in vacuo and purified by flash chromatography (SiO<sub>2</sub>, hexanes/ethyl acetate) to give the corresponding cinnamyl alcohols as described below.</div><div id="sec4_11_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> (<i>E</i>)-3-(4-Fluorophenyl)prop-2-en-1-ol (<b>1a</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with (<i>E</i>)-3-(4-fluorophenyl)acrylic acid (2.06 g, 12.4 mmol), TEA (1.26 g, 12.4 mmol), ethyl chloroformate (1.35 g, 12.4 mmol), and NaBH<sub>4</sub> (4.70 g, 124.2 mmol) to afford <b>1a</b> as a white solid (762 mg, 40.3%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.36–7.33 (2H, qd, <i>J</i> = 12.0 Hz), 7.03–6.99 (2H, t), 6.60–6.56 (1H, d, <i>J</i> = 16.0 Hz), 6.32–6.25 (1H, m), 4.33–4.31 (2H, d, <i>J</i> = 8.0 Hz).</div></div><div id="sec4_11_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> (<i>E</i>)-3-(4-(Trifluoromethyl)phenyl)prop-2-en-1-ol (<b>1b</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with (<i>E</i>)-3-(4-(trifluoromethyl)phenyl)acrylic acid (2.15 g, 9.25 mmol), TEA (936 mg, 9.25 mmol), ethyl chloroformate (1.00 g, 9.25 mmol), and NaBH<sub>4</sub> (1.29 g, 35.2 mmol) to afford <b>1b</b> as a white solid (1.84 g, 91.2%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.57–7.55 (2H, d, <i>J</i> = 8.0 Hz), 7.47–7.45 (2H, d, <i>J</i> = 8.0 Hz), 6.68–6.64 (1H, d, <i>J</i> = 16.0 Hz), 6.48–6.42 (1H, m), 4.37–4.35 (2H, d, <i>J</i> = 8.0 Hz).</div></div><div id="sec4_11_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> (<i>E</i>)-3-(4-Bromophenyl)prop-2-en-1-ol (<b>1c</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with (<i>E</i>)-3-(4-bromophenyl)acrylic acid (3.00 g, 13.2 mmol), TEA (1.34 g, 13.2 mmol), ethyl chloroformate (1.43 g, 13.2 mmol), and NaBH<sub>4</sub> (1.85 g, 50.2 mmol) to afford <b>1c</b> as a white solid (2.27 g, 81.6%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.44–7.42 (2H, d, <i>J</i> = 8.0 Hz), 7.25–7.23 (2H, d, <i>J</i> = 8.0 Hz), 6.57–6.53 (1H, d, <i>J</i> = 16.0 Hz), 6.38–6.31 (1H, m), 4.32–4.30 (2H, d, <i>J</i> = 8 Hz).</div></div><div id="sec4_11_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> (<i>E</i>)-3-(4-(Difluoromethoxy)phenyl)prop-2-en-1-ol (<b>1d</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with (<i>E</i>)-3-(4-(difluoromethoxy)phenyl)acrylic acid (1.14 g, 5.32 mmol), TEA (540 mg, 5.32 mmol), ethyl chloroformate (579 mg, 5.32 mmol), and NaBH<sub>4</sub> (2.24 g, 60.7 mmol) to afford <b>1d</b> as a white solid (923 mg, 86.3%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.34–7.32 (2H, d, <i>J</i> = 8.0 Hz), 7.05–7.03 (2H, d, <i>J</i> = 8.0 Hz), 6.68–6.49 (2H, m), 6.32–6.25 (1H, m), 4.31–4.30 (2H, d, <i>J</i> = 4.0 Hz).</div></div><div id="sec4_11_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> (<i>E</i>)-3-(4-Methoxyphenyl)prop-2-en-1-ol (<b>1e</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with (<i>E</i>)-3-(4-methoxyphenyl)acrylic acid (3.00 g, 16.8 mmol), TEA (1.70 g, 16.8 mmol), ethyl chloroformate (1.83 g, 16.8 mmol), and NaBH<sub>4</sub> (4.46 g, 118 mmol) to afford <b>1e</b> as a white solid (1.95 g, 70.7%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.37–7.35 (2H, d, <i>J</i> = 8.0 Hz), 6.90–6.88 (2H, d, <i>J</i> = 8.0 Hz), 6.52–6.48 (1H, d, <i>J</i> = 16.0 Hz), 6.26–6.19 (1H, m), 4.11–4.10 (2H, d, <i>J</i> = 4.0 Hz), 3.75 (3H, s).</div></div><div id="sec4_11_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> (<i>E</i>)-3-(<i>p</i>-Tolyl)prop-2-en-1-ol (<b>1f</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with (<i>E</i>)-3-(<i>p</i>-tolyl)acrylic acid (3.04 g, 18.7 mmol), TEA (1.90 g, 18.7 mmol), ethyl chloroformate (2.03 g, 18.7 mmol), and NaBH<sub>4</sub> (2.69 g, 71.2 mmol) to afford <b>1f</b> as a white solid (1.57 g, 56.5%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.28–7.26 (2H, d, <i>J</i> = 8.0 Hz), 7.13–7.11 (2H, d, <i>J</i> = 8.0 Hz), 6.59–6.55 (1H, d, <i>J</i> = 16.0 Hz), 6.34–6.27 (1H, m), 4.30–4.28 (2H, d, <i>J</i> = 8.0 Hz), 2.33 (1H, s).</div></div><div id="sec4_11_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> (<i>E</i>)-3-(4-Chlorophenyl)prop-2-en-1-ol (<b>1g</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with (<i>E</i>)-3-(4-chlorophenyl)acrylic acid (2.00 g, 11.0 mmol), TEA (1.11 g, 11.0 mmol), ethyl chloroformate (1.19 g, 11.0 mmol), and NaBH<sub>4</sub> (1.57 g, 41.6 mmol) to afford <b>1g</b> as a white solid (1.30 g, 70.6%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.31–7.26 (4H, d, <i>J</i> = 8.0 Hz), 6.58–6.54 (1H, d, <i>J</i> = 16.0 Hz), 6.36–6.30 (1H, m), 4.32–4.31 (2H, d, <i>J</i> = 4.0 Hz).</div></div><div id="sec4_11_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> (<i>E</i>)-3-Phenylprop-2-en-1-ol (<b>1h</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with (<i>E</i>)-3-phenylprop-2-enoic acid (2.00 g, 13.5 mmol), TEA (1.50 g, 14.9 mmol), and ethyl chloroformate (1.61 g, 14.9 mmol) to afford <b>1h</b> as a white solid (1.46 g, 80.5%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.42–7.41 (2H, d, <i>J</i> = 4.0 Hz), 7.36–7.34 (2H, t), 7.29–7.28 (1H, t), 6.66–6.63 (1H, d, <i>J</i> = 12.0 Hz), 6.42–6.38 (1H, m), 4.36–4.35 (2H, d, <i>J</i> = 4.0 Hz).</div></div></div><div id="sec4_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> General Cyclization Procedure</h4><div class="NLM_p">The appropriate cinnamyl alcohol (1 equiv) was dissolved in AcOH:DMF (1:1) and brought to 0 °C under argon. Sodium nitrite (10 equiv) was then added. The reaction was stirred for 1 h at 0 °C. The reaction mixture was heated at 40 °C; sodium nitrite was added (5 equiv), and the mixture was heated to 80 °C over 1.5 h. The reaction was diluted with ice water (100 mL) and extracted with EA (3 × 50 mL). Combined organic layers were washed with brine (1 × 100 mL), and the organic layer was concentrated by rotary evaporation. The combined organic layers were concentrated in vacuo and purified by flash chromatography (SiO<sub>2</sub>, hexanes/ethyl acetate) to give the corresponding furoxan as indicated below.</div><div id="sec4_11_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 4-(4-Fluorophenyl)-3-(hydroxymethyl)-1,2,5-oxadiazole 2-Oxide (<b>2a</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>1a</b> (762 mg, 5.01 mmol) and NaNO<sub>2</sub> (5.19 g, 75.2 mmol) to afford <b>2a</b> as a yellow solid (278 mg, 26.4%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.92–7.88 (2H, qd, <i>J</i> = 16.0 Hz), 7.31–7.29 (2H, t), 4.78 (2H, s).</div></div><div id="sec4_11_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 3-(Hydroxymethyl)-4-(4-(trifluoromethyl)phenyl)-1,2,5-oxadiazole 2-Oxide (<b>2b</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>1b</b> (1.51 g, 7.47 mmol) and NaNO<sub>2</sub> (5.15 g, 74.7 mmol) to afford <b>2b</b> as a yellow solid (699 mg, 36.0%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.24–8.22 (2H, d, <i>J</i> = 8.0 Hz), 8.02–8.00 (2H, d, <i>J</i> = 8.0 Hz), 4.76–4.72 (2H, d, <i>J</i> = 16.0 Hz), 4.01 (1H, s).</div></div><div id="sec4_11_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 4-(4-Bromophenyl)-3-(hydroxymethyl)-1,2,5-oxadiazole 2-Oxide (<b>2c</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>1c</b> (1.11 g, 5.21 mmol) and NaNO<sub>2</sub> (5.39 g, 78.1 mmol) to afford <b>2c</b> as a reddish-brown solid (993 mg, 70.4%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.96–7.95 (2H, d, <i>J</i> = 4.0 Hz), 7.85–7.80 (2H, d, <i>J</i> = 20.0 Hz), 4.65 (2H, s).</div></div><div id="sec4_11_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 4-(4-(Difluoromethoxy)phenyl)-3-(hydroxymethyl)-1,2,5-oxadiazole 2-Oxide (<b>2d</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>1d</b> (923 mg, 4.61 mmol) and NaNO<sub>2</sub> (2.47 g, 35.8 mmol) to afford <b>2d</b> as a yellow solid (306 mg, 25.7%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.88–7.86 (2H, d, <i>J</i> = 8.0 Hz), 7.30–7.28 (2H, d, <i>J</i> = 8.0 Hz), 6.80–6.43 (1H, m), 4.73 (2H, s).</div></div><div id="sec4_11_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 3-(Hydroxymethyl)-4-(4-methoxyphenyl)-1,2,5-oxadiazole 2-Oxide (<b>2e</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>1e</b> (1.88 g, 11.5 mmol) and NaNO<sub>2</sub> (7.89 g, 114 mmol) to afford <b>2e</b> as a yellow solid (523 mg, 20.6%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.92–7.90 (2H, d, <i>J</i> = 8.0 Hz), 7.21–7.19 (2H, d, <i>J</i> = 8.0 Hz), 6.03 (1H, s), 4.57 (2H, s), 3.89 (1H, s).</div></div><div id="sec4_11_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 3-(Hydroxymethyl)-4-(<i>p</i>-tolyl)-1,2,5-oxadiazole 2-Oxide (<b>2f</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>1f</b> (2.28 g, 15.2 mmol) and NaNO<sub>2</sub> (10.6 g, 154 mmol) to afford <b>2f</b> as a yellow solid (687 mg, 21.7%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.69–7.68 (2H, d, <i>J</i> = 4.0 Hz), 7.33–7.31 (2H, d, <i>J</i> = 8.0 Hz), 4.7 (2H, s), 2.47–2.36 (4H, qd).</div></div><div id="sec4_11_2_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 4-(4-Chlorophenyl)-3-(hydroxymethyl)-1,2,5-oxadiazole 2-Oxide (<b>2g</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>1g</b> (1.67 g, 9.90 mmol) and NaNO<sub>2</sub> (13.7 g, 198 mmol) to afford <b>2g</b> as a yellow solid (495 mg, 22.1%). <sup>1</sup>H NMR (CDCl3, 400 MHz): δ 7.81–7.79 (2H, d, <i>J</i> = 8.0 Hz), 7.53–7.51 (2H, d, <i>J</i> = 8.0 Hz), 4.72 (2H, s).</div></div><div id="sec4_11_2_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 3-(Hydroxymethyl)-4-phenyl-1,2,5-oxadiazole 2-Oxide (<b>2h</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>1h</b> (1.00 g, 7.45 mmol) and NaNO<sub>2</sub> (5.14 g, 74.5 mmol) to afford <b>2h</b> as a yellow solid (727 mg, 50.9%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.81–7.80 (2H, m), 7.59–7.56 (3H, m), 4.75 (2H, s).</div></div></div><div id="sec4_11_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> General Bromination Procedure</h4><div class="NLM_p">The appropriate furoxan (1 equiv) was dissolved in anhydrous CH<sub>2</sub>Cl<sub>2</sub> at 0 °C under argon. PPh<sub>3</sub> (1.2 equiv) was added in one portion. The reaction was stirred for 15 min followed by addition of CBr<sub>4</sub> (1.2 equiv). The ice bath was removed, and reaction was maintained at room temp for 2 h. The combined organic layers were concentrated in vacuo and purified by flash chromatography (SiO<sub>2</sub>, hexanes/ethyl acetate) to give the corresponding furoxans.</div><div id="sec4_11_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> 3-(Bromomethyl)-4-(4-fluorophenyl)-1,2,5-oxadiazole 2-Oxide (<b>3a</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>2a</b> (408 mg, 2.12 mmol), PPh<sub>3</sub> (668 mg, 2.55 mmol), and CBr<sub>4</sub> (844 mg, 2.55 mmol) to afford <b>3a</b> as a yellow solid (306 mg, 57.8%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.83–7.79 (2H, qd), 7.31–7.29 (2H, t), 4.40 (2H, s).</div></div><div id="sec4_11_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 3-(Bromomethyl)-4-(4-(trifluoromethyl)phenyl)-1,2,5-oxadiazole 2-Oxide (<b>3b</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>2b</b> (877 mg, 3.37 mmol), PPh<sub>3</sub> (1.06 g, 4.05 mmol), and CBr<sub>4</sub> (1.34 g, 4.05 mmol) to afford <b>3b</b> as a yellow solid (366 mg, 33.6%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.98–7.96 (2H, d, <i>J</i> = 8.0 Hz), 7.88–7.86 (2H, d, <i>J</i> = 8.0 Hz), 4.45 (2H, s).</div></div><div id="sec4_11_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 3-(Bromomethyl)-4-(4-bromophenyl)-1,2,5-oxadiazole 2-Oxide (<b>3c</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>2c</b> (772 mg, 2.85 mmol), PPh<sub>3</sub> (897 mg, 3.42 mmol), and CBr<sub>4</sub> (1.13 g, 3.42 mmol) to afford <b>3c</b> as a yellow solid (554 mg, 58.3%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.79–7.76 (2H, m), 7.60–7.57 (2H, m), 4.39 (2H, s).</div></div><div id="sec4_11_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> 3-(Bromomethyl)-4-(4-(difluoromethoxy)phenyl)-1,2,5-oxadiazole 2-Oxide (<b>3d</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>2d</b> (306 mg, 1.19 mmol), PPh<sub>3</sub> (373 mg, 1.42 mmol), and CBr<sub>4</sub> (579 mg, 1.42 mmol) to afford <b>3d</b> as a white solid oil (334 mg, 81.0%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.81–7.79 (2H, d, <i>J</i> = 8.0 Hz), 7.33–7.31 (2H, d, <i>J</i> = 8.0 Hz), 6.80–6.44 (1H, m), 4.38 (2H, s).</div></div><div id="sec4_11_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> 3-(Bromomethyl)-4-(4-methoxyphenyl)-1,2,5-oxadiazole 2-Oxide (<b>3e</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>2e</b> (523 mg, 2.35 mmol), PPh<sub>3</sub> (1.00 g, 3.81 mmol), and CBr<sub>4</sub> (1.26 g, 3.81 mmol) to afford <b>3e</b> as a yellow oil (578 mg, 86.1%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.76–7.74 (2H, d, <i>J</i> = 8.0 Hz), 7.11–7.09 (2H, d, <i>J</i> = 8.0 Hz), 4.42 (2H, s), 3.91 (3H, s).</div></div><div id="sec4_11_3_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> 3-(Bromomethyl)-4-(<i>p</i>-tolyl)-1,2,5-oxadiazole 2-Oxide (<b>3f</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>2f</b> (650 mg, 3.15 mmol), PPh<sub>3</sub> (992 mg, 3.78 mmol), and CBr<sub>4</sub> (1.25 g, 3.78 mmol) to afford <b>3f</b> as a white solid (605 mg, 71.3%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.69–7.67 (2H, d, <i>J</i> = 8.0 Hz), 7.40–7.38 (2H, d, <i>J</i> = 8.0 Hz), 4.40 (2H, s), 2.46 (3H, s).</div></div><div id="sec4_11_3_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> 3-(Bromomethyl)-4-(4-chlorophenyl)-1,2,5-oxadiazole 2-Oxide (<b>3g</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>2g</b> (711 mg, 3.14 mmol), PPh<sub>3</sub> (988 mg, 3.76 mmol), and CBr<sub>4</sub> (1.25 g, 3.76 mmol) to afford <b>3g</b> as a yellow oil (477 mg, 52.5%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.77–7.75 (2H, d, <i>J</i> = 8.0 Hz), 7.59–7.57 (2H, d, <i>J</i> = 8.0 Hz), 4.40 (2H, s).</div></div><div id="sec4_11_3_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> 3-(Bromomethyl)-4-phenyl-1,2,5-oxadiazole 2-Oxide (<b>3h</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>2h</b> (303 mg, 1.58 mmol), PPh<sub>3</sub> (496 mg, 1.89 mmol), and CBr<sub>4</sub> (627 mg, 1.89 mmol) to afford <b>3h</b> as a yellow solid (230 mg, 57.3%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.80–7.78 (2H, m), 7.60–7.57 (3H, m), 4.41 (2H, s).</div></div></div><div id="sec4_11_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> General Substitution Procedure</h4><div class="NLM_p">The appropriate furoxan (1 equiv) was dissolved in either dichloromethane (CH<sub>2</sub>Cl<sub>2</sub>) or dimethylformaldyhide (DMF) (solvent used is specified for each compound below) under argon and placed at either 50 °C (for reactions in CH<sub>2</sub>Cl<sub>2</sub>) or 100 °C (for reactions in DMF). 4-Methylpiperidine (1.1 equiv) was added neat in one portion immediately followed by addition of base (1.1 equiv) in one portion (triethylamine [TEA] or K<sub>2</sub>CO<sub>3</sub>, as specified for each compound below). The reaction mixture was concentrated in vacuo and purified by flash chromatography (SiO<sub>2</sub>, hexanes/ethyl acetate) to give the corresponding furoxans as indicated below. Note: using TEA as the base gave the best reaction yields.</div><div id="sec4_11_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> 4-(4-Fluorophenyl)-3-((4-methylpiperidin-1-yl)methyl)-1,2,5-oxadiazole 2-Oxide (<b>4a</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>3a</b> (1.60 g, 5.86 mmol) was dissolved in DMF (20 mL) at 50 °C, K<sub>2</sub>CO<sub>3</sub> (972 mg, 7.03 mmol), and 4-methylpiperidine (697 mg, 7.03 mmol) to afford <b>4a</b> as yellow oil (1.57 g, 91.5%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.11–8.07 (2H, m), 7.23–7.18 (2H, m), 3.47 (2H, s), 2.83–2.80 (2H, d, <i>J</i> = 12.0 Hz), 2.22–2.15 (2H, t), 1.67–1.64 (2H, d, <i>J</i> = 12.0 Hz), 1.40 (1H, m), 1.26–1.19 (2H, m), 0.94–0.93 (3H, d, <i>J</i> = 4.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 165.7, 163.2, 156.8, 130.5, 123.4–123.3, 116.4–116.1, 53.7, 50.5, 34.2, 30.4, 21.7. Measured purity at 254 nm: 96.6%; 282 nm: 96.0%. HRMS: calcd for (C<sub>15</sub>H<sub>18</sub>FN<sub>3</sub>O<sub>2</sub>): 291.1383; found 292.1458 (M + H<sup>+</sup>).</div></div><div id="sec4_11_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> 3-((4-Methylpiperidin-1-yl)methyl)-4-(4-trifluoromethyl)phenyl)-1,2,5-oxadiazole 2-Oxide (<b>4b</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>3b</b> (300 mg, 0.93 mmol) dissolved in DMF (2 mL) and heated to 100 °C and then K<sub>2</sub>CO<sub>3</sub> (141 mg, 1.02 mmol) and 4-methylpiperidine (101 mg, 1.02 mmol) to afford <b>4b</b> as white, crystalline solid (240 mg, 75.7%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.26–8.24 (2H, d, <i>J</i> = 8.0 Hz), 7.80–7.78 (2H, d, <i>J</i> = 8.0 Hz), 3.49 (2H, s), 2.83–2.80 (2H, d, <i>J</i> = 12.0 Hz), 2.23–2.17 (2H, m), 1.68–1.65 (2H, d, <i>J</i> = 12.0 Hz), 1.42–1.40 (1H, m), 1.25–1.18 (2H, m), 0.96–0.93 (3H, m). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 156.6, 132.9–132.7, 130.5, 128.7, 126.1–126.0, 124.6, 122.8, 53.7, 50.5, 34.2, 30.3, 21.7. Measured purity at 254 nm: 97.2%; 282 nm: 92.2%. Mp 88–89 °C. HRMS: calcd for (C<sub>16</sub>H<sub>18</sub>F<sub>3</sub>N<sub>3</sub>O<sub>2</sub>): 341.1351; found 342.1429 (M + H<sup>+</sup>).</div></div><div id="sec4_11_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> 4-(4-Bromophenyl)-3-((4-methylpiperidin-1-yl)methyl)-1,2,5-oxadiazole 2-Oxide (<b>4c</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>3c</b> (300 mg, 0.90 mmol) dissolved in DMF (2 mL) and heated to 100 °C and then K<sub>2</sub>CO<sub>3</sub> (137 mg, 0.99 mmol) and 4-methylpiperidine (98.0 mg, 0.99 mmol) to afford <b>4c</b> as a white solid (178 mg, 56.1%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.98–7.95 (2H, m), 7.67–7.64 (2H, m), 3.46 (2H, s), 2.81–2.78 (2H, d, <i>J</i> = 12.0 Hz), 2.21–2.15 (2H, m), 1.66–1.63 (2H, d, <i>J</i> = 12.0 Hz), 1.42–1.38 (1H, m), 1.22–1.15 (2H, m), 0.94–0.92 (3H, d, <i>J</i> = 8.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 156.9, 132.4, 129.8, 126.0–125.8, 112.9, 53.7, 50.5, 34.2, 30.3, 21.8. Measured purity at 254 nm: 98.7%; 282 nm: 98.4%. Mp 84–85 °C. HRMS: calcd for (C<sub>15</sub>H<sub>18</sub>BrN<sub>3</sub>O<sub>2</sub>): 351.0582; found 352.0662 (M + H<sup>+</sup>).</div></div><div id="sec4_11_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> 4-(4-(Difluoromethoxy)phenyl)-3-((4-methylpiperidin-1-yl)methyl)-1,2,5-oxadiazole 2-Oxide (<b>4d</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>3d</b> (270 mg, 0.84 mmol) in DMF (2 mL) heated to 100 °C and then K<sub>2</sub>CO<sub>3</sub> (139 mg, 1.01 mmol) and 4-methylpiperidine (100 mg, 1.01 mmol) to afford <b>4d</b> as a yellow solid (235 mg, 82%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.12–8.10 (2H, d, <i>J</i> = 8.0 Hz), 7.27–7.25 (2H, d, <i>J</i> = 8.0 Hz), 6.79–6.43 (1H, m), 3.47 (2H, s), 2.82–2.79 (2H, d, <i>J</i> = 12.0 Hz), 2.21–2.16 (2H, t), 1.67–1.64 (2H, d, <i>J</i> = 12.0 Hz), 1.42–1.39 (2H, m), 1.26–1.16 (2H, m), 0.94–0.93 (3H, d, <i>J</i> = 8.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 156.8, 153.1, 130.1, 124.1, 119.8, 117.2, 115.5, 113.7, 113.0, 53.8, 50.5, 34.2, 30.3, 21.7. Measured purity at 254 nm: 95.9%; 282 nm: 97.9%. Mp 48–49 °C. HRMS: calcd for (C<sub>16</sub>H<sub>19</sub>F<sub>2</sub>N<sub>3</sub>O<sub>3</sub>): 339.1394; found 340.1464 (M + H<sup>+</sup>).</div></div><div id="sec4_11_4_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> 4-(4-Methoxyphenyl)-3-((4-methylpiperdin-1-yl)methyl)-1,2,5-oxadiazole 2-Oxide (<b>4e</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>3e</b> (550 mg, 1.93 mmol) in DMF (5 mL) heated to 70 °C and then K<sub>2</sub>CO<sub>3</sub> (497 mg, 3.60 mmol) and 4-methylpiperidine (357 mg, 3.60 mmol) to afford <b>4e</b> as a white solid (563 mg, 96.2%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.91–7.89 (2H, d, <i>J</i> = 8.0 Hz), 6.94–6.92 (2H, d, <i>J</i> = 8.0 Hz), 3.79 (3H, s), 3.39 (2H, s), 2.74–2.71 (2H, d, <i>J</i> = 12.0 Hz), 2.11–2.06 (2H, t), 1.57–1.54 (2H, d, <i>J</i> = 12.0 Hz), 1.32–1.29 (2H, m), 1.17–1.12 (2H, m), 0.85–0.83 (3H, d, <i>J</i> = 8.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 161.8, 157.5, 129.8, 199.4, 114.5, 133.2, 55.4, 53.7, 50.5, 34.2, 30.4, 21.8. Measured purity at 254 nm: 99.1%;, 282 nm: 97.4%. Mp 67–68 °C. HRMS: calcd for (C<sub>16</sub>H<sub>21</sub>N<sub>3</sub>O<sub>3</sub>): 303.1583; found 304.1653 (M + H<sup>+</sup>).</div></div><div id="sec4_11_4_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> 3-((4-Methylpiperdin-1-yl)methyl)-4-(<i>p</i>-tolyl)-1,2,5-oxadiazole 2-Oxide (<b>4f</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>3f</b> (178 mg, 0.66 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) and carried out at room temperature with TEA (201 mg, 1.98 mmol) and 4-methylpiperidine (66 mg, 0.66 mmol) to afford <b>4f</b> as a white solid (141 mg, 74.4%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.95–7.94 (2H, d, <i>J</i> = 4.0 Hz), 7.35–7.34 (2H, d, <i>J</i> = 4.0 Hz), 3.5 (2H, s), 2.84–2.82 (2H, d, <i>J</i> = 8.0 Hz), 2.46–2.44 (3H, s), 2.21–2.17 (2H, m), 1.67–1.65 (2H, d, <i>J</i> = 8.0 Hz), 1.41–1.26 (1H, s), 1.24–1.20 (2H, m), 0.95–0.94 (3H, d, <i>J</i> = 4.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 157.8, 141.4, 129.8, 128.1, 124.2, 113.3, 53.7, 50.5, 34.2, 30.4, 21.8–21.5. Measured purity at 254 nm: 98.5%; 282 nm: 97.5%. Mp 72–73 °C. HRMS: calcd for (C<sub>16</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub>): 287.1634; found 288.1712 (M + H<sup>+</sup>).</div></div><div id="sec4_11_4_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> 4-(4-Chlorophenyl)-3-((4-methylpiperidin-1-yl)methyl)-1,2,5-oxadiazole 2-Oxide (<b>4g</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>3g</b> (476 mg, 1.64 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1.5 mL) heated to 35 °C and with TEA (499 mg, 4.93 mmol) and 4-methylpiperidine (196 mg, 1.97 mmol) to afford <b>4g</b> as pale yellow solid (400 mg, 79.1%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.15–8.13 (2H, d, <i>J</i> = 8.0 Hz), 7.61–7.59 (2H, d, <i>J</i> = 8.0 Hz), 3.52 (2H, s), 2.91–2.88 (2H, d, <i>J</i> = 12.0 Hz), 2.31–2.26 (2H, m), 1.76–1.73 (2H, d, <i>J</i> = 12.0 Hz), 1.35–1.28 (1H, m), 1.04–1.02 (3H, d, <i>J</i> = 8.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 156.8, 137.4, 129.6, 129.4, 125.5, 113.0, 53.7, 50.5, 34.2, 30.3, 21.7. Measured purity at 254 nm: 99.7%; 282 nm: 99.9%. Mp 67–68 °C. HRMS: calcd for (C<sub>15</sub>H<sub>18</sub>ClN<sub>3</sub>O<sub>2</sub>): 307.1088; found 308.1161 (M + H<sup>+</sup>).</div></div><div id="sec4_11_4_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> 3-((4-Methylpiperidin-1-yl)methyl)-4-phenyl-1,2,5-oxadiaozle 2-Oxide (<b>4h</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>3h</b> (245 mg, 0.96 mmol) in DMF [20 mL] heated to 100 °C and with K<sub>2</sub>CO<sub>3</sub> (146 mg, 1.06 mmol) and 4-methylpiperidine (105 mg, 1.06 mmol) to afford <b>4h</b> as a white solid (198 mg, 75.4%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.04–8.02 (2H, d, <i>J</i> = 8.0 Hz), 7.54–7.52 (2H, d, <i>J</i> = 8.0 Hz), 3.48 (2H, s), 2.82–2.79 (2H, d, <i>J</i> = 12.0 Hz), 2.20–2.14 (2H, m), 1.65–1.62 (2H, d, <i>J</i> = 12.0 Hz), 1.39–1.37 (2H, m), 1.25–1.12 (2H, m), 0.93–0.91 (3H, d, <i>J</i> = 8.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 157.7, 131.0, 129.0, 128.4, 128.2, 127.1, 113.1, 53.6, 50.5, 34.2, 30.3, 21.7. Measured purity at 254 nm: 98.6%; 282 nm: 98.6%. Mp 62–63 °C. HRMS: calcd for (C<sub>15</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub>): 273.1477; found 274.1565 (M + H<sup>+</sup>).</div></div></div><div id="sec4_11_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> General Tautomerization Procedure</h4><div class="NLM_p">The appropriate furoxan was dissolved in toluene (15 mL) and refluxed for 7 days under argon. The resulting tautomeric mixture was purified using reverse-phase column chromatography (mobile phase: 25 mM ammonia formate, 0.1% formic acid: methanol, 0.1% formic acid). Yields are reported as “isolated yield”, which possessed the desired purity for biological testing.</div><div id="sec4_11_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> 3-(4-Fluorophenyl)-4-((4-methylpiperidin-1-yl)methyl)-1,2,5-oxadiaozle 2-Oxide (<b>5a</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>4a</b> (1.56 g, 5.35 mmol) to afford <b>5a</b> as a white crystalline solid (isolated yield = 556.0 mg, 35.6%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.23–8.19 (2H, m), 7.26–7.18 (2H, m), 3.55 (2H, s), 2.94–2.92 (2H, d, <i>J</i> = 8.0 Hz), 2.20–2.14 (2H, t), 1.69–1.66 (2H, d, <i>J</i> = 12.0 Hz), 1.57 (1H, s), 1.44–1.42 (2H, m), 1.25–1.20 (2H, m), 0.95–0.93 (3H, d, <i>J</i> = 8.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 164.4, 162.7, 154.5, 130.6, 130.5, 119.3–119.2, 116.2, 116.0, 115.0, 53.6, 53.5, 34.2, 30.5, 21.8. Measured purity at 254 nm: 95.6%; 282 nm: 98.5%. Free base, mp 55 °C. HCl salt, mp 167–168 °C. HRMS: calcd for (C<sub>15</sub>H<sub>18</sub>FN<sub>3</sub>O<sub>2</sub>): 291.1383; found 292.1468 (M + H<sup>+</sup>).</div></div><div id="sec4_11_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> 4-((4-Methylpiperdin-1-yl)methyl)-3-(4-(trifluoromethyl)phenyl)-1,2,5-oxadiazole 2-Oxide (<b>5b</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>4b</b> (100 mg, 0.29 mmol) to afford <b>5b</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.39–8.37 (2H, d, <i>J</i> = 8.0 Hz), 7.80–7.79 (2H, d, <i>J</i> = 4.0 Hz), 3.60 (2H, s), 2.97–2.95 (2H, d, <i>J</i> = 8.0 Hz), 1.72–1.70 (2H, d, <i>J</i> = 8.0 Hz), 1.46–1.45 (1H, m), 1.28–1.20 (3H, m), 0.97–0.96 (2H, d, <i>J</i> = 4.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 154.4, 128.5, 125.8, 125.7 (2C), 114.8, 53.6, 53.5, 34.2, 30.5, 21.7. Measured purity at 254 nm: 91.7%; 282 nm: 97.7%. Mp 78–79 °C. HRMS: calcd for (C<sub>16</sub>H<sub>18</sub>F<sub>3</sub>N<sub>3</sub>O<sub>2</sub>): 341.1351; found 342.1431 (M + H<sup>+</sup>).</div></div><div id="sec4_11_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> 3-(4-Bromophenyl)-4-((4-methylpiperdin-1-yl)methyl)-1,2,5-oxadiazole 2-Oxide (<b>5c</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>4c</b> (100 mg, 0.28 mmol) to afford <b>5c</b> as a white crystalline solid (isolated yield = 25.0 mg, 25.0%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.13–8.11 (2H, d, <i>J</i> = 8.0 Hz), 7.68–7.67 (2H, d, <i>J</i> = 8.0 Hz), 3.57 (2H, s), 2.95–2.94 (2H, d, <i>J</i> = 4.0 Hz), 2.21–2.17 (2H, t), 1.71–1.69 (2H, d, <i>J</i> = 8.0 Hz), 1.46–1.44 (1H, m), 1.28–1.19 (2H, m), 0.97–0.96 (3H, d, <i>J</i> = 4.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 154.4, 132.2, 129.7, 124.9, 122.2, 115.2, 53.6–53.5, 34.2, 30.5, 21.8. Measured purity at 254 nm: 95.0%; 282 nm: 96.8%. Mp 68–69 °C. HRMS: calcd for (C<sub>15</sub>H<sub>18</sub>BrN<sub>3</sub>O<sub>2</sub>): 351.0582; found 352.0664 (M + H<sup>+</sup>).</div></div><div id="sec4_11_5_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> 3-(4-(Difluoromethoxy)phenyl)-4-((4-methylpiperidin-1-yl)methyl)-1,2,5-oxadiazole 2-Oxide (<b>5d</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>4d</b> (235.0 mg, 0.69 mmol) to afford <b>5d</b> as a white crystalline solid (isolated yield = 78.0 mg, 33.2%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.24–8.22 (2H, d, <i>J</i> = 8.0 Hz), 7.26–7.24 (2H, d, <i>J</i> = 8.0 Hz), 6.78–6.41 (1H, t), 3.55 (2H, s), 2.95–2.92 (2H, d, <i>J</i> = 12.0 Hz), 2.20–2.15 (2H, t), 1.69–1.66 (2H, d, <i>J</i> = 12.0), 1.57 (2H, s), 1.25–1.20 (2H, m), 0.95–0.94 (3H, d, <i>J</i> = 4.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 154.5, 152.3, 130.1, 120.3, 119.6, 117.2, 115.5, 115.0, 113.7, 53.6–53.5, 34.2, 30.5, 21.8. Measured purity at 254 nm: 93.6%; 282 nm: 96.9%. Mp 56–57 °C. HRMS: calcd for (C<sub>16</sub>H<sub>19</sub>F<sub>2</sub>N<sub>3</sub>O<sub>3</sub>): 339.1394; found 340.1764 (M + H<sup>+</sup>).</div></div><div id="sec4_11_5_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> 3-(4-Methoxyphenyl)-4-((methylpiperidin-1-yl)methyl)-1,2,5-oxadiazole 2-Oxide (<b>5e</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>4e</b> (250.0 mg, 0.82 mmol) to afford <b>5e</b> as a white crystalline solid (isolated yield = 130.0 mg, 52.0%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.12–8.10 (2H, d, <i>J</i> = 8.0 Hz), 7.03–7.01 (2H, d, <i>J</i> = 8.0 Hz), 3.87 (3H, s), 3.54 (2H, s), 2.96–2.93 (2H, d, <i>J</i> = 12.0 Hz), 2.19–2.13 (2H, t), 1.69–1.66 (2H, d, <i>J</i> = 12.0 Hz), 1.43–1.41 (2H, m), 1.28–1.18 (2H, m), 0.95–0.93 (3H, d, <i>J</i> = 8.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 161.0, 154.6, 129.8, 115.6, 115.2, 114.3, 55.4, 53.6–53.5, 34.2, 30.6, 21.8. Measured purity at 254 nm: 99.8%; 282 nm: 99.2%. Mp 54–55 °C. HRMS: calcd for (C<sub>16</sub>H<sub>21</sub>N<sub>3</sub>O<sub>3</sub>): 303.1583; found 304.1662 (M + H<sup>+</sup>).</div></div><div id="sec4_11_5_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> 4-((4-Methylpiperdin-1-yl)methyl)-3-(<i>p</i>-tolyl)-1,2,5-oxadiazole 2-Oxide (<b>5f</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>4f</b> (119.0 mg, 0.41 mmol) to afford <b>5f</b> as a white crystalline solid (isolated yield = 12.4 mg, 10.4%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.03–8.02 (2H, d, <i>J</i> = 4.0 Hz), 7.33–7.32 (2H, d, <i>J</i> = 4.0 Hz), 3.55 (2H, s), 2.96–2.94 (2H, d, <i>J</i> = 8.0 Hz), 2.42 (3H, s), 2.18–2.14 (2H, t), 1.68–1.66 (2H, d, <i>J</i> = 8.0 Hz), 1.42 (1H, s), 1.26–1.20 (2H, m), 0.95–0.94 (3H, d, <i>J</i> = 4.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 154.7, 140.7, 129.6, 128.1, 120.2, 115.7, 53.6, 53.5, 34.2, 30.5, 21.8, 21.5. Measured purity at 254 nm: 98.9%; 282 nm: 99.7%. Mp 77–78 °C. HRMS: calcd for (C<sub>16</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub>): 287.1634; found 288.1712 (M + H<sup>+</sup>).</div></div><div id="sec4_11_5_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> 3-(4-Chlorophenyl)-4-((4-methylpiperidin-1-yl)methyl)-1,2,5-oxadiazole 2-Oxide (<b>5g</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>4g</b> (338.4 mg, 1.10 mmol) to afford <b>4g</b> as a pale, yellow solid (isolated yield = 28.9 mg, 8.9%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.18–8.17 (2H, d, <i>J</i> = 4.0 Hz), 7.52–7.50 (2H, d, <i>J</i> = 8.0 Hz), 3.57 (2H, s), 2.95–2.93 (2H, d, <i>J</i> = 8.0 Hz), 2.21–2.17 (3H, m), 1.70–1.68 (2H, d, <i>J</i> = 8.0 Hz), 1.46–1.42 (1H, m), 1.27–1.19 (3H, m), 0.97–0.95 (3H, d, <i>J</i> = 4.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 154.4, 136.5, 129.5, 129.2, 121.7, 115.0, 53.6, 53.5, 34.2, 31.0, 30.5, 21.8. Measured purity at 254 nm: 95.8%; 282 nm: 98.5%. Mp 68–69 °C. HRMS: calcd for (C<sub>15</sub>H<sub>18</sub>ClN<sub>3</sub>O<sub>2</sub>): 307.1088; found 308.1158 (M + H<sup>+</sup>).</div></div><div id="sec4_11_5_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> 4-((4-Methylpiperdin-1-yl)methyl)-3-phenyl-1,2,5-oxadiazole 2-Oxide (<b>5h</b>)</h5><div class="NLM_p last">This compound was synthesized using the general procedure with <b>4h</b> (250 mg, 0.91 mmol) to afford <b>5h</b> as a pale, yellow solid (isolated yield = 53.0 mg, 21.2%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.15–8.14 (2H, d, <i>J</i> = 4.0 Hz), 7.55–7.49 (3H, m), 3.58 (2H, s), 2.98–2.96 (2H, d, <i>J</i> = 8.0 Hz), 2.20–2.16 (2H, m), 1.70–1.68 (2H, d, <i>J</i> = 8.0 Hz), 1.45–1.41 (1H, m), 1.28–1.21 (2H, m), 0.97–0.95 (2H, d, <i>J</i> = 8.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 154.7, 130.4, 128.9, 128.2, 123.2, 115.6, 53.6, 53.4, 34.2, 30.5, 21.8. Measured purity at 254 nm: 92.3%; 282 nm: 95.8%. Mp 36–37 °C. HRMS: calcd for (C<sub>15</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub>): 273.1477; found 274.1557 (M + H<sup>+</sup>).</div></div></div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Radiolabeled Synthesis</h3><div id="sec4_12_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Radiolabeled Substitution Procedure</h4><div class="NLM_p">All radiolabeled reagents were purchased from commercially available sources and used without further purification. Compound <b>4a</b> (255 mg, 0.93 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) while stirring at r.t. under argon. A stirred solution of TEA (283 mg, 2.80 mmol) and 4-methylpiperidine-2,2,6,6-<i>d</i><sub>4</sub> (100 mg, 0.93 mmol) was added to the <b>4a</b> solution. The reaction was stirred for 10 min and then purified using column chromatography (mobile phase: hexanes/ethyl acetate) to give <b>6a</b> as a white crystalline solid (255 mg, 91.1%).</div><div id="sec4_12_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> 4-(4-Fluorophenyl)-3-((4-methylpiperidin-1-yl-2,2,6,6-d<sub>4</sub>)methyl)-1,2,5-oxadiazole 2-Oxide (<b>6a</b>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.10–8.09 (2H, t), 7.24–7.21 (2H, t), 3.49 (2H, s), 1.67–1.64 (2H, dd), 1.43–1.39 (1H, m), 1.22–1.18 (2H, t), 0.95–0.94 (3H, d, <i>J</i> = 4.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 165.2, 163.6, 156.9, 130.5, 130.5, 123.2, 123.2, 116.4, 116.2, 113.0, 53.1–52.5, 50.4, 34.1, 30.2, 21.8. Measured purity at 254 nm: 97.6%; 282 nm: 96.0%. Mp 54–55 °C. HRMS: calcd for (C<sub>15</sub>H<sub>14</sub>D<sub>4</sub>FN<sub>3</sub>O<sub>2</sub>): 295.1634; found 296.1710 (M + H<sup>+</sup>).</div></div></div><div id="sec4_12_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Radiolabeled Tautomerization Procedure</h4><div class="NLM_p">Compound <b>6a</b> (215 mg, 0.73 mmol) was dissolved in toluene (5 mL) and refluxed for 7 days to afford <b>7a</b>. Separation was carried out according to the general procedure. Compound <b>7a</b> was isolated as a white crystalline solid (isolated yield = 52 mg, 24.2%).</div><div id="sec4_12_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> 3-(4-Fluorophenyl)-4-((4-methylpiperidin-1-yl-2,2,6,6-d<sub>4</sub>)methyl)-1,2,5-oxadiazole 2-Oxide (<b>7a</b>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.24–8.21 (2H, m), 7.24–7.21 (2H, t), 3.57 (2H, s), 1.69–1.67 (2H, dd), 1.46–1.44 (1H, m), 1.24–1.19 (2H, t), 0.97–0.96 (3H, d, <i>J</i> = 4.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): 164.4, 162.7, 130.6–130.5, 119.3, 119.3, 116.2, 116.1, 115.1, 53.4, 53.0, 52.5, 34.1, 30.4, 21.8. Measured purity at 254 nm: 95.9%; 282 nm: 95.9%. Mp 52–53 °C. HRMS: calcd for (C<sub>15</sub>H<sub>14</sub>D<sub>4</sub>FN<sub>3</sub>O<sub>2</sub>): 295.1634; found 296.1712 (M + H<sup>+</sup>).</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00389" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68000" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">.doc .pdf .pdf .pdf .csv The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00389" class="ext-link">10.1021/acs.jmedchem.8b00389</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Supporting information (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Supplemental characterization (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_003.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Supplemental crystal structure report (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_004.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Supplemental pharmacokinetic data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_005.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_001.csv">jm8b00389_si_001.csv (1.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_002.pdf">jm8b00389_si_002.pdf (1.27 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_003.pdf">jm8b00389_si_003.pdf (4.84 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_004.pdf">jm8b00389_si_004.pdf (1.03 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_005.pdf">jm8b00389_si_005.pdf (1.42 MB)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The X-ray crystal structure of <b>5a</b> has been deposited into the Cambridge Crystallographic Data Centre, ID code: CCDC 1838464.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b00389" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68625" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68625" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isaac T. Schiefer</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal and Biological Chemistry and , University of Toledo, Toledo, Ohio 43614, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4749-408X" title="Orcid link">http://orcid.org/0000-0003-4749-408X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7118021010125f02121918141714033104051e1d14151e5f141504"><span class="__cf_email__" data-cfemail="7019031111135e03131819151615023005041f1c15141f5e151405">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Austin Horton</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal and Biological Chemistry and , University of Toledo, Toledo, Ohio 43614, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Nash</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Experimental
Therapeutics, College of Pharmacy and Pharmaceutical Sciences and , University of Toledo, Toledo, Ohio 43614, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ethel Tackie-Yarboi</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal and Biological Chemistry and , University of Toledo, Toledo, Ohio 43614, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander Kostrevski</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal and Biological Chemistry and , University of Toledo, Toledo, Ohio 43614, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam Novak</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal and Biological Chemistry and , University of Toledo, Toledo, Ohio 43614, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aparna Raghavan</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal and Biological Chemistry and , University of Toledo, Toledo, Ohio 43614, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jatin Tulsulkar</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal and Biological Chemistry and , University of Toledo, Toledo, Ohio 43614, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qasim Alhadidi</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal and Biological Chemistry and , University of Toledo, Toledo, Ohio 43614, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nathan Wamer</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal and Biological Chemistry and , University of Toledo, Toledo, Ohio 43614, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryn Langenderfer</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal and Biological Chemistry and , University of Toledo, Toledo, Ohio 43614, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kalee Royster</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal and Biological Chemistry and , University of Toledo, Toledo, Ohio 43614, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maxwell Ducharme</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal and Biological Chemistry and , University of Toledo, Toledo, Ohio 43614, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katelyn Hagood</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal and Biological Chemistry and , University of Toledo, Toledo, Ohio 43614, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Megan Post</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal and Biological Chemistry and , University of Toledo, Toledo, Ohio 43614, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zahoor A. Shah</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal and Biological Chemistry and , University of Toledo, Toledo, Ohio 43614, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written by I.T.S. in close collaboration with A.H. with contributions from all authors. A.H., A.K., N.W., M.D., E.T.Y., and I.T.S. carried out the synthetic organic chemistry. K.N., A.R., J.T., Q.A., and M.P. carried out the cell biology studies. K.R. and B.L. peformed the animal pharmacokinetic administrations and specimen collection. A.N. and I.T.S. carried out the STPA studies. I.T.S., K.N., and K.H. carried out the bioanalytical (HPLC and LC-MS) work. Z.S. provided guidance and infrastructure to support the cell biology work and revised his portions of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3904-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78487" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78487" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">LC-MS/MS was carried out at the University of Toledo Shimadzu Laboratory for Pharmaceutical Research Excellence. <i>K</i><sub>i</sub> determinations, receptor binding profiles, and HERG data were generously provided by the National Institute of Mental Health’s Psychoactive Drug Screening Program, Contract # HHSN-271-2013-00017-C (NIMH PDSP). The NIMH PDSP is Directed by Bryan L. Roth MD, PhD at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscoll at NIMH, Bethesda MD, USA. Small-molecule X-ray crystallography and high-resolution mass spectrometry were performed by the Instrumentation Center in the Department of Chemistry and Biochemistry at the University of Toledo with special thanks to Dr. Kristin Kirschbaum and Dr. Dragan Isailovic. This work was funded in part by a New Investigator Award from the American Association of Colleges of Pharmacy (AACP), the Alzheimer’s Association (NIRG-15-363739) and  National Institutes of Health R01AG057598. Student stipend support was provided by the Office of Undergraduate Research at the University of Toledo and National Science Foundation Award #1432921.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ACN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid beta</p></td></tr><tr><td class="NLM_term">B:P</td><td class="NLM_def"><p class="first last">brain to plasma ratio</p></td></tr><tr><td class="NLM_term">clogP</td><td class="NLM_def"><p class="first last">calculated partition coefficient</p></td></tr><tr><td class="NLM_term">cGMP</td><td class="NLM_def"><p class="first last">cyclic guanosine monophosphate</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">COSY</td><td class="NLM_def"><p class="first last">homonuclear correlation spectroscopy</p></td></tr><tr><td class="NLM_term">CREB</td><td class="NLM_def"><p class="first last">cAMP response element binding protein</p></td></tr><tr><td class="NLM_term">EA</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">FA</td><td class="NLM_def"><p class="first last">formic acid</p></td></tr><tr><td class="NLM_term">IND</td><td class="NLM_def"><p class="first last">investigational new drug application</p></td></tr><tr><td class="NLM_term">LC-MS/MS</td><td class="NLM_def"><p class="first last">tandem mass spectrometry</p></td></tr><tr><td class="NLM_term">LOD</td><td class="NLM_def"><p class="first last">limit of detection</p></td></tr><tr><td class="NLM_term">LLOQ</td><td class="NLM_def"><p class="first last">lower limit of quantitation</p></td></tr><tr><td class="NLM_term">LTP</td><td class="NLM_def"><p class="first last">long-term potentiation</p></td></tr><tr><td class="NLM_term">HMQC</td><td class="NLM_def"><p class="first last">heteronuclear multiple quantum coherence spectroscopy</p></td></tr><tr><td class="NLM_term">MRM</td><td class="NLM_def"><p class="first last">multiple reaction monitoring</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl-tetrazolium bromide</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">NEM</td><td class="NLM_def"><p class="first last"><i>N</i>-ethylmaleimide</p></td></tr><tr><td class="NLM_term">NO</td><td class="NLM_def"><p class="first last">nitric oxide</p></td></tr><tr><td class="NLM_term">OGD</td><td class="NLM_def"><p class="first last">oxygen glucose deprivation</p></td></tr><tr><td class="NLM_term">ODQ</td><td class="NLM_def"><p class="first last">(1<i>H</i>-[1,2,4]oxadiazolo-[4,3-<i>a</i>]quinoxalin-1-one)</p></td></tr><tr><td class="NLM_term">ODZ-2N</td><td class="NLM_def"><p class="first last">oxadiazole-2<i>N</i>-oxide</p></td></tr><tr><td class="NLM_term">ODZ-4N</td><td class="NLM_def"><p class="first last">oxadiazole-4<i>N</i>-oxide</p></td></tr><tr><td class="NLM_term">PDA</td><td class="NLM_def"><p class="first last">photodiode array detector</p></td></tr><tr><td class="NLM_term">PDEi</td><td class="NLM_def"><p class="first last">phosphodiesterase inhibitors</p></td></tr><tr><td class="NLM_term">Pgp</td><td class="NLM_def"><p class="first last">P-glycoproteins</p></td></tr><tr><td class="NLM_term">PKA</td><td class="NLM_def"><p class="first last">protein kinase A</p></td></tr><tr><td class="NLM_term">PKG</td><td class="NLM_def"><p class="first last">protein kinase G</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">S/N</td><td class="NLM_def"><p class="first last">signal-to-noise</p></td></tr><tr><td class="NLM_term">SPE</td><td class="NLM_def"><p class="first last">solid phase extraction</p></td></tr><tr><td class="NLM_term">sGC</td><td class="NLM_def"><p class="first last">soluble guanylyl cyclase</p></td></tr><tr><td class="NLM_term">STPA</td><td class="NLM_def"><p class="first last">step-through passive avoidance</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">tPSA</td><td class="NLM_def"><p class="first last">total polar surface area</p></td></tr><tr><td class="NLM_term">UPLC</td><td class="NLM_def"><p class="first last">ultra-high-pressure liquid chromatography</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22258" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22258" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 53 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandel, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, R. D.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">10250</span>– <span class="NLM_lpage">10261</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.19-23-10250.1999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1523%2FJNEUROSCI.19-23-10250.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10575022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADyaK1MXnslyrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=10250-10261&issue=23&author=Y.+F.+Luauthor=E.+R.+Kandelauthor=R.+D.+Hawkins&title=Nitric+oxide+signaling+contributes+to+late-phase+LTP+and+CREB+phosphorylation+in+the+hippocampus&doi=10.1523%2FJNEUROSCI.19-23-10250.1999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus</span></div><div class="casAuthors">Lu, Yun-Fei; Kandel, Eric R.; Hawkins, Robert D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10250-10261</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Long-term potentiation (LTP) in the hippocampus has an early phase (E-LTP) that can be induced by 1- or 2-train tetanization, lasts ∼1 h, and is cAMP-dependent protein kinase A (PKA)- and protein synthesis-independent and a late phase (L-LTP) that can be induced by 3- or 4-train tetanization, lasts >3 h, and is reduced by inhibitors of PKA and of protein or RNA synthesis.  NO is thought to be involved in E-LTP, but until now there has been no information about the role of the NO-signaling pathway in L-LTP.  Here, the authors examd. this question at the Schaffer collateral-CA1 synapses in slices of mouse hippocampus.  An inhibitor of nitric oxide synthase blocked L-LTP induced by 3-train tetanization and reduced L-LTP induced by 4-train tetanization, whereas an inhibitor of PKA was more effective in blocking 4-train L-LTP than 3-train L-LTP.  Three-train L-LTP was also blocked by inhibitors of guanylyl cyclase or cGMP-dependent protein kinase G (PKG).  Conversely, either NO or cGMP analogs paired with 1-train tetanization produced late-phase potentiation, and the cGMP-induced potentiation was blocked by inhibitors of protein or RNA synthesis and an inhibitor of PKG, but not by an inhibitor of PKA.  To test a possible downstream target of PKG, the authors examd. changes in phospho-CRE-binding protein (phospho-CREB) immunofluorescence in the CA1 cell body area and obtained results similar to those of the electrophysiol. expts.  The results suggested that NO contributes to L-LTP by stimulating guanylyl cyclase and PKG, which acts in parallel with PKA to increase phosphorylation of transcription factor CREB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY0i0LYOPf7LVg90H21EOLACvtfcHk0lgwZ_-3Vk8Ouw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslyrt70%253D&md5=6d09b68560c09b81e38354826f7c21b6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-23-10250.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-23-10250.1999%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%2BF.%26aulast%3DKandel%26aufirst%3DE.%2BR.%26aulast%3DHawkins%26aufirst%3DR.%2BD.%26atitle%3DNitric%2520oxide%2520signaling%2520contributes%2520to%2520late-phase%2520LTP%2520and%2520CREB%2520phosphorylation%2520in%2520the%2520hippocampus%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26issue%3D23%26spage%3D10250%26epage%3D10261%26doi%3D10.1523%2FJNEUROSCI.19-23-10250.1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ciani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guidi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartesaghi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contestabile, A.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: implication for a survival role of nitric oxide</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>82</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1282</span>– <span class="NLM_lpage">1289</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.2002.01080.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1046%2Fj.1471-4159.2002.01080.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=12358775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvVerur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=1282-1289&issue=5&author=E.+Cianiauthor=S.+Guidiauthor=R.+Bartesaghiauthor=A.+Contestabile&title=Nitric+oxide+regulates+cGMP-dependent+cAMP-responsive+element+binding+protein+phosphorylation+and+Bcl-2+expression+in+cerebellar+neurons%3A+implication+for+a+survival+role+of+nitric+oxide&doi=10.1046%2Fj.1471-4159.2002.01080.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: Implication for a survival role of nitric oxide</span></div><div class="casAuthors">Ciani, Elisabetta; Guidi, Sandra; Bartesaghi, Renata; Contestabile, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1282-1289</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">NO is a small, diffusible, highly reactive mol. with a dichotomous regulatory role in the brain as an intra- and intercellular messenger under physiol. conditions and a neurodegenerative agent under pathol. conditions.  The authors recently demonstrated that long-lasting exposure to an neuronal nitric oxide synthase (nNOS) inhibitor down-regulated the serine/threonine kinase Akt survival pathway and caused apoptosis in cerebellar granule cell cultures.  The present study further substantiated the role of NO in neuronal survival by demonstrating that blocking its prodn. down-regulated the activity of cAMP-responsive element binding protein (CREB), a transcription factor involved in cell survival and synaptic plasticity.  Pharmacol. dissection of the pathway linking NO to CREB showed that cGMP and its kinase were intermediate effectors.  The authors also identified Bcl-2 as one of the anti-apoptotic genes down-regulated by NO shortage and decreased CREB phosphorylation.  Thus, these results not only confirmed the role of CREB in neuronal survival but also provided circumstantial evidence for a novel link among NO, CREB activation, and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI4EpdhJVzkrVg90H21EOLACvtfcHk0lgwZ_-3Vk8Ouw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvVerur8%253D&md5=919d465c919f768d97c93a650efde1a9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.01080.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.01080.x%26sid%3Dliteratum%253Aachs%26aulast%3DCiani%26aufirst%3DE.%26aulast%3DGuidi%26aufirst%3DS.%26aulast%3DBartesaghi%26aufirst%3DR.%26aulast%3DContestabile%26aufirst%3DA.%26atitle%3DNitric%2520oxide%2520regulates%2520cGMP-dependent%2520cAMP-responsive%2520element%2520binding%2520protein%2520phosphorylation%2520and%2520Bcl-2%2520expression%2520in%2520cerebellar%2520neurons%253A%2520implication%2520for%2520a%2520survival%2520role%2520of%2520nitric%2520oxide%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D82%26issue%3D5%26spage%3D1282%26epage%3D1289%26doi%3D10.1046%2Fj.1471-4159.2002.01080.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johannessen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delghandi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moens, U.</span></span> <span> </span><span class="NLM_article-title">What turns CREB on?</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1211</span>– <span class="NLM_lpage">1227</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2004.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.cellsig.2004.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=15337521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFSmur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=1211-1227&issue=11&author=M.+Johannessenauthor=M.+P.+Delghandiauthor=U.+Moens&title=What+turns+CREB+on%3F&doi=10.1016%2Fj.cellsig.2004.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">What turns CREB on?</span></div><div class="casAuthors">Johannessen, Mona; Delghandi, Marit Pedersen; Moens, Ugo</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1211-1227</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The transactivation domain of the cAMP response element-binding protein (CREB) consists of two major domains.  The glutamine-rich Q2 domain, which interacts with the general transcription factor TAFII130/135, is sufficient for the recruitment of a functional RNA polymerase II complex and allows basal transcriptional activity.  The kinase-inducible domain, however, mediates signal-induced activation of CREB-mediated transcription.  It is generally believed that recruitment of the coactivators CREB-binding protein (CBP) and p300 after signal-induced phosphorylation of this domain at serine-133 strongly enhances CREB-dependent transcription.  Transcriptional activity of CREB can also be potentiated by phosphoserine-133-independent mechanisms, and not all stimuli that provoke phosphorylation of serine-133 stimulate CREB-dependent transcription.  This review presents an overview of the diversity of stimuli that induce CREB phosphorylation at Ser-133, focuses on phosphoserine-133-dependent and -independent mechanisms that affect CREB-mediated transcription, and discusses different models that may explain the discrepancy between CREB Ser-133 phosphorylation and activation of CREB-mediated transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeVRXxe4S8IrVg90H21EOLACvtfcHk0lgZ5FE5cgWbMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFSmur0%253D&md5=8cbcc82b3eb5d491ce28ff2a4f8eae3e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2004.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2004.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DJohannessen%26aufirst%3DM.%26aulast%3DDelghandi%26aufirst%3DM.%2BP.%26aulast%3DMoens%26aufirst%3DU.%26atitle%3DWhat%2520turns%2520CREB%2520on%253F%26jtitle%3DCell.%2520Signalling%26date%3D2004%26volume%3D16%26issue%3D11%26spage%3D1211%26epage%3D1227%26doi%3D10.1016%2Fj.cellsig.2004.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teich, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzzo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purgatorio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span> <span> </span><span class="NLM_article-title">Synaptic therapy in Alzheimer’s disease: a CREB-centric approach</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1007/s13311-014-0327-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1007%2Fs13311-014-0327-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=25575647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvVSlt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=29-41&issue=1&author=A.+F.+Teichauthor=R.+E.+Nichollsauthor=D.+Puzzoauthor=J.+Fioritoauthor=R.+Purgatorioauthor=M.+Faauthor=O.+Arancio&title=Synaptic+therapy+in+Alzheimer%E2%80%99s+disease%3A+a+CREB-centric+approach&doi=10.1007%2Fs13311-014-0327-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Synaptic Therapy in Alzheimer's Disease: A CREB-centric Approach</span></div><div class="casAuthors">Teich, Andrew F.; Nicholls, Russell E.; Puzzo, Daniela; Fiorito, Jole; Purgatorio, Rosa; Fa, Mauro; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-41</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1878-7479</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Therapeutic attempts to cure Alzheimer's disease (AD) have failed, and new strategies are desperately needed.  Motivated by this reality, many labs. (including our own) have focused on synaptic dysfunction in AD because synaptic changes are highly correlated with the severity of clin. dementia.  In particular, memory formation is accompanied by altered synaptic strength, and this phenomenon (and its dysfunction in AD) has been a recent focus for many labs.  The mol. cyclic adenosine monophosphate response element-binding protein (CREB) is at a central converging point of pathways and mechanisms activated during the processes of synaptic strengthening and memory formation, as CREB phosphorylation leads to transcription of memory-assocd. genes.  Disruption of these mechanisms in AD results in a redn. of CREB activation with accompanying memory impairment.  Thus, it is likely that strategies aimed at these mechanisms will lead to future therapies for AD.  In this review, we will summarize literature that investigates 5 possible therapeutic pathways for rescuing synaptic dysfunction in AD: 4 enzymic pathways that lead to CREB phosphorylation (the cyclic adenosine monophosphate cascade, the serine/threonine kinases extracellular regulated kinases 1 and 2, the nitric oxide cascade, and the calpains), as well as histone acetyltransferases and histone deacetylases (2 enzymes that regulate the histone acetylation necessary for gene transcription).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtuWRTEQW78bVg90H21EOLACvtfcHk0lgZ5FE5cgWbMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvVSlt78%253D&md5=1b1cd3d1f31fa90e6bc317e10af44be2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs13311-014-0327-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-014-0327-5%26sid%3Dliteratum%253Aachs%26aulast%3DTeich%26aufirst%3DA.%2BF.%26aulast%3DNicholls%26aufirst%3DR.%2BE.%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DFiorito%26aufirst%3DJ.%26aulast%3DPurgatorio%26aufirst%3DR.%26aulast%3DFa%26aufirst%3DM.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DSynaptic%2520therapy%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520CREB-centric%2520approach%26jtitle%3DNeurotherapeutics%26date%3D2015%26volume%3D12%26issue%3D1%26spage%3D29%26epage%3D41%26doi%3D10.1007%2Fs13311-014-0327-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puzzo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span> <span> </span><span class="NLM_article-title">Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer’s disease</span>. <i>Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">523</span>, <span class="refDoi"> DOI: 10.1515/REVNEURO.2006.17.5.497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1515%2FREVNEURO.2006.17.5.497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=17180876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlentbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=497-523&issue=5&author=D.+Puzzoauthor=A.+Palmeriauthor=O.+Arancio&title=Involvement+of+the+nitric+oxide+pathway+in+synaptic+dysfunction+following+amyloid+elevation+in+Alzheimer%E2%80%99s+disease&doi=10.1515%2FREVNEURO.2006.17.5.497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer's disease</span></div><div class="casAuthors">Puzzo, Daniela; Palmeri, Agostino; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in the Neurosciences (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">497-523</span>CODEN:
                <span class="NLM_cas:coden">RNEUEO</span>;
        ISSN:<span class="NLM_cas:issn">0334-1763</span>.
    
            (<span class="NLM_cas:orgname">Freund & Pettman</span>)
        </div><div class="casAbstract">A review.  Amyloid-beta (Aβ), a peptide thought to play a crucial role in Alzheimer's disease (AD), has attracted scientific interest with the aim of characterizing the mechanisms by which it is involved in AD pathogenesis.  Aβ has been found to markedly impair hippocampal long-term potentiation (LTP), a widely studied cellular model of synaptic plasticity that is thought to underlie learning and memory.  The overall purpose of this review is to define the role of the nitric oxide (NO)/cGMP/cAMP-regulatory element binding (CREB) pathway in beta-amyloid-induced changes of basal neurotransmission and synaptic plasticity in the hippocampus, a structure within the temporal lobe of the brain crit. for memory storage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzLKNBiiakNLVg90H21EOLACvtfcHk0lgZ5FE5cgWbMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlentbzJ&md5=faa3271286d20c9cd431f9b001476089</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1515%2FREVNEURO.2006.17.5.497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FREVNEURO.2006.17.5.497%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DInvolvement%2520of%2520the%2520nitric%2520oxide%2520pathway%2520in%2520synaptic%2520dysfunction%2520following%2520amyloid%2520elevation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DRev.%2520Neurosci.%26date%3D2006%26volume%3D17%26issue%3D5%26spage%3D497%26epage%3D523%26doi%3D10.1515%2FREVNEURO.2006.17.5.497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saura, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valero, J.</span></span> <span> </span><span class="NLM_article-title">The role of CREB signaling in Alzheimer’s disease and other cognitive disorders</span>. <i>Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1515/rns.2011.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1515%2Frns.2011.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=21476939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlWktrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=153-169&issue=2&author=C.+A.+Sauraauthor=J.+Valero&title=The+role+of+CREB+signaling+in+Alzheimer%E2%80%99s+disease+and+other+cognitive+disorders&doi=10.1515%2Frns.2011.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The role of CREB signaling in Alzheimer's disease and other cognitive disorders</span></div><div class="casAuthors">Saura, Carlos A.; Valero, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in the Neurosciences (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-169</span>CODEN:
                <span class="NLM_cas:coden">RNEUEO</span>;
        ISSN:<span class="NLM_cas:issn">0334-1763</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review.  Gene expression changes in the brain affect cognition during normal and pathol. aging.  Progress in understanding the cellular processes regulating gene expression networks in cognition is relevant to develop therapeutic interventions for age-related cognitive disorders.  Synaptic efficacy mediating memory storage requires the activation of specific gene expression programs regulated, among others, by the transcription factor cAMP-response element binding protein (CREB).  CREB signaling is essential for long-lasting changes in synaptic plasticity that mediates the conversion of short-term memory to long-term memory.  CREB signaling has been recently involved in several brain pathol. conditions including cognitive and neurodegenerative disorders.  The β-amyloid (Aβ) peptide, which plays a crucial role in the pathogenesis of Alzheimer's disease, alters hippocampal-dependent synaptic plasticity and memory and mediates synapse loss through the CREB signaling pathway.  The fact that altered CREB signaling has been implicated in other cognitive disorders including Huntington's disease and Rubinstein-Taybi and Coffin-Lowry syndromes suggests a crucial role of CREB signaling in cognitive dysfunction.  In this review paper, we summarize recent findings indicating a role of CREB and its coactivators CREB binding protein and CREB-regulated transcription coactivator in cognition during normal and pathol. aging.  We also discuss the development of novel therapeutic strategies based on CREB targeting to ameliorate cognitive decline in aging and cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTvPO2NdVSi7Vg90H21EOLACvtfcHk0lgGlLGzPUXV7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlWktrzI&md5=64b6b432822be2ae925b5f58e279d0a9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1515%2Frns.2011.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Frns.2011.018%26sid%3Dliteratum%253Aachs%26aulast%3DSaura%26aufirst%3DC.%2BA.%26aulast%3DValero%26aufirst%3DJ.%26atitle%3DThe%2520role%2520of%2520CREB%2520signaling%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520other%2520cognitive%2520disorders%26jtitle%3DRev.%2520Neurosci.%26date%3D2011%26volume%3D22%26issue%3D2%26spage%3D153%26epage%3D169%26doi%3D10.1515%2Frns.2011.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pugazhenthi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sze, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckman, C. B.</span></span> <span> </span><span class="NLM_article-title">Downregulation of CREB expression in Alzheimer’s brain and in Abeta-treated rat hippocampal neurons</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">60</span>, <span class="refDoi"> DOI: 10.1186/1750-1326-6-60</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1186%2F1750-1326-6-60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=21854604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1SqtLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=60&author=S.+Pugazhenthiauthor=M.+Wangauthor=S.+Phamauthor=C.+I.+Szeauthor=C.+B.+Eckman&title=Downregulation+of+CREB+expression+in+Alzheimer%E2%80%99s+brain+and+in+Abeta-treated+rat+hippocampal+neurons&doi=10.1186%2F1750-1326-6-60"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Downregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons</span></div><div class="casAuthors">Pugazhenthi, Subbiah; Wang, Maorong; Pham, Serena; Sze, Chun-I.; Eckman, Christopher B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">60</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Oxidative stress plays an important role in neuronal dysfunction and neuron loss in Alzheimer's brain.  Previous studies have reported downregulation of CREB-mediated transcription by oxidative stress and Aβ.  The promoter for CREB itself contains cAMP response elements.  Therefore, we examd. the expression of CREB in the hippocampal neurons of Tg2576 mice, AD post-mortem brain and in cultured rat hippocampal neurons exposed to Aβ aggregates.  Results: Laser Capture Microdissection of hippocampal neurons from Tg2576 mouse brain revealed decreases in the mRNA levels of CREB and its target, BDNF.  Immunohistochem. anal. of Tg2576 mouse brain showed decreases in CREB levels in hippocampus and cortex.  Markers of oxidative stress were detected in transgenic mouse brain and decreased CREB staining was obsd. in regions showing abundance of astrocytes.  There was also an inverse correlation between SDS-extd. Aβ and CREB protein levels in Alzheimer's post-mortem hippocampal samples.  The levels of CREB-regulated BDNF and BIRC3, a caspase inhibitor, decreased and the active cleaved form of caspase-9, a marker for the intrinsic pathway of apoptosis, was elevated in these samples.  Exposure of rat primary hippocampal neurons to Aβ fibrils decreased CREB promoter activity.  Decrease in CREB mRNA levels in Aβ-treated neurons was reversed by the antioxidant, N-acetyl cysteine.  Overexpression of CREB by adenoviral transduction led to significant protection against Aβ-induced neuronal apoptosis.  Conclusions: Our findings suggest that chronic downregulation of CREB-mediated transcription results in decrease of CREB content in the hippocampal neurons of AD brain which may contribute to exacerbation of disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-Jy8qMsXYa7Vg90H21EOLACvtfcHk0lgGlLGzPUXV7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1SqtLrM&md5=d844676fb6b7ce36eca53a5438528665</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-6-60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-6-60%26sid%3Dliteratum%253Aachs%26aulast%3DPugazhenthi%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DPham%26aufirst%3DS.%26aulast%3DSze%26aufirst%3DC.%2BI.%26aulast%3DEckman%26aufirst%3DC.%2BB.%26atitle%3DDownregulation%2520of%2520CREB%2520expression%2520in%2520Alzheimer%25E2%2580%2599s%2520brain%2520and%2520in%2520Abeta-treated%2520rat%2520hippocampal%2520neurons%26jtitle%3DMol.%2520Neurodegener.%26date%3D2011%26volume%3D6%26spage%3D60%26doi%3D10.1186%2F1750-1326-6-60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puzzo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitolo, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinchese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span> <span> </span><span class="NLM_article-title">Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">29</span>),  <span class="NLM_fpage">6887</span>– <span class="NLM_lpage">6897</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.5291-04.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1523%2FJNEUROSCI.5291-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=16033898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmslClt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=6887-6897&issue=29&author=D.+Puzzoauthor=O.+Vitoloauthor=F.+Trincheseauthor=J.+P.+Jacobauthor=A.+Palmeriauthor=O.+Arancio&title=Amyloid-beta+peptide+inhibits+activation+of+the+nitric+oxide%2FcGMP%2FcAMP-responsive+element-binding+protein+pathway+during+hippocampal+synaptic+plasticity&doi=10.1523%2FJNEUROSCI.5291-04.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity</span></div><div class="casAuthors">Puzzo, Daniela; Vitolo, Ottavio; Trinchese, Fabrizio; Jacob, Joel P.; Palmeri, Agostino; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">6887-6897</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Amyloid-β (Aβ), a peptide thought to play a crucial role in Alzheimer's disease (AD), has many targets that, in turn, activate different 2nd-messenger cascades.  Interestingly, Aβ was found to markedly impair hippocampal long-term potentiation (LTP).  To identify a new pathway that might be responsible for such impairment, the authors analyzed the role of the NO/sol. guanylyl cyclase (sGC)/cGMP/cGMP-dependent protein kinase (cGK)/cAMP-responsive element-binding protein (CREB) cascade because of its involvement in LTP.  The use of the NO donor 2-(N,N-dethylamino)-diazenolate-2-oxide diethylammonium salt (DEA/NO), the sGC stimulator 3-(4-amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine, or the cGMP-analogs 8-bromo-cGMP and 8-(4-chlorophenylthio)-cGMP reversed the Aβ-induced impairment of CA1-LTP through cGK activation.  Furthermore, these compds. reestablished the enhancement of CREB phosphorylation occurring during LTP in slices exposed to Aβ.  We also found that Aβ blocks the increase in cGMP immunoreactivity occurring immediately after LTP and that DEA/NO counteracts the effect of Aβ.  These results strongly suggest that, when modulating hippocampal synaptic plasticity, Aβ downregulates the NO/cGMP/cGK/CREB pathway; thus, enhancement of the NO/cGMP signaling may provide a novel approach to the treatment of AD and other neurodegenerative diseases with elevated prodn. of Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT_M3WUlYelLVg90H21EOLACvtfcHk0lgGlLGzPUXV7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmslClt78%253D&md5=448717d56147ceb9665d8c1ce8136c98</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5291-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5291-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DVitolo%26aufirst%3DO.%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DJacob%26aufirst%3DJ.%2BP.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DAmyloid-beta%2520peptide%2520inhibits%2520activation%2520of%2520the%2520nitric%2520oxide%252FcGMP%252FcAMP-responsive%2520element-binding%2520protein%2520pathway%2520during%2520hippocampal%2520synaptic%2520plasticity%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26issue%3D29%26spage%3D6887%26epage%3D6897%26doi%3D10.1523%2FJNEUROSCI.5291-04.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusky, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatcher, G. R.</span></span> <span> </span><span class="NLM_article-title">Cognitive deficits in rats after forebrain cholinergic depletion are reversed by a novel NO mimetic nitrate ester</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">505</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1038/sj.npp.1301054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1038%2Fsj.npp.1301054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=505-513&issue=3&author=B.+M.+Bennettauthor=J.+N.+Reynoldsauthor=G.+T.+Pruskyauthor=R.+M.+Douglasauthor=R.+J.+Sutherlandauthor=G.+R.+Thatcher&title=Cognitive+deficits+in+rats+after+forebrain+cholinergic+depletion+are+reversed+by+a+novel+NO+mimetic+nitrate+ester&doi=10.1038%2Fsj.npp.1301054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1301054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1301054%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DB.%2BM.%26aulast%3DReynolds%26aufirst%3DJ.%2BN.%26aulast%3DPrusky%26aufirst%3DG.%2BT.%26aulast%3DDouglas%26aufirst%3DR.%2BM.%26aulast%3DSutherland%26aufirst%3DR.%2BJ.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%26atitle%3DCognitive%2520deficits%2520in%2520rats%2520after%2520forebrain%2520cholinergic%2520depletion%2520are%2520reversed%2520by%2520a%2520novel%2520NO%2520mimetic%2520nitrate%2520ester%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D32%26issue%3D3%26spage%3D505%26epage%3D513%26doi%3D10.1038%2Fsj.npp.1301054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VandeVrede, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Aissa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teich, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Souza, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elharram, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koster, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaDu, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatcher, G. R. J.</span></span> <span> </span><span class="NLM_article-title">A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer’s disease</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">35</span>, <span class="refDoi"> DOI: 10.1186/s13024-016-0103-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1186%2Fs13024-016-0103-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=27129593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsFGgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=35&issue=1&author=J.+Luoauthor=S.+H.+Leeauthor=L.+VandeVredeauthor=Z.+Qinauthor=M.+Ben+Aissaauthor=J.+Larsonauthor=A.+F.+Teichauthor=O.+Arancioauthor=Y.+D%E2%80%99Souzaauthor=A.+Elharramauthor=K.+Kosterauthor=L.+M.+Taiauthor=M.+J.+LaDuauthor=B.+M.+Bennettauthor=G.+R.+J.+Thatcher&title=A+multifunctional+therapeutic+approach+to+disease+modification+in+multiple+familial+mouse+models+and+a+novel+sporadic+model+of+Alzheimer%E2%80%99s+disease&doi=10.1186%2Fs13024-016-0103-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease</span></div><div class="casAuthors">Luo, Jia; Lee, Sue H.; Vande Vrede, Lawren; Qin, Zhihui; Ben Aissa, Manel; Larson, John; Teich, Andrew F.; Arancio, Ottavio; D'Souza, Yohan; Elharram, Ahmed; Koster, Kevin; Tai, Leon M.; LaDu, Mary Jo; Bennett, Brian M.; Thatcher, Gregory R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35/1-35/14</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Clin. failures singularly targeting amyloid-β pathol. indicate a crit. need for alternative Alzheimer's disease (AD) therapeutic strategies.  The mixed pathol. reported in a large population of AD patients demands a multifunctional drug approach.  Since activation of cAMP response element binding protein (CREB) plays a crucial role in synaptic strengthening and memory formation, we retooled a clin. drug with known neuroprotective and anti-inflammatory activity to activate CREB, and validated this novel multifunctional drug, NMZ, in 4 different mouse models of AD.  Results: NMZ was tested in three mouse models of familial AD and one model of sporadic AD.  In 3 × Tg hippocampal slices, NMZ restored LTP.  In vivo, memory was improved with NMZ in all animal models with robust cognitive deficits.  NMZ treatment lowered neurotoxic forms of Aβ in both APP/PS1 and 3 × Tg transgenic mice while also restoring neuronal plasticity biomarkers in the 3 × Tg mice.  In EFAD mice, incorporation of the major genetic AD risk factor, hAPOE4, did not mute the beneficial drug effects.  In a novel sporadic mouse model that manifests AD-like pathol. caused by accelerated oxidative stress in the absence of any familial AD mutation, oral administration of NMZ attenuated hallmark AD pathol. and restored biomarkers of synaptic and neuronal function.  Conclusions: The multifunctional approach, embodied by NMZ, was successful in mouse models of AD incorporating Aβ pathol. (APP/PS1), tau pathol. (3 × Tg), and APOE4, the major human genetic risk factor for AD (EFAD).  The efficacy obsd. in a novel model of sporadic AD (Aldh2-/-) demonstrates that the therapeutic approach is not limited to rare, familial AD genetic mutations.  The multifunctional drug, NMZ, was not designed directly to target Aβ and tau pathol.; however, the attenuation of this hallmark pathol. suggests the approach to be a highly promising, disease-modifying strategy for AD and mixed pathol. dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_wPT-pA9Iz7Vg90H21EOLACvtfcHk0liZ71gtQRv59Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsFGgur4%253D&md5=92dc7fdc5709d681f46997c1407f5396</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1186%2Fs13024-016-0103-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13024-016-0103-6%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DVandeVrede%26aufirst%3DL.%26aulast%3DQin%26aufirst%3DZ.%26aulast%3DBen%2BAissa%26aufirst%3DM.%26aulast%3DLarson%26aufirst%3DJ.%26aulast%3DTeich%26aufirst%3DA.%2BF.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DY.%26aulast%3DElharram%26aufirst%3DA.%26aulast%3DKoster%26aufirst%3DK.%26aulast%3DTai%26aufirst%3DL.%2BM.%26aulast%3DLaDu%26aufirst%3DM.%2BJ.%26aulast%3DBennett%26aufirst%3DB.%2BM.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26atitle%3DA%2520multifunctional%2520therapeutic%2520approach%2520to%2520disease%2520modification%2520in%2520multiple%2520familial%2520mouse%2520models%2520and%2520a%2520novel%2520sporadic%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Neurodegener.%26date%3D2016%26volume%3D11%26issue%3D1%26spage%3D35%26doi%3D10.1186%2Fs13024-016-0103-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chien, W.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, K.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, F.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W.-M.</span></span> <span> </span><span class="NLM_article-title">Enhancement of long-term potentiation by a potent nitric oxide-guanylyl cyclase activator, 3-(5-hydroxymethyl-2-furyl)-1-benzyl-indazole</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1322</span>– <span class="NLM_lpage">1328</span>, <span class="refDoi"> DOI: 10.1124/mol.63.6.1322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1124%2Fmol.63.6.1322" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=1322-1328&issue=6&author=W.-L.+Chienauthor=K.-C.+Liangauthor=C.-M.+Tengauthor=S.-C.+Kuoauthor=F.-Y.+Leeauthor=W.-M.+Fu&title=Enhancement+of+long-term+potentiation+by+a+potent+nitric+oxide-guanylyl+cyclase+activator%2C+3-%285-hydroxymethyl-2-furyl%29-1-benzyl-indazole&doi=10.1124%2Fmol.63.6.1322"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1124%2Fmol.63.6.1322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.63.6.1322%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DW.-L.%26aulast%3DLiang%26aufirst%3DK.-C.%26aulast%3DTeng%26aufirst%3DC.-M.%26aulast%3DKuo%26aufirst%3DS.-C.%26aulast%3DLee%26aufirst%3DF.-Y.%26aulast%3DFu%26aufirst%3DW.-M.%26atitle%3DEnhancement%2520of%2520long-term%2520potentiation%2520by%2520a%2520potent%2520nitric%2520oxide-guanylyl%2520cyclase%2520activator%252C%25203-%25285-hydroxymethyl-2-furyl%2529-1-benzyl-indazole%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D63%26issue%3D6%26spage%3D1322%26epage%3D1328%26doi%3D10.1124%2Fmol.63.6.1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Privitera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giunta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loreto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzzo, D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of phosphodiesterase-5 rescues age-related impairment of synaptic plasticity and memory</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>240</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2012.10.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.bbr.2012.10.060" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=240&publication_year=2013&pages=11-20&author=A.+Palmeriauthor=L.+Priviteraauthor=S.+Giuntaauthor=C.+Loretoauthor=D.+Puzzo&title=Inhibition+of+phosphodiesterase-5+rescues+age-related+impairment+of+synaptic+plasticity+and+memory&doi=10.1016%2Fj.bbr.2012.10.060"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2012.10.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2012.10.060%26sid%3Dliteratum%253Aachs%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DPrivitera%26aufirst%3DL.%26aulast%3DGiunta%26aufirst%3DS.%26aulast%3DLoreto%26aufirst%3DC.%26aulast%3DPuzzo%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520phosphodiesterase-5%2520rescues%2520age-related%2520impairment%2520of%2520synaptic%2520plasticity%2520and%2520memory%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2013%26volume%3D240%26spage%3D11%26epage%3D20%26doi%3D10.1016%2Fj.bbr.2012.10.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puzzo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loreto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giunta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musumeci, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frasca, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podda, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmeri, A.</span></span> <span> </span><span class="NLM_article-title">Effect of phosphodiesterase-5 inhibition on apoptosis and beta amyloid load in aged mice</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">520</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2013.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.neurobiolaging.2013.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=24112792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFykur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=520-531&issue=3&author=D.+Puzzoauthor=C.+Loretoauthor=S.+Giuntaauthor=G.+Musumeciauthor=G.+Frascaauthor=M.+V.+Poddaauthor=O.+Arancioauthor=A.+Palmeri&title=Effect+of+phosphodiesterase-5+inhibition+on+apoptosis+and+beta+amyloid+load+in+aged+mice&doi=10.1016%2Fj.neurobiolaging.2013.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of phosphodiesterase-5 inhibition on apoptosis and beta amyloid load in aged mice</span></div><div class="casAuthors">Puzzo, Daniela; Loreto, Carla; Giunta, Salvatore; Musumeci, Giuseppe; Frasca, Giuseppina; Podda, Maria Vittoria; Arancio, Ottavio; Palmeri, Agostino</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">520-531</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Age-related cognitive decline is accompanied by an increase of neuronal apoptosis and a dysregulation of neuroplasticity-related mols. such as brain-derived neurotrophic factor and neurotoxic factors including beta amyloid (Aβ) peptide.  Because it has been previously demonstrated that phosphodiesterase-5 inhibitors (PDE5-Is) protect against hippocampal synaptic dysfunction and memory deficits in mouse models of Alzheimer's disease and physiol. aging, we investigated the effect of a treatment with the PDE5-I, sildenafil, on cell death, pro- and antiapoptotic mols., and Aβ prodn.  We demonstrated that chronic i.p. injection of sildenafil (3 mg/kg for 3 wk) decreased terminal deoxyuridine triphosphate nick end labeling-pos. cells in the CA1 hippocampal area of 26-30-mo-old mice, downregulating the proapoptotic proteins, caspase-3 and B-cell lymphoma 2-assocd. X, and increasing antiapoptotic mols. such as B-cell lymphoma protein-2 and brain-derived neurotrophic factor.  Also, sildenafil reverted the shifting of amyloid precursor protein processing toward Aβ42 prodn. and the increase of the Aβ42:Aβ40 ratio in aged mice.  Our data suggest that PDE5-I might be beneficial to treat age-related detrimental features in a physiol. mouse model of aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQfx5_aPXHqbVg90H21EOLACvtfcHk0liZ71gtQRv59Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFykur%252FI&md5=4f8f5b69a3340d0e6fa552052d194940</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2013.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2013.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DLoreto%26aufirst%3DC.%26aulast%3DGiunta%26aufirst%3DS.%26aulast%3DMusumeci%26aufirst%3DG.%26aulast%3DFrasca%26aufirst%3DG.%26aulast%3DPodda%26aufirst%3DM.%2BV.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DPalmeri%26aufirst%3DA.%26atitle%3DEffect%2520of%2520phosphodiesterase-5%2520inhibition%2520on%2520apoptosis%2520and%2520beta%2520amyloid%2520load%2520in%2520aged%2520mice%26jtitle%3DNeurobiol.%2520Aging%26date%3D2014%26volume%3D35%26issue%3D3%26spage%3D520%26epage%3D531%26doi%3D10.1016%2Fj.neurobiolaging.2013.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, H.</span></span> <span> </span><span class="NLM_article-title">Anticancer efficacy of a nitric oxide-modified derivative of bifendate against multidrug-resistant cancer cells</span>. <i>J. Cell Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1095</span>– <span class="NLM_lpage">1105</span>, <span class="refDoi"> DOI: 10.1111/jcmm.12796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1111%2Fjcmm.12796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=26864945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos1Srt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=1095-1105&issue=6&author=Z.+Renauthor=X.+Guauthor=B.+Luauthor=Y.+Chenauthor=G.+Chenauthor=J.+Fengauthor=J.+Linauthor=Y.+Zhangauthor=H.+Peng&title=Anticancer+efficacy+of+a+nitric+oxide-modified+derivative+of+bifendate+against+multidrug-resistant+cancer+cells&doi=10.1111%2Fjcmm.12796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer efficacy of a nitric oxide-modified derivative of bifendate against multidrug-resistant cancer cells</span></div><div class="casAuthors">Ren, Zhiguang; Gu, Xiaoke; Lu, Bin; Chen, Yaqiong; Chen, Guojiang; Feng, Jiannan; Lin, Jizhen; Zhang, Yihua; Peng, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1095-1105</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-4934</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The development of multidrug resistance (MDR) not only actively transports a wide range of cytotoxic drugs across drug transporters but is also a complex interaction between a no. of important cellular signalling pathways.  Nitric oxide donors appear to be a new class of anticancer therapeutics for satisfying all the above conditions.  Previously, we reported furoxan-based nitric oxide-releasing compds. that exhibited selective antitumor activity in vitro and in vivo.  Herein, we demonstrate that bifendate (DDB)-nitric oxide, a synthetic furoxan-based nitric oxide-releasing deriv. of bifendate, effectively inhibits the both sensitive and MDR tumor cell viability at a comparatively low concn.  Interestingly, the potency of DDB-nitric oxide is the independent of inhibition of the functions and expressions of three major ABC transporters.  The mechanism of DDB-nitric oxide appears to be in two modes of actions by inducing mitochondrial tyrosine nitration and apoptosis, as well as by down-regulating HIF-1α expression and protein kinase B (AKT), extracellular signal-regulated kinases (ERK), nuclear factor κB (NF-κB) activation in MDR cells.  Moreover, the addn. of a typical nitric oxide scavenger significantly attenuated all the effects of DDB-nitric oxide, indicating that the cytotoxicity of DDB-nitric oxide is as a result of higher levels of nitric oxide release in MDR cancer cells.  Given that acquired MDR to nitric oxide donors is reportedly difficult to achieve and genetically unstable, compd. like DDB-nitric oxide may be a new type of therapeutic agent for the treatment of MDR tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplHi8uVSb7J7Vg90H21EOLACvtfcHk0liZ71gtQRv59Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos1Srt78%253D&md5=b0bbc08e2f956075b8adf5759ca47c46</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fjcmm.12796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjcmm.12796%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DZ.%26aulast%3DGu%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DH.%26atitle%3DAnticancer%2520efficacy%2520of%2520a%2520nitric%2520oxide-modified%2520derivative%2520of%2520bifendate%2520against%2520multidrug-resistant%2520cancer%2520cells%26jtitle%3DJ.%2520Cell%2520Mol.%2520Med.%26date%3D2016%26volume%3D20%26issue%3D6%26spage%3D1095%26epage%3D1105%26doi%3D10.1111%2Fjcmm.12796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Almeida, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passalacqua, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, F. A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peccinini, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chegaev, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guglielmo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruttero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graminha, M. A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">dos
Santos, J. L.</span></span> <span> </span><span class="NLM_article-title">Leishmanicidal activities of novel synthetic furoxan and benzofuroxan derivatives</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4837</span>– <span class="NLM_lpage">4847</span>, <span class="refDoi"> DOI: 10.1128/AAC.00052-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1128%2FAAC.00052-14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=4837-4847&issue=8&author=L.+A.+Dutraauthor=L.+de+Almeidaauthor=T.+G.+Passalacquaauthor=J.+S.+Reisauthor=F.+A.+E.+Torresauthor=I.+Martinezauthor=R.+G.+Peccininiauthor=C.+M.+Chinauthor=K.+Chegaevauthor=S.+Guglielmoauthor=R.+Frutteroauthor=M.+A.+S.+Graminhaauthor=J.+L.+dos%0ASantos&title=Leishmanicidal+activities+of+novel+synthetic+furoxan+and+benzofuroxan+derivatives&doi=10.1128%2FAAC.00052-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FAAC.00052-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00052-14%26sid%3Dliteratum%253Aachs%26aulast%3DDutra%26aufirst%3DL.%2BA.%26aulast%3Dde%2BAlmeida%26aufirst%3DL.%26aulast%3DPassalacqua%26aufirst%3DT.%2BG.%26aulast%3DReis%26aufirst%3DJ.%2BS.%26aulast%3DTorres%26aufirst%3DF.%2BA.%2BE.%26aulast%3DMartinez%26aufirst%3DI.%26aulast%3DPeccinini%26aufirst%3DR.%2BG.%26aulast%3DChin%26aufirst%3DC.%2BM.%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DGuglielmo%26aufirst%3DS.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DGraminha%26aufirst%3DM.%2BA.%2BS.%26aulast%3Ddos%2BSantos%26aufirst%3DJ.%2BL.%26atitle%3DLeishmanicidal%2520activities%2520of%2520novel%2520synthetic%2520furoxan%2520and%2520benzofuroxan%2520derivatives%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26issue%3D8%26spage%3D4837%26epage%3D4847%26doi%3D10.1128%2FAAC.00052-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tosco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertinaria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Stilo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cena, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorba, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruttero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasco, A.</span></span> <span> </span><span class="NLM_article-title">Furoxan analogues of the histamine H3-receptor antagonist imoproxifan and related furazan derivatives</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">4750</span>– <span class="NLM_lpage">4759</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.bmc.2005.05.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=4750-4759&issue=15&author=P.+Toscoauthor=M.+Bertinariaauthor=A.+Di+Stiloauthor=C.+Cenaauthor=G.+Sorbaauthor=R.+Frutteroauthor=A.+Gasco&title=Furoxan+analogues+of+the+histamine+H3-receptor+antagonist+imoproxifan+and+related+furazan+derivatives&doi=10.1016%2Fj.bmc.2005.05.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DTosco%26aufirst%3DP.%26aulast%3DBertinaria%26aufirst%3DM.%26aulast%3DDi%2BStilo%26aufirst%3DA.%26aulast%3DCena%26aufirst%3DC.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DGasco%26aufirst%3DA.%26atitle%3DFuroxan%2520analogues%2520of%2520the%2520histamine%2520H3-receptor%2520antagonist%2520imoproxifan%2520and%2520related%2520furazan%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26issue%3D15%26spage%3D4750%26epage%3D4759%26doi%3D10.1016%2Fj.bmc.2005.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chegaev, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cena, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolando, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertinaria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruttero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrupt, P.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasco, A.</span></span> <span> </span><span class="NLM_article-title">Edaravone derivatives containing NO-donor functions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">574</span>– <span class="NLM_lpage">578</span>, <span class="refDoi"> DOI: 10.1021/jm8007008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8007008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=574-578&issue=2&author=K.+Chegaevauthor=C.+Cenaauthor=M.+Giorgisauthor=B.+Rolandoauthor=P.+Toscoauthor=M.+Bertinariaauthor=R.+Frutteroauthor=P.-A.+Carruptauthor=A.+Gasco&title=Edaravone+derivatives+containing+NO-donor+functions&doi=10.1021%2Fjm8007008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm8007008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8007008%26sid%3Dliteratum%253Aachs%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DCena%26aufirst%3DC.%26aulast%3DGiorgis%26aufirst%3DM.%26aulast%3DRolando%26aufirst%3DB.%26aulast%3DTosco%26aufirst%3DP.%26aulast%3DBertinaria%26aufirst%3DM.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26aulast%3DGasco%26aufirst%3DA.%26atitle%3DEdaravone%2520derivatives%2520containing%2520NO-donor%2520functions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D2%26spage%3D574%26epage%3D578%26doi%3D10.1021%2Fjm8007008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waseem, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sana, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somakala, K.</span></span> <span> </span><span class="NLM_article-title">Furoxan derivatives as nitric oxide donors and their therapeutic potential</span>. <i>Int. Res. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">599</span>, <span class="refDoi"> DOI: 10.7897/2230-8407.069115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.7897%2F2230-8407.069115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFemu7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=585-599&issue=9&author=M.+Amirauthor=A.+M.+Waseemauthor=T.+Sanaauthor=K.+Somakala&title=Furoxan+derivatives+as+nitric+oxide+donors+and+their+therapeutic+potential&doi=10.7897%2F2230-8407.069115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Furoxan derivatives as nitric oxide donors and their therapeutic potential</span></div><div class="casAuthors">Amir, Mohammad; Waseem, Akhter Mohammad; Sana, Tariq; Somakala, Kanagasabai</div><div class="citationInfo"><span class="NLM_cas:title">International Research Journal of Pharmacy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">585-599</span>CODEN:
                <span class="NLM_cas:coden">IRJPBS</span>;
        ISSN:<span class="NLM_cas:issn">2230-8407</span>.
    
            (<span class="NLM_cas:orgname">Moksha Publishing House</span>)
        </div><div class="casAbstract">Nitric oxide synthesized in endothelial cells that line blood vessels, was first described in 1980 as an endothelium derived vascular relaxing factor.  It is an important signalling mol. in various pathol. and physiol. processes.  Dysfunction of NO formation has been implicated in the pathogenesis of a no. of disorders.  Exogenous NO sources constitute a powerful way to supplement NO when the body cannot generate enough for normal biol. functions.  Furoxan, 1,2,5-oxadiazole 2-oxide, has been a very important scaffold in Medicinal Chem. as nitric oxide (NO) donor.  This article explores some of the most promising recent advances in NO donor drug development.  Major focus is placed on recently developed Furoxan derivs. as NO donors and their pharmacol. actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoanFomb-2pPrVg90H21EOLACvtfcHk0lgUraFR7ip3ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFemu7vL&md5=f77e1eefed3e5001931edacbcfe76940</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.7897%2F2230-8407.069115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7897%252F2230-8407.069115%26sid%3Dliteratum%253Aachs%26aulast%3DAmir%26aufirst%3DM.%26aulast%3DWaseem%26aufirst%3DA.%2BM.%26aulast%3DSana%26aufirst%3DT.%26aulast%3DSomakala%26aufirst%3DK.%26atitle%3DFuroxan%2520derivatives%2520as%2520nitric%2520oxide%2520donors%2520and%2520their%2520therapeutic%2520potential%26jtitle%3DInt.%2520Res.%2520J.%2520Pharm.%26date%3D2015%26volume%3D6%26issue%3D9%26spage%3D585%26epage%3D599%26doi%3D10.7897%2F2230-8407.069115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velazquez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, P. N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaus, E. E.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2749</span>– <span class="NLM_lpage">2757</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.02.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.bmc.2005.02.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=2749-2757&issue=8&author=C.+Velazquezauthor=P.+N.+P.+Raoauthor=R.+McDonaldauthor=E.+E.+Knaus&title=Synthesis+and+biological+evaluation+of+3%2C4-diphenyl-1%2C2%2C5-oxadiazole-2-oxides+and+3%2C4-diphenyl-1%2C2%2C5-oxadiazoles+as+potential+hybrid+COX-2+inhibitor%2Fnitric+oxide+donor+agents&doi=10.1016%2Fj.bmc.2005.02.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.02.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.02.034%26sid%3Dliteratum%253Aachs%26aulast%3DVelazquez%26aufirst%3DC.%26aulast%3DRao%26aufirst%3DP.%2BN.%2BP.%26aulast%3DMcDonald%26aufirst%3DR.%26aulast%3DKnaus%26aufirst%3DE.%2BE.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25203%252C4-diphenyl-1%252C2%252C5-oxadiazole-2-oxides%2520and%25203%252C4-diphenyl-1%252C2%252C5-oxadiazoles%2520as%2520potential%2520hybrid%2520COX-2%2520inhibitor%252Fnitric%2520oxide%2520donor%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26issue%3D8%26spage%3D2749%26epage%3D2757%26doi%3D10.1016%2Fj.bmc.2005.02.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schiefer, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VandeVrede, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatcher, G. R. J.</span></span> <span> </span><span class="NLM_article-title">Furoxans (1,2,5-oxadiazole-N-oxides) as novel NO mimetic neuroprotective and procognitive agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3076</span>– <span class="NLM_lpage">3087</span>, <span class="refDoi"> DOI: 10.1021/jm201504s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201504s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3076-3087&issue=7&author=I.+T.+Schieferauthor=L.+VandeVredeauthor=M.+Faauthor=O.+Arancioauthor=G.+R.+J.+Thatcher&title=Furoxans+%281%2C2%2C5-oxadiazole-N-oxides%29+as+novel+NO+mimetic+neuroprotective+and+procognitive+agents&doi=10.1021%2Fjm201504s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm201504s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201504s%26sid%3Dliteratum%253Aachs%26aulast%3DSchiefer%26aufirst%3DI.%2BT.%26aulast%3DVandeVrede%26aufirst%3DL.%26aulast%3DFa%26aufirst%3DM.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26atitle%3DFuroxans%2520%25281%252C2%252C5-oxadiazole-N-oxides%2529%2520as%2520novel%2520NO%2520mimetic%2520neuroprotective%2520and%2520procognitive%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D7%26spage%3D3076%26epage%3D3087%26doi%3D10.1021%2Fjm201504s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chegaev, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolando, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruttero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morbin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fugnanesi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badiola, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasparini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grassi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasco, A.</span></span> <span> </span><span class="NLM_article-title">NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">4688</span>– <span class="NLM_lpage">4698</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.05.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.bmc.2015.05.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=4688-4698&issue=15&author=K.+Chegaevauthor=A.+Federicoauthor=E.+Mariniauthor=B.+Rolandoauthor=R.+Frutteroauthor=M.+Morbinauthor=G.+Rossiauthor=V.+Fugnanesiauthor=A.+Bastoneauthor=M.+Salmonaauthor=N.+B.+Badiolaauthor=L.+Gaspariniauthor=S.+Coccoauthor=C.+Ripoliauthor=C.+Grassiauthor=A.+Gasco&title=NO-donor+thiacarbocyanines+as+multifunctional+agents+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2015.05.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.05.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.05.050%26sid%3Dliteratum%253Aachs%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DFederico%26aufirst%3DA.%26aulast%3DMarini%26aufirst%3DE.%26aulast%3DRolando%26aufirst%3DB.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DMorbin%26aufirst%3DM.%26aulast%3DRossi%26aufirst%3DG.%26aulast%3DFugnanesi%26aufirst%3DV.%26aulast%3DBastone%26aufirst%3DA.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DBadiola%26aufirst%3DN.%2BB.%26aulast%3DGasparini%26aufirst%3DL.%26aulast%3DCocco%26aufirst%3DS.%26aulast%3DRipoli%26aufirst%3DC.%26aulast%3DGrassi%26aufirst%3DC.%26aulast%3DGasco%26aufirst%3DA.%26atitle%3DNO-donor%2520thiacarbocyanines%2520as%2520multifunctional%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26issue%3D15%26spage%3D4688%26epage%3D4698%26doi%3D10.1016%2Fj.bmc.2015.05.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gleeson, M. P.</span></span> <span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">817</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1021/jm701122q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&issue=4&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb&doi=10.1021%2Fjm701122q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0licb2YHUIxTDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D4%26spage%3D817%26epage%3D834%26doi%3D10.1021%2Fjm701122q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rankovic, Z.</span></span> <span> </span><span class="NLM_article-title">CNS drug design: balancing physicochemical properties for optimal brain exposure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2584</span>– <span class="NLM_lpage">2608</span>, <span class="refDoi"> DOI: 10.1021/jm501535r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501535r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2584-2608&issue=6&author=Z.+Rankovic&title=CNS+drug+design%3A+balancing+physicochemical+properties+for+optimal+brain+exposure&doi=10.1021%2Fjm501535r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure</span></div><div class="casAuthors">Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2584-2608</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins.  Designing mols. that can overcome this protection system and achieve optimal concn. at the desired therapeutic target in the brain is a specific and major challenge for medicinal chemists working in CNS drug discovery.  Analogous to the now widely accepted rule of 5 in the design of oral drugs, the physicochem. properties required for optimal brain exposure have been extensively studied in an attempt to similarly define the attributes of successful CNS drugs and drug candidates.  This body of work is systematically reviewed here, with a particular emphasis on the interplay between the most crit. physicochem. and pharmacokinetic parameters of CNS drugs as well as their impact on medicinal chem. strategies toward mols. with optimal brain exposure.  A summary of modern CNS pharmacokinetic concepts and methods is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8V0N1j49uuLVg90H21EOLACvtfcHk0licb2YHUIxTDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP&md5=f01e3f2dc4e2eff7b0618124277a5cf8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm501535r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501535r%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DCNS%2520drug%2520design%253A%2520balancing%2520physicochemical%2520properties%2520for%2520optimal%2520brain%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D6%26spage%3D2584%26epage%3D2608%26doi%3D10.1021%2Fjm501535r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cecchelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berezowski, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundquist, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renftel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehouck, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenart, L.</span></span> <span> </span><span class="NLM_article-title">Modelling of the blood-brain barrier in drug discovery and development</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1038/nrd2368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1038%2Fnrd2368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=17667956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotl2qtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=650-661&issue=8&author=R.+Cecchelliauthor=V.+Berezowskiauthor=S.+Lundquistauthor=M.+Culotauthor=M.+Renftelauthor=M.-P.+Dehouckauthor=L.+Fenart&title=Modelling+of+the+blood-brain+barrier+in+drug+discovery+and+development&doi=10.1038%2Fnrd2368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Modelling of the blood-brain barrier in drug discovery and development</span></div><div class="casAuthors">Cecchelli, Romeo; Berezowski, Vincent; Lundquist, Stefan; Culot, Maxime; Renftel, Mila; Dehouck, Marie-Pierre; Fenart, Laurence</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">650-661</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The market for neuropharmaceuticals is potentially one of the largest sectors of the global pharmaceutical market owing to the increase in av. life expectancy and the fact that many neurol. disorders have been largely refractory to pharmacotherapy.  The brain is a delicate organ that can efficiently protect itself from harmful compds. and precisely regulate its microenvironment.  Unfortunately, the same mechanisms can also prove to be formidable hurdles in drug development.  An improved understanding of the regulatory interfaces that exist between blood and brain may provide novel and more effective strategies to treat neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2naeQVJt75bVg90H21EOLACvtfcHk0liLLWrfTnPUCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotl2qtLc%253D&md5=94e3cea28faa1ba4e9ad98123a3fa4bd</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnrd2368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2368%26sid%3Dliteratum%253Aachs%26aulast%3DCecchelli%26aufirst%3DR.%26aulast%3DBerezowski%26aufirst%3DV.%26aulast%3DLundquist%26aufirst%3DS.%26aulast%3DCulot%26aufirst%3DM.%26aulast%3DRenftel%26aufirst%3DM.%26aulast%3DDehouck%26aufirst%3DM.-P.%26aulast%3DFenart%26aufirst%3DL.%26atitle%3DModelling%2520of%2520the%2520blood-brain%2520barrier%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26issue%3D8%26spage%3D650%26epage%3D661%26doi%3D10.1038%2Fnrd2368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitteringham, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, P. M.</span></span> <span> </span><span class="NLM_article-title">Metabolism of fluorine-containing drugs</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1146/annurev.pharmtox.41.1.443</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1146%2Fannurev.pharmtox.41.1.443" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=443-470&issue=1&author=B.+K.+Parkauthor=N.+R.+Kitteringhamauthor=P.+M.+O%E2%80%99Neill&title=Metabolism+of+fluorine-containing+drugs&doi=10.1146%2Fannurev.pharmtox.41.1.443"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.41.1.443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.41.1.443%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DB.%2BK.%26aulast%3DKitteringham%26aufirst%3DN.%2BR.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26atitle%3DMetabolism%2520of%2520fluorine-containing%2520drugs%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2001%26volume%3D41%26issue%3D1%26spage%3D443%26epage%3D470%26doi%3D10.1146%2Fannurev.pharmtox.41.1.443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruela, A. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueiredo, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, G. R.</span></span> <span> </span><span class="NLM_article-title">LC-PDA and LC-MS studies of donepezil hydrochloride degradation behaviour in forced stress conditions</span>. <i>J. Braz. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2094</span>– <span class="NLM_lpage">2101</span>, <span class="refDoi"> DOI: 10.5935/0103-5053.20140199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.5935%2F0103-5053.20140199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktVyqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=2094-2101&author=A.+L.+M.+Ruelaauthor=M.+G.+Santosauthor=E.+C.+Figueiredoauthor=G.+R.+Pereira&title=LC-PDA+and+LC-MS+studies+of+donepezil+hydrochloride+degradation+behaviour+in+forced+stress+conditions&doi=10.5935%2F0103-5053.20140199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">LC-PDA and LC-MS studies of donepezil hydrochloride degradation behaviour in forced stress conditions</span></div><div class="casAuthors">Ruela, Andre L. M.; Santos, Mariane G.; Figueiredo, Eduardo C.; Pereira, Gislaine R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Brazilian Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2094-2101</span>CODEN:
                <span class="NLM_cas:coden">JOCSET</span>;
        ISSN:<span class="NLM_cas:issn">0103-5053</span>.
    
            (<span class="NLM_cas:orgname">Sociedade Brasileira de Quimica</span>)
        </div><div class="casAbstract">The aim of this work was to study the intrinsic stability of donepezil hydrochloride in conditions of forced degrdn. (acid stress, alk. stress, oxidant stress, light exposure and dry heat).  The degrdn. profile of donepezil was characterized by liq. chromatog.-mass spectrometry (LC-MS) and high-performance liq. chromatog. coupled with photodiode array detection (LC-PDA).  According to the results, the degrdn. products were sepd. and detected in acid and alk. solns.  After seven days at room temp., the recovery of donepezil in alk. soln. (0.1 mol L-1 NaOH) was about 42%, and three degrdn. products were detected.  In acid soln. (0.1 mol L-1 HCl), the drug recovery was about 86%, and three degrdn. products were detected.  Thus, it was possible to propose a rapid and selective stability-indicating assay method using reversed-phase liq. chromatog. for anal. of donepezil and their degrdn. products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzbov7GB9BZLVg90H21EOLACvtfcHk0liLLWrfTnPUCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktVyqsQ%253D%253D&md5=1eba03d5c7257f7620de2a4c7b72d5c7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.5935%2F0103-5053.20140199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5935%252F0103-5053.20140199%26sid%3Dliteratum%253Aachs%26aulast%3DRuela%26aufirst%3DA.%2BL.%2BM.%26aulast%3DSantos%26aufirst%3DM.%2BG.%26aulast%3DFigueiredo%26aufirst%3DE.%2BC.%26aulast%3DPereira%26aufirst%3DG.%2BR.%26atitle%3DLC-PDA%2520and%2520LC-MS%2520studies%2520of%2520donepezil%2520hydrochloride%2520degradation%2520behaviour%2520in%2520forced%2520stress%2520conditions%26jtitle%3DJ.%2520Braz.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D25%26spage%3D2094%26epage%3D2101%26doi%3D10.5935%2F0103-5053.20140199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugan, L. L.</span></span> <span> </span><span class="NLM_article-title">Techniques for assessing neuroprotective drugs in vitro</span>. <i>Int. Rev. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/S0074-7742(08)60716-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2FS0074-7742%2808%2960716-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1996&pages=69-93&author=M.+P.+Goldbergauthor=U.+Strasserauthor=L.+L.+Dugan&title=Techniques+for+assessing+neuroprotective+drugs+in+vitro&doi=10.1016%2FS0074-7742%2808%2960716-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0074-7742%2808%2960716-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0074-7742%252808%252960716-3%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DM.%2BP.%26aulast%3DStrasser%26aufirst%3DU.%26aulast%3DDugan%26aufirst%3DL.%2BL.%26atitle%3DTechniques%2520for%2520assessing%2520neuroprotective%2520drugs%2520in%2520vitro%26jtitle%3DInt.%2520Rev.%2520Neurobiol.%26date%3D1996%26volume%3D40%26spage%3D69%26epage%3D93%26doi%3D10.1016%2FS0074-7742%2808%2960716-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shineman, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basi, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bizon, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colton, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollister, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lincecum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morse, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Refolo, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scearce-Levie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yrjanheikki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillit, H. M.</span></span> <span> </span><span class="NLM_article-title">Accelerating drug discovery for Alzheimer’s disease: best practices for preclinical animal studies</span>. <i>Alzheimer's Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">28</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1186/alzrt90</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1186%2Falzrt90" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=1-13&issue=28&author=D.+W.+Shinemanauthor=G.+S.+Basiauthor=J.+L.+Bizonauthor=C.+A.+Coltonauthor=B.+D.+Greenbergauthor=B.+A.+Hollisterauthor=J.+Lincecumauthor=G.+G.+Leblancauthor=L.+B.+Leeauthor=F.+Luoauthor=D.+Morganauthor=I.+Morseauthor=L.+M.+Refoloauthor=D.+R.+Riddellauthor=K.+Scearce-Levieauthor=P.+Sweeneyauthor=J.+Yrjanheikkiauthor=H.+M.+Fillit&title=Accelerating+drug+discovery+for+Alzheimer%E2%80%99s+disease%3A+best+practices+for+preclinical+animal+studies&doi=10.1186%2Falzrt90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1186%2Falzrt90&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt90%26sid%3Dliteratum%253Aachs%26aulast%3DShineman%26aufirst%3DD.%2BW.%26aulast%3DBasi%26aufirst%3DG.%2BS.%26aulast%3DBizon%26aufirst%3DJ.%2BL.%26aulast%3DColton%26aufirst%3DC.%2BA.%26aulast%3DGreenberg%26aufirst%3DB.%2BD.%26aulast%3DHollister%26aufirst%3DB.%2BA.%26aulast%3DLincecum%26aufirst%3DJ.%26aulast%3DLeblanc%26aufirst%3DG.%2BG.%26aulast%3DLee%26aufirst%3DL.%2BB.%26aulast%3DLuo%26aufirst%3DF.%26aulast%3DMorgan%26aufirst%3DD.%26aulast%3DMorse%26aufirst%3DI.%26aulast%3DRefolo%26aufirst%3DL.%2BM.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSweeney%26aufirst%3DP.%26aulast%3DYrjanheikki%26aufirst%3DJ.%26aulast%3DFillit%26aufirst%3DH.%2BM.%26atitle%3DAccelerating%2520drug%2520discovery%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520best%2520practices%2520for%2520preclinical%2520animal%2520studies%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2011%26volume%3D3%26issue%3D28%26spage%3D1%26epage%3D13%26doi%3D10.1186%2Falzrt90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glicksman, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hull-Ryde, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span> <span> </span><span class="NLM_article-title">Tackling reproducibility in academic preclinical drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">733</span>– <span class="NLM_lpage">734</span>, <span class="refDoi"> DOI: 10.1038/nrd4737</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1038%2Fnrd4737" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=733-734&issue=11&author=S.+V.+Fryeauthor=M.+R.+Arkinauthor=C.+H.+Arrowsmithauthor=P.+J.+Connauthor=M.+A.+Glicksmanauthor=E.+A.+Hull-Rydeauthor=B.+S.+Slusher&title=Tackling+reproducibility+in+academic+preclinical+drug+discovery&doi=10.1038%2Fnrd4737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnrd4737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4737%26sid%3Dliteratum%253Aachs%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DGlicksman%26aufirst%3DM.%2BA.%26aulast%3DHull-Ryde%26aufirst%3DE.%2BA.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26atitle%3DTackling%2520reproducibility%2520in%2520academic%2520preclinical%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26issue%3D11%26spage%3D733%26epage%3D734%26doi%3D10.1038%2Fnrd4737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferriero, D.</span></span> <span> </span><span class="NLM_article-title">Signaling pathway involved in hypoxia-inducible factor-1alpha regulation in hypoxic-ischemic cortical neurons in vitro</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>461</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.1016/j.neulet.2009.03.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.neulet.2009.03.091" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=1-6&issue=1&author=L.+Zhangauthor=Y.+Quauthor=C.+Yangauthor=J.+Tangauthor=X.+Zhangauthor=M.+Maoauthor=D.+Muauthor=D.+Ferriero&title=Signaling+pathway+involved+in+hypoxia-inducible+factor-1alpha+regulation+in+hypoxic-ischemic+cortical+neurons+in+vitro&doi=10.1016%2Fj.neulet.2009.03.091"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2009.03.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2009.03.091%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DQu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DM.%26aulast%3DMu%26aufirst%3DD.%26aulast%3DFerriero%26aufirst%3DD.%26atitle%3DSignaling%2520pathway%2520involved%2520in%2520hypoxia-inducible%2520factor-1alpha%2520regulation%2520in%2520hypoxic-ischemic%2520cortical%2520neurons%2520in%2520vitro%26jtitle%3DNeurosci.%2520Lett.%26date%3D2009%26volume%3D461%26issue%3D1%26spage%3D1%26epage%3D6%26doi%3D10.1016%2Fj.neulet.2009.03.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chung, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span> <span> </span><span class="NLM_article-title">Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells</span>. <i>J. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>198</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.1677/JOE-08-0160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1677%2FJOE-08-0160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=18541646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Clt7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2008&pages=511-521&issue=3&author=H.+Chungauthor=S.+Seoauthor=M.+Moonauthor=S.+Park&title=Phosphatidylinositol-3-kinase%2FAkt%2Fglycogen+synthase+kinase-3+beta+and+ERK1%2F2+pathways+mediate+protective+effects+of+acylated+and+unacylated+ghrelin+against+oxygen-glucose+deprivation-induced+apoptosis+in+primary+rat+cortical+neuronal+cells&doi=10.1677%2FJOE-08-0160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3β and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells</span></div><div class="casAuthors">Chung, Hyunju; Seo, Sanghee; Moon, Minho; Park, Seungjoon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endocrinology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">511-521</span>CODEN:
                <span class="NLM_cas:coden">JOENAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-0795</span>.
    
            (<span class="NLM_cas:orgname">Society for Endocrinology</span>)
        </div><div class="casAbstract">Only acylated ghrelin (AG) binds GH secretagog receptor 1a (GHS-R1a) and has central endocrine activities.  An anti-apoptotic effect of AG in neuronal cells has recently been reported.  However, whether there is a neuroprotective effect of unacylated ghrelin (UAG), the most abundant form of ghrelin in plasma, is still unknown.  Therefore, we investigated whether UAG was neuroprotective against ischemic neuronal injury using primary cultured rat cortical neurons exposed to oxygen and glucose deprivation (OGD).  Both AG and UAG inhibited OGD-induced apoptosis.  Exposure of cells to the receptor-specific antagonist D-Lys-3-GHRH-6 abolished the protective effects of AG against OGD, whereas those of UAG were preserved, suggesting the involvement of a receptor that is distinct from GHS-R1a.  Chem. inhibition of MAPK and phosphatidylinositol-3-kinase (PI3K) blocked the anti-apoptotic effects of AG and UAG.  Ghrelin siRNA enhanced apoptosis either during OGD or even in normoxic conditions.  The protective effects of AG and UAG were accompanied by an increased phosphorylation of extracellular signal-regulated kinase (ERK)1/2, Akt, and glycogen synthase kinase-3β (GSK-3β).  Furthermore, treatment of cells with AG or UAG resulted in nuclear translocation of β-catenin.  In addn., both AG and UAG increased the Bcl-2/Bax ratio, prevented cytochrome c release, and inhibited caspase-3 activation.  The data indicate that, independent of acylation, ghrelin can function as a neuroprotective agent that inhibits apoptotic pathways.  These effects may be mediated via activation of the MAPK and PI3K/Akt pathways.  Our data also suggest that PI3K/Akt-mediated inactivation of GSK-3β and stabilization of β-catenin contribute to the anti-apoptotic effects of ghrelin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptcvd5hjOsm7Vg90H21EOLACvtfcHk0lhbvCFCkoT4ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Clt7zE&md5=c5cc644ff57e49325df2a7db7b802934</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1677%2FJOE-08-0160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252FJOE-08-0160%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DH.%26aulast%3DSeo%26aufirst%3DS.%26aulast%3DMoon%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DS.%26atitle%3DPhosphatidylinositol-3-kinase%252FAkt%252Fglycogen%2520synthase%2520kinase-3%2520beta%2520and%2520ERK1%252F2%2520pathways%2520mediate%2520protective%2520effects%2520of%2520acylated%2520and%2520unacylated%2520ghrelin%2520against%2520oxygen-glucose%2520deprivation-induced%2520apoptosis%2520in%2520primary%2520rat%2520cortical%2520neuronal%2520cells%26jtitle%3DJ.%2520Endocrinol.%26date%3D2008%26volume%3D198%26issue%3D3%26spage%3D511%26epage%3D521%26doi%3D10.1677%2FJOE-08-0160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span> <span> </span><span class="NLM_article-title">Demystifying brain penetration in central nervous system drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1021/jm301297f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301297f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2-12&issue=1&author=L.+Diauthor=H.+Rongauthor=B.+Feng&title=Demystifying+brain+penetration+in+central+nervous+system+drug+discovery&doi=10.1021%2Fjm301297f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Demystifying Brain Penetration in Central Nervous System Drug Discovery</span></div><div class="casAuthors">Di, Li; Rong, Haojing; Feng, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-12</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This Perspective provides important concepts about the blood-brain barrier (BBB) in drug discovery and how they should be applied effectively in designing successful CNS drugs.  Key parameters for brain penetration are discussed, including unbound brain concn., unbound brain-to-plasma ratio, BBB permeability, fraction unbound in brain and plasma, and transporters.  Results from a retrospective anal. of 32 Pfizer CNS clin. drug candidates are described.  Frequently encountered misconceptions about brain penetration in drug discovery programs are clarified.  Strategies and guidance are provided to enhance or minimize brain exposure for CNS or peripheral targets, resp.  Recommendations for screening methodologies and a cascade in assessing brain penetration potential are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmurs7cfju37Vg90H21EOLACvtfcHk0lhbvCFCkoT4ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrJ&md5=8b88e2044bf41898ab40c45e18f2a20d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm301297f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301297f%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DB.%26atitle%3DDemystifying%2520brain%2520penetration%2520in%2520central%2520nervous%2520system%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D1%26spage%3D2%26epage%3D12%26doi%3D10.1021%2Fjm301297f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vandevrede, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavassoli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pepperberg, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatcher, G. R.</span></span> <span> </span><span class="NLM_article-title">Novel analogues of chlormethiazole are neuroprotective in four cellular models of neurodegeneration by a mechanism with variable dependence on GABAA receptor potentiation</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1111/bph.12454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1111%2Fbph.12454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=24116891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FktFyrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=389-402&issue=2&author=L.+Vandevredeauthor=E.+Tavassoliauthor=J.+Luoauthor=Z.+Qinauthor=L.+Yueauthor=D.+R.+Pepperbergauthor=G.+R.+Thatcher&title=Novel+analogues+of+chlormethiazole+are+neuroprotective+in+four+cellular+models+of+neurodegeneration+by+a+mechanism+with+variable+dependence+on+GABAA+receptor+potentiation&doi=10.1111%2Fbph.12454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel analogues of chlormethiazole are neuroprotective in four cellular models of neurodegeneration by a mechanism with variable dependence on GABA(A) receptor potentiation</span></div><div class="casAuthors">Vandevrede Lawren; Tavassoli Ehsan; Luo Jia; Qin Zhihui; Yue Lan; Pepperberg David R; Thatcher Gregory R</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">389-402</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Chlormethiazole (CMZ), a clinical sedative/anxiolytic agent, did not reach clinical efficacy in stroke trials despite neuroprotection demonstrated in numerous animal models.  Using CMZ as a lead compound, neuroprotective methiazole (MZ) analogues were developed, and neuroprotection and GABA(A) receptor dependence were studied.  EXPERIMENTAL APPROACH:  Eight MZs were selected from a novel library, of which two were studied in detail.  Neuroprotection, glutamate release, intracellular calcium and response to GABA blockade by picrotoxin were measured in rat primary cortical cultures using four cellular models of neurodegeneration.  GABA potentiation was assayed in oocytes expressing the α1β2γ2 GABA(A) receptor.  KEY RESULTS:  Neuroprotection against a range of insults was retained even with substantial chemical modification.  Dependence on GABAA receptor activity was variable: at the extremes, neuroprotection by GN-28 was universally sensitive to picrotoxin, while GN-38 was largely insensitive.  In parallel, effects on extracellular glutamate and intracellular calcium were associated with GABA(A) dependence.  Consistent with these findings, GN-28 potentiated α1β2γ2 GABA(A) function, whereas GN-38 had a weak inhibitory effect.  Neuroprotection against moderate dose oligomeric Aβ1 42 was also tolerant to structural changes.  CONCLUSIONS AND IMPLICATIONS:  The results support the concept that CMZ does not contain a single pharmacophore, rather that broad-spectrum neuroprotection results from a GABA(A)-dependent mechanism represented by GN-28, combined with a mechanism represented in GN-38 that shows the least dependence on GABA(A) receptors.  These findings allow further refinement of the neuroprotective pharmacophore and investigation into secondary mechanisms that will assist in identifying MZ-based compounds of use in treating neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR2QiW_eraOHRwLZxei1HN8fW6udTcc2ebftMHo6jnZILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FktFyrsQ%253D%253D&md5=da31587008978a7c5aee468fe69635d8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fbph.12454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12454%26sid%3Dliteratum%253Aachs%26aulast%3DVandevrede%26aufirst%3DL.%26aulast%3DTavassoli%26aufirst%3DE.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DQin%26aufirst%3DZ.%26aulast%3DYue%26aufirst%3DL.%26aulast%3DPepperberg%26aufirst%3DD.%2BR.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%26atitle%3DNovel%2520analogues%2520of%2520chlormethiazole%2520are%2520neuroprotective%2520in%2520four%2520cellular%2520models%2520of%2520neurodegeneration%2520by%2520a%2520mechanism%2520with%2520variable%2520dependence%2520on%2520GABAA%2520receptor%2520potentiation%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26issue%3D2%26spage%3D389%26epage%3D402%26doi%3D10.1111%2Fbph.12454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Besnard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruda, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abecassis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguiz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidah, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constam, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bickerton, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span> <span> </span><span class="NLM_article-title">Automated design of ligands to polypharmacological profiles</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>492</i></span> (<span class="NLM_issue">7428</span>),  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1038/nature11691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1038%2Fnature11691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=23235874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=215-220&issue=7428&author=J.+Besnardauthor=G.+F.+Rudaauthor=V.+Setolaauthor=K.+Abecassisauthor=R.+M.+Rodriguizauthor=X.+P.+Huangauthor=S.+Norvalauthor=M.+F.+Sassanoauthor=A.+I.+Shinauthor=L.+A.+Websterauthor=F.+R.+Simeonsauthor=L.+Stojanovskiauthor=A.+Pratauthor=N.+G.+Seidahauthor=D.+B.+Constamauthor=G.+R.+Bickertonauthor=K.+D.+Readauthor=W.+C.+Wetselauthor=I.+H.+Gilbertauthor=B.+L.+Rothauthor=A.+L.+Hopkins&title=Automated+design+of+ligands+to+polypharmacological+profiles&doi=10.1038%2Fnature11691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Automated design of ligands to polypharmacological profiles</span></div><div class="casAuthors">Besnard, Jeremy; Ruda, Gian Filippo; Setola, Vincent; Abecassis, Keren; Rodriguiz, Ramona M.; Huang, Xi-Ping; Norval, Suzanne; Sassano, Maria F.; Shin, Antony I.; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Prat, Annik; Seidah, Nabil G.; Constam, Daniel B.; Bickerton, G. Richard; Read, Kevin D.; Wetsel, William C.; Gilbert, Ian H.; Roth, Bryan L.; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">492</span>
        (<span class="NLM_cas:issue">7428</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy and safety of a drug is detd. by its activity profile across many proteins in the proteome.  However, designing drugs with a specific multi-target profile is both complex and difficult.  Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery.  Here is described a new approach for the automated design of ligands against profiles of multiple drug targets.  The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug donepezil (I) into brain-penetrable ligands with either specific polypharmacol. or exquisite selectivity profiles for G-protein-coupled receptors.  Overall, 800 ligand-target predictions of prospectively designed ligands were tested exptl., of which 75% were confirmed to be correct.  Target engagement in vivo is also demonstrated.  The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNu5bwrBD3tbVg90H21EOLACvtfcHk0lj6R9Do5mVcMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN&md5=ace6cced250cf968d327b482a5bf1798</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnature11691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11691%26sid%3Dliteratum%253Aachs%26aulast%3DBesnard%26aufirst%3DJ.%26aulast%3DRuda%26aufirst%3DG.%2BF.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DAbecassis%26aufirst%3DK.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DShin%26aufirst%3DA.%2BI.%26aulast%3DWebster%26aufirst%3DL.%2BA.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DConstam%26aufirst%3DD.%2BB.%26aulast%3DBickerton%26aufirst%3DG.%2BR.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DAutomated%2520design%2520of%2520ligands%2520to%2520polypharmacological%2520profiles%26jtitle%3DNature%26date%3D2012%26volume%3D492%26issue%3D7428%26spage%3D215%26epage%3D220%26doi%3D10.1038%2Fnature11691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hufeisen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Identification of human Ether-a-go-go related gene modulators by three screening platforms in an academic drug-discovery setting</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">742</span>, <span class="refDoi"> DOI: 10.1089/adt.2010.0331</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1089%2Fadt.2010.0331" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=727-742&issue=6&author=X.+P.+Huangauthor=T.+Manganoauthor=S.+Hufeisenauthor=V.+Setolaauthor=B.+L.+Roth&title=Identification+of+human+Ether-a-go-go+related+gene+modulators+by+three+screening+platforms+in+an+academic+drug-discovery+setting&doi=10.1089%2Fadt.2010.0331"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1089%2Fadt.2010.0331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2010.0331%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DMangano%26aufirst%3DT.%26aulast%3DHufeisen%26aufirst%3DS.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DIdentification%2520of%2520human%2520Ether-a-go-go%2520related%2520gene%2520modulators%2520by%2520three%2520screening%2520platforms%2520in%2520an%2520academic%2520drug-discovery%2520setting%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2010%26volume%3D8%26issue%3D6%26spage%3D727%26epage%3D742%26doi%3D10.1089%2Fadt.2010.0331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angelucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvisi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosentino, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozzolino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Witt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghirardi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannessi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuliani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guaraldi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramacci, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scolastico, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinti, M. O.</span></span> <span> </span><span class="NLM_article-title">Synthesis and amnesia-reversal activity of a series of 7- and 5-membered 3-acylamino lactams</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1511</span>– <span class="NLM_lpage">1519</span>, <span class="refDoi"> DOI: 10.1021/jm00063a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00063a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=1511-1519&issue=11&author=L.+Angelucciauthor=P.+Calvisiauthor=R.+Catiniauthor=U.+Cosentinoauthor=R.+Cozzolinoauthor=P.+De+Wittauthor=O.+Ghirardiauthor=F.+Giannessiauthor=A.+Giulianiauthor=D.+Guaraldiauthor=D.+Misitiauthor=M.+T.+Ramacciauthor=C.+Scolasticoauthor=M.+O.+Tinti&title=Synthesis+and+amnesia-reversal+activity+of+a+series+of+7-+and+5-membered+3-acylamino+lactams&doi=10.1021%2Fjm00063a001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm00063a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00063a001%26sid%3Dliteratum%253Aachs%26aulast%3DAngelucci%26aufirst%3DL.%26aulast%3DCalvisi%26aufirst%3DP.%26aulast%3DCatini%26aufirst%3DR.%26aulast%3DCosentino%26aufirst%3DU.%26aulast%3DCozzolino%26aufirst%3DR.%26aulast%3DDe%2BWitt%26aufirst%3DP.%26aulast%3DGhirardi%26aufirst%3DO.%26aulast%3DGiannessi%26aufirst%3DF.%26aulast%3DGiuliani%26aufirst%3DA.%26aulast%3DGuaraldi%26aufirst%3DD.%26aulast%3DMisiti%26aufirst%3DD.%26aulast%3DRamacci%26aufirst%3DM.%2BT.%26aulast%3DScolastico%26aufirst%3DC.%26aulast%3DTinti%26aufirst%3DM.%2BO.%26atitle%3DSynthesis%2520and%2520amnesia-reversal%2520activity%2520of%2520a%2520series%2520of%25207-%2520and%25205-membered%25203-acylamino%2520lactams%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26issue%3D11%26spage%3D1511%26epage%3D1519%26doi%3D10.1021%2Fjm00063a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeiffer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccaboni, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banfi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagetti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorigotti, L.</span></span> <span> </span><span class="NLM_article-title">Synthesis and pharmacological activity of a series of dihydro-1H-pyrrolo[1,2-a]imidazole-2,5(3H,6H)-diones, a novel class of potent cognition enhancers</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">4214</span>– <span class="NLM_lpage">4220</span>, <span class="refDoi"> DOI: 10.1021/jm00078a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00078a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=4214-4220&issue=26&author=M.+Pinzaauthor=C.+Farinaauthor=A.+Cerriauthor=U.+Pfeifferauthor=M.+T.+Riccaboniauthor=S.+Banfiauthor=R.+Biagettiauthor=O.+Pozziauthor=M.+Magnaniauthor=L.+Dorigotti&title=Synthesis+and+pharmacological+activity+of+a+series+of+dihydro-1H-pyrrolo%5B1%2C2-a%5Dimidazole-2%2C5%283H%2C6H%29-diones%2C+a+novel+class+of+potent+cognition+enhancers&doi=10.1021%2Fjm00078a011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm00078a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00078a011%26sid%3Dliteratum%253Aachs%26aulast%3DPinza%26aufirst%3DM.%26aulast%3DFarina%26aufirst%3DC.%26aulast%3DCerri%26aufirst%3DA.%26aulast%3DPfeiffer%26aufirst%3DU.%26aulast%3DRiccaboni%26aufirst%3DM.%2BT.%26aulast%3DBanfi%26aufirst%3DS.%26aulast%3DBiagetti%26aufirst%3DR.%26aulast%3DPozzi%26aufirst%3DO.%26aulast%3DMagnani%26aufirst%3DM.%26aulast%3DDorigotti%26aufirst%3DL.%26atitle%3DSynthesis%2520and%2520pharmacological%2520activity%2520of%2520a%2520series%2520of%2520dihydro-1H-pyrrolo%255B1%252C2-a%255Dimidazole-2%252C5%25283H%252C6H%2529-diones%252C%2520a%2520novel%2520class%2520of%2520potent%2520cognition%2520enhancers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26issue%3D26%26spage%3D4214%26epage%3D4220%26doi%3D10.1021%2Fjm00078a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regan, C. M.</span></span> <span> </span><span class="NLM_article-title">Repetitive and transient increases in hippocampal neural cell adhesion molecule polysialylation state following multitrial spatial training</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1268</span>– <span class="NLM_lpage">1274</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.1996.67031268.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1046%2Fj.1471-4159.1996.67031268.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=8752135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADyaK28XltlKkurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1996&pages=1268-1274&issue=3&author=K.+J.+Murphyauthor=A.+W.+O%E2%80%99Connellauthor=C.+M.+Regan&title=Repetitive+and+transient+increases+in+hippocampal+neural+cell+adhesion+molecule+polysialylation+state+following+multitrial+spatial+training&doi=10.1046%2Fj.1471-4159.1996.67031268.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Repetitive and transient increases in hippocampal neural cell adhesion molecule polysialylation state following multitrial spatial training</span></div><div class="casAuthors">Murphy, Keith J.; O'Connell, Alan W.; Regan, Ciaran M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1268-1274</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">Polysialylated neurons, located at the inner border of the dentate granule cell layer, have been demonstrated to exhibit time-dependent change in their frequency at 10-12 h following training in the Morris water maze, a spatial learning paradigm.  Such a change was not obsd. in animals required to locate a visible platform or in those rendered amnesic with scopolamine.  This frequency response was capable of rapid reactivation following further training stimuli in a manner that was independent of circadian influence.  These learning-assocd. modulations in neural cell adhesion mol. (NCAM) polysialylation state did not increase in magnitude despite improved performance suggesting their activation is required for processing information rather than contributing to previously stored, task-assocd. memory.  An increase in NCAM polysialylation appears to be a universal learning response to both spatial and nonspatial paradigms as similar time-dependent changes occurred following training in a one-trial, step-through, passive avoidance response subsequent to water maze training.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriKES1JLCGNrVg90H21EOLACvtfcHk0ljLT-VC0sWFMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltlKkurs%253D&md5=849485cd7883dca55bbc3b7e9778204d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1996.67031268.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1996.67031268.x%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DK.%2BJ.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DA.%2BW.%26aulast%3DRegan%26aufirst%3DC.%2BM.%26atitle%3DRepetitive%2520and%2520transient%2520increases%2520in%2520hippocampal%2520neural%2520cell%2520adhesion%2520molecule%2520polysialylation%2520state%2520following%2520multitrial%2520spatial%2520training%26jtitle%3DJ.%2520Neurochem.%26date%3D1996%26volume%3D67%26issue%3D3%26spage%3D1268%26epage%3D1274%26doi%3D10.1046%2Fj.1471-4159.1996.67031268.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, J. H.</span></span> <span> </span><span class="NLM_article-title">The ameliorating effects of stigmasterol on scopolamine-induced memory impairments in mice</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>676</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2011.11.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.ejphar.2011.11.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=22173129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1GlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=676&publication_year=2012&pages=64-70&issue=1&author=S.+J.+Parkauthor=D.+H.+Kimauthor=J.+M.+Jungauthor=J.+M.+Kimauthor=M.+Caiauthor=X.+Liuauthor=J.+G.+Hongauthor=C.+H.+Leeauthor=K.+R.+Leeauthor=J.+H.+Ryu&title=The+ameliorating+effects+of+stigmasterol+on+scopolamine-induced+memory+impairments+in+mice&doi=10.1016%2Fj.ejphar.2011.11.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The ameliorating effects of stigmasterol on scopolamine-induced memory impairments in mice</span></div><div class="casAuthors">Park, Se Jin; Kim, Dong Hyun; Jung, Jun Man; Kim, Jong Min; Cai, Mudan; Liu, Xiaotong; Hong, Jin Gyu; Lee, Chang Hwan; Lee, Kang Ro; Ryu, Jong Hoon</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">676</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">64-70</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Stigmasterol, a kind of phytosterol, is present in small amts. in various foods.  In the present study, we investigated the effects of stigmasterol on scopolamine-induced memory impairments using the passive avoidance and the Morris water maze tasks in mice.  In addn., changes in memory-related mols., including extracellular signal-regulated kinase (ERK) and cAMP response element-binding protein (CREB), were examd. following the administration of stigmasterol.  Scopolamine-induced memory impairments were significantly attenuated by the administration of stigmasterol (10 mg/kg) in the passive avoidance task.  In the Morris water maze task, the escape latencies were significantly decreased in the stigmasterol-treated group compared to the scopolamine-treated group during the training phase.  The swimming times within the target zone during the probe trial were significantly increased as compared to scopolamine-treated mice.  Furthermore, the ameliorating effect of stigmasterol on scopolamine-induced memory dysfunction was blocked by a sub-ED of dizocilpine (MK-801), an NMDA receptor antagonist, and tamoxifen, an estrogen receptor antagonist, in the passive avoidance task.  In addn., the expression levels of phosphorylated ERK and CREB in the hippocampus were significantly increased by stigmasterol, which was blocked by tamoxifen or MK-801 with scopolamine.  These results suggest that stigmasterol-induced cognitive ameliorative effects are mediated by the enhancement of cholinergic neurotransmission system via the activation of estrogen or NMDA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRNdp0qIyRVLVg90H21EOLACvtfcHk0ljLT-VC0sWFMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1GlsA%253D%253D&md5=fc3cbb4f86b23379d666160955812685</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2011.11.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2011.11.050%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DJung%26aufirst%3DJ.%2BM.%26aulast%3DKim%26aufirst%3DJ.%2BM.%26aulast%3DCai%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DHong%26aufirst%3DJ.%2BG.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DLee%26aufirst%3DK.%2BR.%26aulast%3DRyu%26aufirst%3DJ.%2BH.%26atitle%3DThe%2520ameliorating%2520effects%2520of%2520stigmasterol%2520on%2520scopolamine-induced%2520memory%2520impairments%2520in%2520mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D676%26issue%3D1%26spage%3D64%26epage%3D70%26doi%3D10.1016%2Fj.ejphar.2011.11.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, R.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span> <span> </span><span class="NLM_article-title">Neuropeptide S enhances memory and mitigates memory impairment induced by MK801, scopolamine or Aβ1–42 in mice novel object and object location recognition tasks</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2013.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.neuropharm.2013.02.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=261-267&author=R.-W.+Hanauthor=R.-S.+Zhangauthor=H.-J.+Xuauthor=M.+Changauthor=Y.-L.+Pengauthor=R.+Wang&title=Neuropeptide+S+enhances+memory+and+mitigates+memory+impairment+induced+by+MK801%2C+scopolamine+or+A%CE%B21%E2%80%9342+in+mice+novel+object+and+object+location+recognition+tasks&doi=10.1016%2Fj.neuropharm.2013.02.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2013.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2013.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DR.-W.%26aulast%3DZhang%26aufirst%3DR.-S.%26aulast%3DXu%26aufirst%3DH.-J.%26aulast%3DChang%26aufirst%3DM.%26aulast%3DPeng%26aufirst%3DY.-L.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DNeuropeptide%2520S%2520enhances%2520memory%2520and%2520mitigates%2520memory%2520impairment%2520induced%2520by%2520MK801%252C%2520scopolamine%2520or%2520A%25CE%25B21%25E2%2580%259342%2520in%2520mice%2520novel%2520object%2520and%2520object%2520location%2520recognition%2520tasks%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D70%26spage%3D261%26epage%3D267%26doi%3D10.1016%2Fj.neuropharm.2013.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Detrait, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dardenne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamberty, Y.</span></span> <span> </span><span class="NLM_article-title">The inhibitory avoidance test optimized for discovery of cognitive enhancers</span>. <i>Behav Res. Meth</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">811</span>, <span class="refDoi"> DOI: 10.3758/BRM.41.3.805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.3758%2FBRM.41.3.805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=19587195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A280%3ADC%252BD1MvntlKhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=805-811&issue=3&author=E.+R.+Detraitauthor=E.+Hanonauthor=B.+Dardenneauthor=Y.+Lamberty&title=The+inhibitory+avoidance+test+optimized+for+discovery+of+cognitive+enhancers&doi=10.3758%2FBRM.41.3.805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The inhibitory avoidance test optimized for discovery of cognitive enhancers</span></div><div class="casAuthors">Detrait Eric R A Y; Hanon Etienne; Dardenne Bertrand; Lamberty Yves</div><div class="citationInfo"><span class="NLM_cas:title">Behavior research methods</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">805-11</span>
        ISSN:<span class="NLM_cas:issn">1554-351X</span>.
    </div><div class="casAbstract">In the present article, we describe a new protocol for the inhibitory avoidance test, with a dual purpose: (1) to provide a less variable and more reliable assessment of the efficacy of potential cognitive enhancers in antagonizing scopolamine-induced long-term-memory deficits, and (2) to secure a high throughput for pharmacological screening of cognitive enhancers.  The new protocol consists of two acquisition trials that are followed 24 h later by a single retention trial.  In the present study, this protocol clearly dissociated the frequency distributions of retention latencies between scopolamine- and vehicle-treated groups and allowed validation by means of two acetylcholinesterase inhibitors-tacrine and donepezil-that proved to be active in counteracting the scopolamine-induced memory deficit.  This protocol also produced stability of the behavioral response to pharmacological agents over a 3-year period.  A statistical power analysis indicated that, depending on the efficacy of the drug/dose, a sample size of 5-12 mice was required in order to show a reversal of the scopolamine-induced memory deficit.  The double-trial acquisition protocol is suitable for testing cognitive enhancers, while also providing a clearly enhanced throughput.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-il4nnhF7lMkU0YCbOU3EfW6udTcc2eZU-U3w1bn4K7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvntlKhsw%253D%253D&md5=eccc0b8ade233eca6b90dc7d782b97c6</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.3758%2FBRM.41.3.805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3758%252FBRM.41.3.805%26sid%3Dliteratum%253Aachs%26aulast%3DDetrait%26aufirst%3DE.%2BR.%26aulast%3DHanon%26aufirst%3DE.%26aulast%3DDardenne%26aufirst%3DB.%26aulast%3DLamberty%26aufirst%3DY.%26atitle%3DThe%2520inhibitory%2520avoidance%2520test%2520optimized%2520for%2520discovery%2520of%2520cognitive%2520enhancers%26jtitle%3DBehav%2520Res.%2520Meth%26date%3D2009%26volume%3D41%26issue%3D3%26spage%3D805%26epage%3D811%26doi%3D10.3758%2FBRM.41.3.805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ota, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploski, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Queen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafe, G. E.</span></span> <span> </span><span class="NLM_article-title">The NO-cGMP-PKG signaling pathway regulates synaptic plasticity and fear memory consolidation in the lateral amygdala via activation of ERK/MAP kinase</span>. <i>Learn. Mem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">792</span>– <span class="NLM_lpage">805</span>, <span class="refDoi"> DOI: 10.1101/lm.1114808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1101%2Flm.1114808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=18832566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsV2nsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=792-805&issue=10&author=K.+T.+Otaauthor=V.+J.+Pierreauthor=J.+E.+Ploskiauthor=K.+Queenauthor=G.+E.+Schafe&title=The+NO-cGMP-PKG+signaling+pathway+regulates+synaptic+plasticity+and+fear+memory+consolidation+in+the+lateral+amygdala+via+activation+of+ERK%2FMAP+kinase&doi=10.1101%2Flm.1114808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The NO-cGMP-PKG signaling pathway regulates synaptic plasticity and fear memory consolidation in the lateral amygdala via activation of ERK/MAP kinase</span></div><div class="casAuthors">Ota, Kristie T.; Pierre, Vicki J.; Ploski, Jonathan E.; Queen, Kaila; Schafe, Glenn E.</div><div class="citationInfo"><span class="NLM_cas:title">Learning & Memory</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7-12</span>),
    <span class="NLM_cas:pages">792-805</span>CODEN:
                <span class="NLM_cas:coden">LEMEFO</span>;
        ISSN:<span class="NLM_cas:issn">1072-0502</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Recent studies have shown that nitric oxide (NO) signaling plays a crucial role in memory consolidation of Pavlovian fear conditioning and in synaptic plasticity in the lateral amygdala (LA).  In the present expts., we examd. the role of the cGMP-dependent protein kinase (PKG), a downstream effector of NO, in fear memory consolidation and long-term potentiation (LTP) at thalamic and cortical input pathways to the LA.  In behavioral expts., rats given intra-LA infusions of either the PKG inhibitor Rp-8-Br-PET-cGMPS or the PKG activator 8-Br-cGMP exhibited dose-dependent impairments or enhancements of fear memory consolidation, resp.  In slice electrophysiol. expts., bath application of Rp-8-Br-PET-cGMPS or the guanylyl cyclase inhibitor LY83583 impaired LTP at thalamic, but not cortical inputs to the LA, while bath application of 8-Br-cGMP or the guanylyl cyclase activator YC-1 resulted in enhanced LTP at thalamic inputs to the LA.  Interestingly, YC-1-induced enhancement of LTP in the LA was reversed by concurrent application of the MEK inhibitor U0126, suggesting that the NO-cGMP-PKG signaling pathway may promote synaptic plasticity and fear memory formation in the LA, in part by activating the ERK/MAPK signaling cascade.  As a test of this hypothesis, we next showed that rats given intra-LA infusion of the PKG inhibitor Rp-8-Br-PET-cGMPS or the PKG activator 8-Br-cGMP exhibit impaired or enhanced activation, resp., of ERK/MAPK in the LA after fear conditioning.  Collectively, our findings suggest that an NO-cGMP-PKG-dependent form of synaptic plasticity at thalamic input synapses to the LA may underlie memory consolidation of Pavlovian fear conditioning, in part, via activation of the ERK/MAPK signaling cascade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvU68ba_ZL5LVg90H21EOLACvtfcHk0ljtuDzbid0Qsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2nsLw%253D&md5=a59ff3eb4bce97a42173cb13ff1f77ae</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1101%2Flm.1114808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Flm.1114808%26sid%3Dliteratum%253Aachs%26aulast%3DOta%26aufirst%3DK.%2BT.%26aulast%3DPierre%26aufirst%3DV.%2BJ.%26aulast%3DPloski%26aufirst%3DJ.%2BE.%26aulast%3DQueen%26aufirst%3DK.%26aulast%3DSchafe%26aufirst%3DG.%2BE.%26atitle%3DThe%2520NO-cGMP-PKG%2520signaling%2520pathway%2520regulates%2520synaptic%2520plasticity%2520and%2520fear%2520memory%2520consolidation%2520in%2520the%2520lateral%2520amygdala%2520via%2520activation%2520of%2520ERK%252FMAP%2520kinase%26jtitle%3DLearn.%2520Mem.%26date%3D2008%26volume%3D15%26issue%3D10%26spage%3D792%26epage%3D805%26doi%3D10.1101%2Flm.1114808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vanmierlo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creemers, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkerman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Duinen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambeth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span> <span> </span><span class="NLM_article-title">The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2016.01.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.bbr.2016.01.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2016&pages=26-33&author=T.+Vanmierloauthor=P.+Creemersauthor=S.+Akkermanauthor=M.+van+Duinenauthor=A.+Sambethauthor=J.+De+Vryauthor=T.+Uzauthor=A.+Bloklandauthor=J.+Prickaerts&title=The+PDE4+inhibitor+roflumilast+improves+memory+in+rodents+at+non-emetic+doses&doi=10.1016%2Fj.bbr.2016.01.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2016.01.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2016.01.031%26sid%3Dliteratum%253Aachs%26aulast%3DVanmierlo%26aufirst%3DT.%26aulast%3DCreemers%26aufirst%3DP.%26aulast%3DAkkerman%26aufirst%3DS.%26aulast%3Dvan%2BDuinen%26aufirst%3DM.%26aulast%3DSambeth%26aufirst%3DA.%26aulast%3DDe%2BVry%26aufirst%3DJ.%26aulast%3DUz%26aufirst%3DT.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DThe%2520PDE4%2520inhibitor%2520roflumilast%2520improves%2520memory%2520in%2520rodents%2520at%2520non-emetic%2520doses%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2016%26volume%3D303%26spage%3D26%26epage%3D33%26doi%3D10.1016%2Fj.bbr.2016.01.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proulx-Lafrance, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claffey, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuttle, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleiman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menniti, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span> <span> </span><span class="NLM_article-title">Design and discovery of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one(PF-04447943), a selective brain penetrant PDE9A inhibitor for the treatment of cognitive disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">9045</span>– <span class="NLM_lpage">9054</span>, <span class="refDoi"> DOI: 10.1021/jm3007799</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3007799" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9045-9054&issue=21&author=P.+R.+Verhoestauthor=K.+R.+Fonsecaauthor=X.+Houauthor=C.+Proulx-Lafranceauthor=M.+Cormanauthor=C.+J.+Helalauthor=M.+M.+Claffeyauthor=J.+B.+Tuttleauthor=K.+J.+Coffmanauthor=S.+Liuauthor=F.+Nelsonauthor=R.+J.+Kleimanauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=M.+Vanase-Frawleyauthor=S.+Liras&title=Design+and+discovery+of+6-%5B%283S%2C4S%29-4-methyl-1-%28pyrimidin-2-ylmethyl%29pyrrolidin-3-yl%5D-1-%28tetrahydro-2H-pyran-4-yl%29-1%2C5-dihydro-4H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-one%28PF-04447943%29%2C+a+selective+brain+penetrant+PDE9A+inhibitor+for+the+treatment+of+cognitive+disorders&doi=10.1021%2Fjm3007799"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm3007799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007799%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DProulx-Lafrance%26aufirst%3DC.%26aulast%3DCorman%26aufirst%3DM.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26aulast%3DTuttle%26aufirst%3DJ.%2BB.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DDesign%2520and%2520discovery%2520of%25206-%255B%25283S%252C4S%2529-4-methyl-1-%2528pyrimidin-2-ylmethyl%2529pyrrolidin-3-yl%255D-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C5-dihydro-4H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2528PF-04447943%2529%252C%2520a%2520selective%2520brain%2520penetrant%2520PDE9A%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D21%26spage%3D9045%26epage%3D9054%26doi%3D10.1021%2Fjm3007799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
der Staay, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barfacker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erb, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckroth, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karthaus, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tersteegen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kampen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymann, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, M.</span></span> <span> </span><span class="NLM_article-title">The novel selective PDE9 inhibitor BAY 73–6691 improves learning and memory in rodents</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">918</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.neuropharm.2008.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=18674549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFajurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=908-918&issue=5&author=F.+J.+Van%0Ader+Staayauthor=K.+Ruttenauthor=L.+Barfackerauthor=J.+Devryauthor=C.+Erbauthor=H.+Heckrothauthor=D.+Karthausauthor=A.+Tersteegenauthor=M.+van+Kampenauthor=A.+Bloklandauthor=J.+Prickaertsauthor=K.+G.+Reymannauthor=U.+H.+Schroderauthor=M.+Hendrix&title=The+novel+selective+PDE9+inhibitor+BAY+73%E2%80%936691+improves+learning+and+memory+in+rodents&doi=10.1016%2Fj.neuropharm.2008.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents</span></div><div class="casAuthors">van der Staay, F. Josef; Rutten, Kris; Baerfacker, Lars; DeVry, Jean; Erb, Christina; Heckroth, Heike; Karthaus, Dagmar; Tersteegen, Adrian; van Kampen, Marja; Blokland, Arjan; Prickaerts, Jos; Reymann, Klaus G.; Schroeder, Ulrich H.; Hendrix, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">908-918</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study investigated the putative pro-cognitive effects of the novel selective PDE9 inhibitor BAY 73-6691.  The effects on basal synaptic transmission and long-term potentiation (LTP) were investigated in rat hippocampal slices.  Pro-cognitive effects were assessed in a series of learning and memory tasks using rodents as subjects.  BAY 73-6691 had no effect on basal synaptic transmission in hippocampal slices prepd. from young adult (7- to 8-wk-old) Wistar rats.  A dose of 10 μM, but not 30 μM, BAY 73-6691 enhanced early LTP after weak tetanic stimulation.  The dose effective in young adult Wistar rats did not affect LTP in hippocampal slices prepd. from young (7- to 8-wk-old) Fischer 344 X Brown Norway (FBNF1) rats, probably reflecting strain differences.  However, it increased basal synaptic transmission and enhanced early LTP after weak tetanic stimulation in hippocampal slices prepd. from very old (31- to 35-mo-old) FBNF1 rats.  BAY 73-6691 enhanced acquisition, consolidation, and retention of long-term memory (LTM) in a social recognition task and tended to enhance LTM in an object recognition task.  Bay 73-6691 attenuated the scopolamine-induced retention deficit in a passive avoidance task, and the MK-801-induced short-term memory deficits in a T-maze alternation task.  The mechanism of action, possibly through modulation of the NO/cGMP-PKG/CREB pathway, is discussed.  Our findings support the notion that PDE9 inhibition may be a novel target for treating memory deficits that are assocd. with aging and neurodegenerative disorders such as Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8HiWHIitIm7Vg90H21EOLACvtfcHk0ljtuDzbid0Qsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFajurzP&md5=627896c9c5f4b8526c50b9c1814c1647</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BStaay%26aufirst%3DF.%2BJ.%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DBarfacker%26aufirst%3DL.%26aulast%3DDevry%26aufirst%3DJ.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DHeckroth%26aufirst%3DH.%26aulast%3DKarthaus%26aufirst%3DD.%26aulast%3DTersteegen%26aufirst%3DA.%26aulast%3Dvan%2BKampen%26aufirst%3DM.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DReymann%26aufirst%3DK.%2BG.%26aulast%3DSchroder%26aufirst%3DU.%2BH.%26aulast%3DHendrix%26aufirst%3DM.%26atitle%3DThe%2520novel%2520selective%2520PDE9%2520inhibitor%2520BAY%252073%25E2%2580%25936691%2520improves%2520learning%2520and%2520memory%2520in%2520rodents%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26issue%3D5%26spage%3D908%26epage%3D918%26doi%3D10.1016%2Fj.neuropharm.2008.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vardigan, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Converso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutson, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uslaner, J. M.</span></span> <span> </span><span class="NLM_article-title">The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 attenuates a scopolamine-induced deficit in a novel rodent attention task</span>. <i>J. Neurogenet.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.3109/01677063.2011.630494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.3109%2F01677063.2011.630494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=22070409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=120-126&issue=4&author=J.+D.+Vardiganauthor=A.+Conversoauthor=P.+H.+Hutsonauthor=J.+M.+Uslaner&title=The+selective+phosphodiesterase+9+%28PDE9%29+inhibitor+PF-04447943+attenuates+a+scopolamine-induced+deficit+in+a+novel+rodent+attention+task&doi=10.3109%2F01677063.2011.630494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The Selective Phosphodiesterase 9 (PDE9) Inhibitor PF-04447943 Attenuates a Scopolamine-Induced Deficit in a Novel Rodent Attention Task</span></div><div class="casAuthors">Vardigan, Joshua D.; Converso, Antonella; Hutson, Pete H.; Uslaner, Jason M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurogenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">120-126</span>CODEN:
                <span class="NLM_cas:coden">JLNEDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-7063</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Numerous changes occur during aging and Alzheimer's disease (AD) progression, including a decline in cholinergic functioning and cognition, as well as alterations in gene expression and activity in the nitric oxide/cyclic guanosine monophosphate (NO/cGMP) pathway.  Donepezil, the current std. of care for Alzheimer's disease, improves cholinergic functioning and has demonstrated effects on multiple domains of cognition, including memory and attention in both preclin. species and patients.  We previously found that increasing activation of the NO/cGMP pathway via phosphodiesterase 9 (PDE9) inhibition also improves memory in rodents and suggested that PDE9 might be a promising target for novel treatments for AD.  Here we investigated whether PDE9 inhibition also enhances attention using a novel attention task in rats.  We validated this task using several pharmacol. manipulations and showed that the selective PDE9 inhibitor PF-04447943 produced effects similar to those of donepezil.  These data confirm and extend the hypothesis that PDE9 inhibition might serve as a novel treatment for AD and age-related cognitive decline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJa-1clww9LrVg90H21EOLACvtfcHk0lizYdQpMXu5Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bF&md5=1d03e024134e690d1765bd4ee8576aad</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3109%2F01677063.2011.630494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01677063.2011.630494%26sid%3Dliteratum%253Aachs%26aulast%3DVardigan%26aufirst%3DJ.%2BD.%26aulast%3DConverso%26aufirst%3DA.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520selective%2520phosphodiesterase%25209%2520%2528PDE9%2529%2520inhibitor%2520PF-04447943%2520attenuates%2520a%2520scopolamine-induced%2520deficit%2520in%2520a%2520novel%2520rodent%2520attention%2520task%26jtitle%3DJ.%2520Neurogenet.%26date%3D2011%26volume%3D25%26issue%3D4%26spage%3D120%26epage%3D126%26doi%3D10.3109%2F01677063.2011.630494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>250</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2013.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.bbr.2013.05.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=2013&pages=230-237&author=J.+Zhangauthor=J.+Guoauthor=X.+Zhaoauthor=Z.+Chenauthor=G.+Wangauthor=A.+Liuauthor=Q.+Wangauthor=W.+Zhouauthor=Y.+Xuauthor=C.+Wang&title=Phosphodiesterase-5+inhibitor+sildenafil+prevents+neuroinflammation%2C+lowers+beta-amyloid+levels+and+improves+cognitive+performance+in+APP%2FPS1+transgenic+mice&doi=10.1016%2Fj.bbr.2013.05.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2013.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2013.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DPhosphodiesterase-5%2520inhibitor%2520sildenafil%2520prevents%2520neuroinflammation%252C%2520lowers%2520beta-amyloid%2520levels%2520and%2520improves%2520cognitive%2520performance%2520in%2520APP%252FPS1%2520transgenic%2520mice%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2013%26volume%3D250%26spage%3D230%26epage%3D237%26doi%3D10.1016%2Fj.bbr.2013.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Summerfield, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Carmen
Osuna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spalding, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P.</span></span> <span> </span><span class="NLM_article-title">Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, p-glycoprotein efflux, and free fractions in blood and brain</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>316</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1282</span>– <span class="NLM_lpage">1290</span>, <span class="refDoi"> DOI: 10.1124/jpet.105.092916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1124%2Fjpet.105.092916" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=16330496" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2005&pages=1282-1290&issue=3&author=S.+G.+Summerfieldauthor=A.+J.+Stevensauthor=L.+Cutlerauthor=M.+del+Carmen%0AOsunaauthor=B.+Hammondauthor=S.-P.+Tangauthor=A.+Herseyauthor=D.+J.+Spaldingauthor=P.+Jeffrey&title=Improving+the+in+vitro+prediction+of+in+vivo+central+nervous+system+penetration%3A+integrating+permeability%2C+p-glycoprotein+efflux%2C+and+free+fractions+in+blood+and+brain&doi=10.1124%2Fjpet.105.092916"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.092916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.092916%26sid%3Dliteratum%253Aachs%26aulast%3DSummerfield%26aufirst%3DS.%2BG.%26aulast%3DStevens%26aufirst%3DA.%2BJ.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3Ddel%2BCarmen%2BOsuna%26aufirst%3DM.%26aulast%3DHammond%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DS.-P.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DSpalding%26aufirst%3DD.%2BJ.%26aulast%3DJeffrey%26aufirst%3DP.%26atitle%3DImproving%2520the%2520in%2520vitro%2520prediction%2520of%2520in%2520vivo%2520central%2520nervous%2520system%2520penetration%253A%2520integrating%2520permeability%252C%2520p-glycoprotein%2520efflux%252C%2520and%2520free%2520fractions%2520in%2520blood%2520and%2520brain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D316%26issue%3D3%26spage%3D1282%26epage%3D1290%26doi%3D10.1124%2Fjpet.105.092916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of orally available first-generation dual-target selective inhibitors of acetylcholinesterase (ache) and phosphodiesterase 5 (pde5) for the treatment of Alzheimer’s disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">345</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00345</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00345" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWrs7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=328-345&issue=2&author=F.+Maoauthor=H.+Wangauthor=W.+Niauthor=X.+Zhengauthor=M.+Wangauthor=K.+Baoauthor=D.+Lingauthor=X.+Liauthor=Y.+Xuauthor=H.+Zhangauthor=J.+Li&title=Design%2C+synthesis%2C+and+biological+evaluation+of+orally+available+first-generation+dual-target+selective+inhibitors+of+acetylcholinesterase+%28ache%29+and+phosphodiesterase+5+%28pde5%29+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facschemneuro.7b00345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Orally Available First-Generation Dual-Target Selective Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Mao, Fei; Wang, Huan; Ni, Wei; Zheng, Xinyu; Wang, Manjiong; Bao, Keting; Ling, Dazheng; Li, Xiaokang; Xu, Yixiang; Zhang, Haiyan; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">328-345</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Through drug discovery strategies of repurposing and redeveloping existing drugs, a series of novel tadalafil derivs. were rationally designed, synthesized, and evaluated to seek dual-target AChE/PDE5 inhibitors as good candidate drugs for Alzheimer's disease (AD).  Among these derivs., (6R,12aR)-6-(benzo[d][1,3]dioxol-5-yl)-2-(2-(1-benzylpiperidin-4yl)ethyl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione (1p, I) and (6R,12aS)-6-(benzo[d][1,3]dioxol-5-yl)-2-(2-(1-benzylpiperidin-4yl)ethyl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione (1w, II) exhibited excellent selective dual-target AChE/PDE5 inhibitory activities and improved blood-brain barrier (BBB) penetrability.  Importantly, II·Cit (citrate of II) could reverse the cognitive dysfunction of scopolamine-induced AD mice and exhibited an excellent effect on enhancing cAMP response element-binding protein (CREB) phosphorylation in vivo, a crucial factor in memory formation and synaptic plasticity.  Moreover, the mol. docking simulations of II with hAChE and hPDE5A confirmed that the design strategy was rational.  In summary, the research provides a potential selective dual-target AChE/PDE5 inhibitor as a good candidate drug for the treatment of AD, and it could also be regarded as a small mol. probe to validate the novel AD therapeutic approach in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoThEyISqB-vrVg90H21EOLACvtfcHk0lizYdQpMXu5Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWrs7rF&md5=f681ad7b8ce0bf011d30d36a869eedd0</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00345%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DNi%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DBao%26aufirst%3DK.%26aulast%3DLing%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520orally%2520available%2520first-generation%2520dual-target%2520selective%2520inhibitors%2520of%2520acetylcholinesterase%2520%2528ache%2529%2520and%2520phosphodiesterase%25205%2520%2528pde5%2529%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26issue%3D2%26spage%3D328%26epage%3D345%26doi%3D10.1021%2Facschemneuro.7b00345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fiorito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vendome, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeed, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staniszewski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, D. W.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel 1,2,3,4-tetrahydrobenzo[b][1,6]naphthyridine analogue as a potent phosphodiesterase 5 inhibitor with improved aqueous solubility for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">8858</span>– <span class="NLM_lpage">8875</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00979</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00979" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8858-8875&issue=21&author=J.+Fioritoauthor=J.+Vendomeauthor=F.+Saeedauthor=A.+Staniszewskiauthor=H.+Zhangauthor=S.+Yanauthor=S.+X.+Dengauthor=O.+Arancioauthor=D.+W.+Landry&title=Identification+of+a+novel+1%2C2%2C3%2C4-tetrahydrobenzo%5Bb%5D%5B1%2C6%5Dnaphthyridine+analogue+as+a+potent+phosphodiesterase+5+inhibitor+with+improved+aqueous+solubility+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.7b00979"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00979%26sid%3Dliteratum%253Aachs%26aulast%3DFiorito%26aufirst%3DJ.%26aulast%3DVendome%26aufirst%3DJ.%26aulast%3DSaeed%26aufirst%3DF.%26aulast%3DStaniszewski%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DS.%2BX.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26atitle%3DIdentification%2520of%2520a%2520novel%25201%252C2%252C3%252C4-tetrahydrobenzo%255Bb%255D%255B1%252C6%255Dnaphthyridine%2520analogue%2520as%2520a%2520potent%2520phosphodiesterase%25205%2520inhibitor%2520with%2520improved%2520aqueous%2520solubility%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D21%26spage%3D8858%26epage%3D8875%26doi%3D10.1021%2Facs.jmedchem.7b00979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puzzo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staniszewski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Privitera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leznik, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-β load in an Alzheimer’s disease mouse model</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">8075</span>– <span class="NLM_lpage">8086</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0864-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1523%2FJNEUROSCI.0864-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=19553447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFKgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=8075-8086&issue=25&author=D.+Puzzoauthor=A.+Staniszewskiauthor=S.+X.+Dengauthor=L.+Priviteraauthor=E.+Leznikauthor=S.+Liuauthor=H.+Zhangauthor=Y.+Fengauthor=A.+Palmeriauthor=D.+W.+Landryauthor=O.+Arancio&title=Phosphodiesterase+5+inhibition+improves+synaptic+function%2C+memory%2C+and+amyloid-%CE%B2+load+in+an+Alzheimer%E2%80%99s+disease+mouse+model&doi=10.1523%2FJNEUROSCI.0864-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-β load in an Alzheimer's disease mouse model</span></div><div class="casAuthors">Puzzo, Daniela; Staniszewski, Agnieszka; Deng, Shi Xian; Privitera, Lucia; Leznik, Elena; Liu, Shumin; Zhang, Hong; Feng, Yan; Palmeri, Agostino; Landry, Donald W.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">8075-8086</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Memory loss, synaptic dysfunction, and accumulation of amyloid β-peptides (Aβ) are major hallmarks of Alzheimer's disease (AD).  Downregulation of the nitric oxide/cGMP/cGMP-dependent protein kinase/c-AMP responsive element-binding protein (CREB) cascade has been linked to the synaptic deficits after Aβ elevation.  Here, we report that the phosphodiesterase 5 inhibitor (PDE5) sildenafil (Viagra), a mol. that enhances phosphorylation of CREB, a mol. involved in memory, through elevation of cGMP levels, is beneficial against the AD phenotype in a mouse model of amyloid deposition.  We demonstrate that the inhibitor produces an immediate and long-lasting amelioration of synaptic function, CREB phosphorylation, and memory.  This effect is also assocd. with a long-lasting redn. of Aβ levels.  Given that side effects of PDE5 inhibitors are widely known and do not preclude their administration to a senile population, these drugs have potential for the treatment of AD and other diseases assocd. with elevated Aβ levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq69pOrzfjxY7Vg90H21EOLACvtfcHk0lgE2VyiCR1Fvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFKgtbw%253D&md5=5aead1f7c92b6166b8591c3e7951f78d</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0864-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0864-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DStaniszewski%26aufirst%3DA.%26aulast%3DDeng%26aufirst%3DS.%2BX.%26aulast%3DPrivitera%26aufirst%3DL.%26aulast%3DLeznik%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DPhosphodiesterase%25205%2520inhibition%2520improves%2520synaptic%2520function%252C%2520memory%252C%2520and%2520amyloid-%25CE%25B2%2520load%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26issue%3D25%26spage%3D8075%26epage%3D8086%26doi%3D10.1523%2FJNEUROSCI.0864-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madineni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhadidi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, Z. A.</span></span> <span> </span><span class="NLM_article-title">Cofilin inhibition restores neuronal cell death in oxygen-glucose deprivation model of ischemia</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">867</span>– <span class="NLM_lpage">878</span>, <span class="refDoi"> DOI: 10.1007/s12035-014-9056-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1007%2Fs12035-014-9056-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=25526862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKmtbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2016&pages=867-878&issue=2&author=A.+Madineniauthor=Q.+Alhadidiauthor=Z.+A.+Shah&title=Cofilin+inhibition+restores+neuronal+cell+death+in+oxygen-glucose+deprivation+model+of+ischemia&doi=10.1007%2Fs12035-014-9056-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Cofilin Inhibition Restores Neuronal Cell Death in Oxygen-Glucose Deprivation Model of Ischemia</span></div><div class="casAuthors">Madineni, Anusha; Alhadidi, Qasim; Shah, Zahoor A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">867-878</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Ischemia is a condition assocd. with decreased blood supply to the brain, eventually leading to death of neurons.  It is assocd. with a diverse cascade of responses involving both degenerative and regenerative mechanisms.  At the cellular level, the changes are initiated prominently in the neuronal cytoskeleton.  Cofilin, a cytoskeletal actin severing protein, is known to be involved in the early stages of apoptotic cell death.  Evidence supports its intervention in the progression of disease states like Alzheimer's and ischemic kidney disease.  In the present study, we have hypothesized the possible involvement of cofilin in ischemia.  Using PC12 cells and mouse primary cultures of cortical neurons, we investigated the potential role of cofilin in ischemia in two different in vitro ischemic models: chem. induced oxidative stress and oxygen-glucose deprivation/reperfusion (OGD/R).  The expression profile studies demonstrated a decrease in phosphocofilin levels in all models of ischemia, implying stress-induced cofilin activation.  Furthermore, calcineurin and slingshot 1L (SSH) phosphatases were found to be the signaling mediators of the cofilin activation.  In primary cultures of cortical neurons, cofilin was found to be significantly activated after 1 h of OGD.  To delineate the role of activated cofilin in ischemia, we knocked down cofilin by small interfering RNA (siRNA) technique and tested the impact of cofilin silencing on neuronal viability.  Cofilin siRNA-treated neurons showed a significant redn. of cofilin levels in all treatment groups (control, OGD, and OGD/R).  Addnl., cofilin siRNA-reduced cofilin mitochondrial translocation and caspase 3 cleavage, with a concomitant increase in neuronal viability.  These results strongly support the active role of cofilin in ischemia-induced neuronal degeneration and apoptosis.  We believe that targeting this protein mediator has a potential for therapeutic intervention in ischemic brain injury and stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMYvX1eRDjbLVg90H21EOLACvtfcHk0lgE2VyiCR1Fvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKmtbzF&md5=f327945197a460db783f6efce84bfb1a</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2Fs12035-014-9056-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-014-9056-3%26sid%3Dliteratum%253Aachs%26aulast%3DMadineni%26aufirst%3DA.%26aulast%3DAlhadidi%26aufirst%3DQ.%26aulast%3DShah%26aufirst%3DZ.%2BA.%26atitle%3DCofilin%2520inhibition%2520restores%2520neuronal%2520cell%2520death%2520in%2520oxygen-glucose%2520deprivation%2520model%2520of%2520ischemia%26jtitle%3DMol.%2520Neurobiol.%26date%3D2016%26volume%3D53%26issue%3D2%26spage%3D867%26epage%3D878%26doi%3D10.1007%2Fs12035-014-9056-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suneja, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potashner, S. J.</span></span> <span> </span><span class="NLM_article-title">Phospho-CREB and other phospho-proteins: improved recovery from brain tissue</span>. <i>J. Neurosci. Methods</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>150</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1016/j.jneumeth.2005.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.jneumeth.2005.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=16087244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnslyksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2006&pages=238-241&issue=2&author=S.+K.+Sunejaauthor=Z.+Moauthor=S.+J.+Potashner&title=Phospho-CREB+and+other+phospho-proteins%3A+improved+recovery+from+brain+tissue&doi=10.1016%2Fj.jneumeth.2005.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Phospho-CREB and other phospho-proteins: improved recovery from brain tissue</span></div><div class="casAuthors">Suneja, Sanoj K.; Mo, Zhicheng; Potashner, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">238-241</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">During attempts to quantify levels of phosphorylated cAMP response element binding protein (CREB-P) in guinea pig brain stem auditory nuclei by Western blotting, we compared the decay of CREB-P levels when tissues were homogenized in traditional Lysis buffer contg. detergents or in 50 mM Tris-HCl buffer contg. 0.32 M sucrose.  The decay of CREB-P levels was retarded considerably in the Tris-Sucrose medium as compared to the Lysis buffer.  Similarly, the levels of two other phospho-proteins, extracellular regulated kinases (ERK1/2-P) and stress activated protein/Jun-N-terminal kinase (SAP/JNK-P), were better preserved by the Tris-Sucrose medium.  These findings imply that the detergents typically present in the Lysis buffer may disrupt organelles and increase the exposure of sol. phospho-proteins to hydrolyzing enzymes.  In contrast, such exposure was probably minimized in the Tris-Sucrose medium, which is thought to preserve organelle integrity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIbAHmb2kPhbVg90H21EOLACvtfcHk0lgE2VyiCR1Fvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnslyksg%253D%253D&md5=e0fac667029e37b5f50f93bec3739f64</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2005.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2005.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DSuneja%26aufirst%3DS.%2BK.%26aulast%3DMo%26aufirst%3DZ.%26aulast%3DPotashner%26aufirst%3DS.%2BJ.%26atitle%3DPhospho-CREB%2520and%2520other%2520phospho-proteins%253A%2520improved%2520recovery%2520from%2520brain%2520tissue%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2006%26volume%3D150%26issue%3D2%26spage%3D238%26epage%3D241%26doi%3D10.1016%2Fj.jneumeth.2005.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ryosuke Matsubara, Akihiro Ando, Hayu Hasebe, Hojin Kim, Takao Tsuneda, <span class="NLM_string-name hlFld-ContribAuthor">Masahiko Hayashi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Synthetic Application of Chloro- and Bromofuroxans. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (9)
                                     , 5959-5972. <a href="https://doi.org/10.1021/acs.joc.0c00326" title="DOI URL">https://doi.org/10.1021/acs.joc.0c00326</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c00326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c00326%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Band%252BSynthetic%252BApplication%252Bof%252BChloro-%252Band%252BBromofuroxans%26aulast%3DMatsubara%26aufirst%3DRyosuke%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09022020%26date%3D13042020%26date%3D03042020%26volume%3D85%26issue%3D9%26spage%3D5959%26epage%3D5972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chuanfu  Hou</span>, <span class="hlFld-ContribAuthor ">Shouneng  Sun</span>, <span class="hlFld-ContribAuthor ">Ziqi  Liu</span>, <span class="hlFld-ContribAuthor ">Hui  Zhang</span>, <span class="hlFld-ContribAuthor ">Yue  Liu</span>, <span class="hlFld-ContribAuthor ">Qi  An</span>, <span class="hlFld-ContribAuthor ">Jian  Zhao</span>, <span class="hlFld-ContribAuthor ">Junjie  Ma</span>, <span class="hlFld-ContribAuthor ">Zhizhong  Sun</span>, <span class="hlFld-ContribAuthor ">Wenyi  Chu</span>. </span><span class="cited-content_cbyCitation_article-title">Visible‐Light‐Induced Decarboxylative Acylation of Pyridine
              N
              ‐Oxides with α‐Oxocarboxylic Acids Using Fluorescein Dimethylammonium as a Photocatalyst. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2021,</strong> <em>363 </em>
                                    (11)
                                     , 2806-2812. <a href="https://doi.org/10.1002/adsc.202100168" title="DOI URL">https://doi.org/10.1002/adsc.202100168</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202100168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202100168%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DVisible%2525E2%252580%252590Light%2525E2%252580%252590Induced%252BDecarboxylative%252BAcylation%252Bof%252BPyridine%252BN%252B%2525E2%252580%252590Oxides%252Bwith%252B%2525CE%2525B1%2525E2%252580%252590Oxocarboxylic%252BAcids%252BUsing%252BFluorescein%252BDimethylammonium%252Bas%252Ba%252BPhotocatalyst%26aulast%3DHou%26aufirst%3DChuanfu%26date%3D2021%26date%3D2021%26volume%3D363%26issue%3D11%26spage%3D2806%26epage%3D2812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dimitra  T. Pournara</span>, <span class="hlFld-ContribAuthor ">Anna  Durner</span>, <span class="hlFld-ContribAuthor ">Eftichia  Kritsi</span>, <span class="hlFld-ContribAuthor ">Alexios  Papakostas</span>, <span class="hlFld-ContribAuthor ">Panagiotis  Zoumpoulakis</span>, <span class="hlFld-ContribAuthor ">Annette  Nicke</span>, <span class="hlFld-ContribAuthor ">Maria  Koufaki</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and
              in vitro
              Evaluation of P2X7 Antagonists. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (24)
                                     , 2530-2543. <a href="https://doi.org/10.1002/cmdc.202000303" title="DOI URL">https://doi.org/10.1002/cmdc.202000303</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000303%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252Bin%2525E2%252580%252585vitro%252BEvaluation%252Bof%252BP2X7%252BAntagonists%26aulast%3DT.%2BPournara%26aufirst%3DDimitra%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D24%26spage%3D2530%26epage%3D2543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalia L.  Merkulova</span>, <span class="hlFld-ContribAuthor ">Ivan D.  Nesterov</span>, <span class="hlFld-ContribAuthor ">Vjacheslav L.  Korolev</span>, <span class="hlFld-ContribAuthor ">Vitaliy M.  Danilenko</span>, <span class="hlFld-ContribAuthor ">Tatyana S.  Pivina</span>. </span><span class="cited-content_cbyCitation_article-title">The tautomerism of imidazo[4,5-e]benzo[1,2-c,3,4-c] difuroxans: A quantum chemical and experimental study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1207 </em>, 127775. <a href="https://doi.org/10.1016/j.molstruc.2020.127775" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.127775</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.127775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.127775%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DThe%252Btautomerism%252Bof%252Bimidazo%25255B4%25252C5-e%25255Dbenzo%25255B1%25252C2-c%25252C3%25252C4-c%25255D%252Bdifuroxans%25253A%252BA%252Bquantum%252Bchemical%252Band%252Bexperimental%252Bstudy%26aulast%3DMerkulova%26aufirst%3DNatalia%2BL.%26date%3D2020%26volume%3D1207%26spage%3D127775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nina N.  Makhova</span>, <span class="hlFld-ContribAuthor ">Leonid L.  Fershtat</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,5-Oxadiazoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00001-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00001-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00001-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00001-9%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C2%25252C5-Oxadiazoles%26aulast%3DMakhova%26aufirst%3DNina%2BN.%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%25204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahrous A.  Abou-Salim</span>, <span class="hlFld-ContribAuthor ">Mohamed A.  Shaaban</span>, <span class="hlFld-ContribAuthor ">Mohammed K.  Abd El Hameid</span>, <span class="hlFld-ContribAuthor ">Yaseen A.M.M.  Elshaier</span>, <span class="hlFld-ContribAuthor ">Fathi  Halaweish</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological study of hybrid drug candidates of nitric oxide releasing cucurbitacin-inspired estrone analogs for treatment of hepatocellular carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>85 </em>, 515-533. <a href="https://doi.org/10.1016/j.bioorg.2019.01.068" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.01.068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.01.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.01.068%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bstudy%252Bof%252Bhybrid%252Bdrug%252Bcandidates%252Bof%252Bnitric%252Boxide%252Breleasing%252Bcucurbitacin-inspired%252Bestrone%252Banalogs%252Bfor%252Btreatment%252Bof%252Bhepatocellular%252Bcarcinoma%26aulast%3DAbou-Salim%26aufirst%3DMahrous%2BA.%26date%3D2019%26volume%3D85%26spage%3D515%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Austin  Horton</span>, <span class="hlFld-ContribAuthor ">Isaac T.  Schiefer</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics and pharmacodynamics of nitric oxide mimetic agents. </span><span class="cited-content_cbyCitation_journal-name">Nitric Oxide</span><span> <strong>2019,</strong> <em>84 </em>, 69-78. <a href="https://doi.org/10.1016/j.niox.2019.01.001" title="DOI URL">https://doi.org/10.1016/j.niox.2019.01.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.niox.2019.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.niox.2019.01.001%26sid%3Dliteratum%253Aachs%26jtitle%3DNitric%2520Oxide%26atitle%3DPharmacokinetics%252Band%252Bpharmacodynamics%252Bof%252Bnitric%252Boxide%252Bmimetic%252Bagents%26aulast%3DHorton%26aufirst%3DAustin%26date%3D2019%26volume%3D84%26spage%3D69%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lu  Lu</span>, <span class="hlFld-ContribAuthor ">Xuemin  Rao</span>, <span class="hlFld-ContribAuthor ">Rigang  Cong</span>, <span class="hlFld-ContribAuthor ">Chenxi  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhimei  Wang</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>, <span class="hlFld-ContribAuthor ">Genzoh  Tanabe</span>, <span class="hlFld-ContribAuthor ">Osamu  Muraoka</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Wu</span>, <span class="hlFld-ContribAuthor ">Weijia  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation of Nitrate Derivatives of Sauropunol A and B as Potent Vasodilatory Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (3)
                                     , 583. <a href="https://doi.org/10.3390/molecules24030583" title="DOI URL">https://doi.org/10.3390/molecules24030583</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24030583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24030583%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNitrate%252BDerivatives%252Bof%252BSauropunol%252BA%252Band%252BB%252Bas%252BPotent%252BVasodilatory%252BAgents%26aulast%3DLu%26aufirst%3DLu%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D3%26spage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N. V.  Obruchnikova</span>, <span class="hlFld-ContribAuthor ">R. A.  Novikov</span>, <span class="hlFld-ContribAuthor ">S. G.  Zlotin</span>, <span class="hlFld-ContribAuthor ">P. V.  Dorovatovskii</span>, <span class="hlFld-ContribAuthor ">V. N.  Khrustalev</span>, <span class="hlFld-ContribAuthor ">O. A.  Rakitin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structural investigation of 4,4′-dimethyl-[3,3′-bi(1,2,5-oxadiazole)] 5,5′-dioxide. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2018,</strong> <em>67 </em>
                                    (11)
                                     , 2044-2048. <a href="https://doi.org/10.1007/s11172-018-2326-x" title="DOI URL">https://doi.org/10.1007/s11172-018-2326-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-018-2326-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-018-2326-x%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DSynthesis%252Band%252Bstructural%252Binvestigation%252Bof%252B4%25252C4%2525E2%252580%2525B2-dimethyl-%25255B3%25252C3%2525E2%252580%2525B2-bi%2525281%25252C2%25252C5-oxadiazole%252529%25255D%252B5%25252C5%2525E2%252580%2525B2-dioxide%26aulast%3DObruchnikova%26aufirst%3DN.%2BV.%26date%3D2018%26date%3D2018%26volume%3D67%26issue%3D11%26spage%3D2044%26epage%3D2048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark E  Obrenovich</span>, <span class="hlFld-ContribAuthor ">Curtis J  Donskey</span>, <span class="hlFld-ContribAuthor ">Isaac T  Schiefer</span>, <span class="hlFld-ContribAuthor ">Rodolfo  Bongiovanni</span>, <span class="hlFld-ContribAuthor ">Ling  Li</span>, <span class="hlFld-ContribAuthor ">George E  Jaskiw</span>. </span><span class="cited-content_cbyCitation_article-title">Quantification of phenolic acid metabolites in humans by LC–MS: a structural and targeted metabolomics approach. </span><span class="cited-content_cbyCitation_journal-name">Bioanalysis</span><span> <strong>2018,</strong> <em>10 </em>
                                    (19)
                                     , 1591-1608. <a href="https://doi.org/10.4155/bio-2018-0140" title="DOI URL">https://doi.org/10.4155/bio-2018-0140</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/bio-2018-0140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fbio-2018-0140%26sid%3Dliteratum%253Aachs%26jtitle%3DBioanalysis%26atitle%3DQuantification%252Bof%252Bphenolic%252Bacid%252Bmetabolites%252Bin%252Bhumans%252Bby%252BLC%2525E2%252580%252593MS%25253A%252Ba%252Bstructural%252Band%252Btargeted%252Bmetabolomics%252Bapproach%26aulast%3DObrenovich%26aufirst%3DMark%2BE%26date%3D2018%26volume%3D10%26issue%3D19%26spage%3D1591%26epage%3D1608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/medium/jm-2018-00389a_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00389&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/medium/jm-2018-00389a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Overview of furoxan development for the CNS. The furoxans described here have more favorable physiochemical properties as potential CNS drugs than previously described furoxans. Furoxans have not been studied in the brain previously. *Abbreviations: MW = molecular weight; tPSA = total polar surface area; cLogP = calculated partition coefficient; Aβ = oligomeric amyloid beta; LTP = long-term potentiation; STPA = step-through passive avoidance.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00389&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/medium/jm-2018-00389a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Design justification for furoxan library. (B) Review of furoxan designation nomenclature. Furoxans tautomerize when heated sufficiently (at least 100 °C for a sustained period of time depending upon substitution pattern) but do not interconvert at physiologically relevant temperatures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00389&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/medium/jm-2018-00389a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Library Synthesis<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00389&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(i) Ethyl chloroformate, triethylamine, sodium borohydride, 0 °C to r.t.; (ii) acetic acid:dimethylformamide (1:1), sodium nitrite, 0 to 60 °C; (iii) triphenylphosphine, carbon tetrabromide, 0 °C to r.t.; (iv) 4-methylpiperidine, triethylamine, r.t. to 60 °C; (v) toluene, reflux, 7 d.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/medium/jm-2018-00389a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the LC-MS/MS Internal Standard<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00389&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(i) 4-Methylpiperidine-2,2,6,6-<i>d</i><sup>4</sup>, triethylamine, r.t. to 60 °C; (ii) toluene, reflux, 7 d.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/medium/jm-2018-00389a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Crystal structure of <b>5a</b> confirming the oxadiazole-4<i>N</i>-oxide ring configuration. (B) HPLC-PDA analysis demonstrating differences in relative polarity and UV absorption properties for ODZ-2N and ODZ-4N furoxans <b>4a</b> and <b>5a</b>, respectively. Chromatograms represent overlay of UV signal at 254 nm with PDA analysis of the representative portion of the chromatogram shown above each peak.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00389&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/medium/jm-2018-00389a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Neuroprotection concentration response curve for <b>5a</b>. PC12 cells were submitted to OGD for 90 min followed by addition of <b>5a</b> (0.1, 1, 5, 10, 25, or 50 μM) and incubated under normoxic conditions for 24 h. Data represent percent change in viability relative to vehicle-treated control mean = 1, Prestoblue readout. Vehicle control viability range (assay baseline [blue]) and viability range control plates not submitted to OGD are shown in yellow. (B) Neuroprotection of <b>5a</b> is dependent on sGC signaling. ODQ (10 μM) abolished neuroprotective activity of <b>5a</b> in a PC12-OGD assay using MTT as a viability readout. Data represented as mean ± SEM (<i>n</i> = 3) of duplicate experiments. *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 compared to vehicle control using one-way ANOVA analysis with Dunnett’s posthoc test. Average viability of the OGD vehicle cells was 51.4% (±4.1) that of vehicle cells based on 20 OGD/vehicle trials, represented as mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00389&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/medium/jm-2018-00389a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Reversal of cholinergic memory deficits in STPA by <b>5a</b>. Male C57BL/6 mice administered either vehicle or <b>5a</b> (0.1, 1, 10, or 20 mg/kg) via ip injection at 1 or 2 h prior to training. Scopolamine (1 mg/kg) was administered 30 min prior to training. Memory was measured as latency to enter a dark chamber 24 h after training. Data represented as mean and SEM (<i>n</i> = 8–9) for <i>n</i> = 8, see exclusion criteria in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. **<i>p</i> < 0.01 and ***<i>p</i> < 0.001 compared to negative scopolamine-treated control using one-way ANOVA analysis with Dunnett’s posthoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00389&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/medium/jm-2018-00389a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Male C57BL/6 mice (<i>N</i> = 4 per cohort) were treated with vehicle or <b>5a</b> (20 mg/kg), and at the specified time, plasma and forebrain were collected and processed as indicated. (B) At the specified time (1, 2, or 12 h), plasma (triangles) and forebrain (circles) were collected, spiked with <b>7a</b>, and extracted. Oral gavage (po) is indicated by solid lines and yellow symbols. Intraperitoneal injection (ip) is indicated by dotted lines and red symbols. Quantitation based on the ratio of the AUC of the MRM transitions for <b>5a</b> versus <b>7a</b> relative to a calibration curve. Concentrations (μM) were calculated after normalizing for tissue weight (assuming tissue/plasma density = 1). Data shown as mean ± SEM (<i>n</i> = 4) for all cohorts except 1 h ip (<i>n</i> = 3), see exclusion criteria in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. (C) Forebrains were homogenized, normalized by bradford, and analyzed for pCREB and tCREB by ELISA (V = veh, D = drug [<b>5a</b>]). The ratio of absorbance values was normalized to Veh mean = 1 for each treatment group. Data represent mean ± SEM (<i>n</i> = 4), analysis by one-way ANOVA with Tukey’s test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00389/20180517/images/large/jm-2018-00389a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00389&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i81">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41812" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41812" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 53 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandel, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, R. D.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">10250</span>– <span class="NLM_lpage">10261</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.19-23-10250.1999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1523%2FJNEUROSCI.19-23-10250.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10575022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADyaK1MXnslyrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=10250-10261&issue=23&author=Y.+F.+Luauthor=E.+R.+Kandelauthor=R.+D.+Hawkins&title=Nitric+oxide+signaling+contributes+to+late-phase+LTP+and+CREB+phosphorylation+in+the+hippocampus&doi=10.1523%2FJNEUROSCI.19-23-10250.1999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus</span></div><div class="casAuthors">Lu, Yun-Fei; Kandel, Eric R.; Hawkins, Robert D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10250-10261</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Long-term potentiation (LTP) in the hippocampus has an early phase (E-LTP) that can be induced by 1- or 2-train tetanization, lasts ∼1 h, and is cAMP-dependent protein kinase A (PKA)- and protein synthesis-independent and a late phase (L-LTP) that can be induced by 3- or 4-train tetanization, lasts >3 h, and is reduced by inhibitors of PKA and of protein or RNA synthesis.  NO is thought to be involved in E-LTP, but until now there has been no information about the role of the NO-signaling pathway in L-LTP.  Here, the authors examd. this question at the Schaffer collateral-CA1 synapses in slices of mouse hippocampus.  An inhibitor of nitric oxide synthase blocked L-LTP induced by 3-train tetanization and reduced L-LTP induced by 4-train tetanization, whereas an inhibitor of PKA was more effective in blocking 4-train L-LTP than 3-train L-LTP.  Three-train L-LTP was also blocked by inhibitors of guanylyl cyclase or cGMP-dependent protein kinase G (PKG).  Conversely, either NO or cGMP analogs paired with 1-train tetanization produced late-phase potentiation, and the cGMP-induced potentiation was blocked by inhibitors of protein or RNA synthesis and an inhibitor of PKG, but not by an inhibitor of PKA.  To test a possible downstream target of PKG, the authors examd. changes in phospho-CRE-binding protein (phospho-CREB) immunofluorescence in the CA1 cell body area and obtained results similar to those of the electrophysiol. expts.  The results suggested that NO contributes to L-LTP by stimulating guanylyl cyclase and PKG, which acts in parallel with PKA to increase phosphorylation of transcription factor CREB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY0i0LYOPf7LVg90H21EOLACvtfcHk0lgyzZ49Z1zz7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslyrt70%253D&md5=6d09b68560c09b81e38354826f7c21b6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-23-10250.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-23-10250.1999%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%2BF.%26aulast%3DKandel%26aufirst%3DE.%2BR.%26aulast%3DHawkins%26aufirst%3DR.%2BD.%26atitle%3DNitric%2520oxide%2520signaling%2520contributes%2520to%2520late-phase%2520LTP%2520and%2520CREB%2520phosphorylation%2520in%2520the%2520hippocampus%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26issue%3D23%26spage%3D10250%26epage%3D10261%26doi%3D10.1523%2FJNEUROSCI.19-23-10250.1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ciani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guidi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartesaghi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contestabile, A.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: implication for a survival role of nitric oxide</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>82</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1282</span>– <span class="NLM_lpage">1289</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.2002.01080.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1046%2Fj.1471-4159.2002.01080.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=12358775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvVerur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=1282-1289&issue=5&author=E.+Cianiauthor=S.+Guidiauthor=R.+Bartesaghiauthor=A.+Contestabile&title=Nitric+oxide+regulates+cGMP-dependent+cAMP-responsive+element+binding+protein+phosphorylation+and+Bcl-2+expression+in+cerebellar+neurons%3A+implication+for+a+survival+role+of+nitric+oxide&doi=10.1046%2Fj.1471-4159.2002.01080.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: Implication for a survival role of nitric oxide</span></div><div class="casAuthors">Ciani, Elisabetta; Guidi, Sandra; Bartesaghi, Renata; Contestabile, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1282-1289</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">NO is a small, diffusible, highly reactive mol. with a dichotomous regulatory role in the brain as an intra- and intercellular messenger under physiol. conditions and a neurodegenerative agent under pathol. conditions.  The authors recently demonstrated that long-lasting exposure to an neuronal nitric oxide synthase (nNOS) inhibitor down-regulated the serine/threonine kinase Akt survival pathway and caused apoptosis in cerebellar granule cell cultures.  The present study further substantiated the role of NO in neuronal survival by demonstrating that blocking its prodn. down-regulated the activity of cAMP-responsive element binding protein (CREB), a transcription factor involved in cell survival and synaptic plasticity.  Pharmacol. dissection of the pathway linking NO to CREB showed that cGMP and its kinase were intermediate effectors.  The authors also identified Bcl-2 as one of the anti-apoptotic genes down-regulated by NO shortage and decreased CREB phosphorylation.  Thus, these results not only confirmed the role of CREB in neuronal survival but also provided circumstantial evidence for a novel link among NO, CREB activation, and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI4EpdhJVzkrVg90H21EOLACvtfcHk0lj-yzcpQRuMgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvVerur8%253D&md5=919d465c919f768d97c93a650efde1a9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.01080.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.01080.x%26sid%3Dliteratum%253Aachs%26aulast%3DCiani%26aufirst%3DE.%26aulast%3DGuidi%26aufirst%3DS.%26aulast%3DBartesaghi%26aufirst%3DR.%26aulast%3DContestabile%26aufirst%3DA.%26atitle%3DNitric%2520oxide%2520regulates%2520cGMP-dependent%2520cAMP-responsive%2520element%2520binding%2520protein%2520phosphorylation%2520and%2520Bcl-2%2520expression%2520in%2520cerebellar%2520neurons%253A%2520implication%2520for%2520a%2520survival%2520role%2520of%2520nitric%2520oxide%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D82%26issue%3D5%26spage%3D1282%26epage%3D1289%26doi%3D10.1046%2Fj.1471-4159.2002.01080.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johannessen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delghandi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moens, U.</span></span> <span> </span><span class="NLM_article-title">What turns CREB on?</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1211</span>– <span class="NLM_lpage">1227</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2004.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.cellsig.2004.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=15337521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFSmur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=1211-1227&issue=11&author=M.+Johannessenauthor=M.+P.+Delghandiauthor=U.+Moens&title=What+turns+CREB+on%3F&doi=10.1016%2Fj.cellsig.2004.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">What turns CREB on?</span></div><div class="casAuthors">Johannessen, Mona; Delghandi, Marit Pedersen; Moens, Ugo</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1211-1227</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The transactivation domain of the cAMP response element-binding protein (CREB) consists of two major domains.  The glutamine-rich Q2 domain, which interacts with the general transcription factor TAFII130/135, is sufficient for the recruitment of a functional RNA polymerase II complex and allows basal transcriptional activity.  The kinase-inducible domain, however, mediates signal-induced activation of CREB-mediated transcription.  It is generally believed that recruitment of the coactivators CREB-binding protein (CBP) and p300 after signal-induced phosphorylation of this domain at serine-133 strongly enhances CREB-dependent transcription.  Transcriptional activity of CREB can also be potentiated by phosphoserine-133-independent mechanisms, and not all stimuli that provoke phosphorylation of serine-133 stimulate CREB-dependent transcription.  This review presents an overview of the diversity of stimuli that induce CREB phosphorylation at Ser-133, focuses on phosphoserine-133-dependent and -independent mechanisms that affect CREB-mediated transcription, and discusses different models that may explain the discrepancy between CREB Ser-133 phosphorylation and activation of CREB-mediated transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeVRXxe4S8IrVg90H21EOLACvtfcHk0lj-yzcpQRuMgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFSmur0%253D&md5=8cbcc82b3eb5d491ce28ff2a4f8eae3e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2004.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2004.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DJohannessen%26aufirst%3DM.%26aulast%3DDelghandi%26aufirst%3DM.%2BP.%26aulast%3DMoens%26aufirst%3DU.%26atitle%3DWhat%2520turns%2520CREB%2520on%253F%26jtitle%3DCell.%2520Signalling%26date%3D2004%26volume%3D16%26issue%3D11%26spage%3D1211%26epage%3D1227%26doi%3D10.1016%2Fj.cellsig.2004.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teich, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzzo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purgatorio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span> <span> </span><span class="NLM_article-title">Synaptic therapy in Alzheimer’s disease: a CREB-centric approach</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1007/s13311-014-0327-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1007%2Fs13311-014-0327-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=25575647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvVSlt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=29-41&issue=1&author=A.+F.+Teichauthor=R.+E.+Nichollsauthor=D.+Puzzoauthor=J.+Fioritoauthor=R.+Purgatorioauthor=M.+Faauthor=O.+Arancio&title=Synaptic+therapy+in+Alzheimer%E2%80%99s+disease%3A+a+CREB-centric+approach&doi=10.1007%2Fs13311-014-0327-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Synaptic Therapy in Alzheimer's Disease: A CREB-centric Approach</span></div><div class="casAuthors">Teich, Andrew F.; Nicholls, Russell E.; Puzzo, Daniela; Fiorito, Jole; Purgatorio, Rosa; Fa, Mauro; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-41</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1878-7479</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Therapeutic attempts to cure Alzheimer's disease (AD) have failed, and new strategies are desperately needed.  Motivated by this reality, many labs. (including our own) have focused on synaptic dysfunction in AD because synaptic changes are highly correlated with the severity of clin. dementia.  In particular, memory formation is accompanied by altered synaptic strength, and this phenomenon (and its dysfunction in AD) has been a recent focus for many labs.  The mol. cyclic adenosine monophosphate response element-binding protein (CREB) is at a central converging point of pathways and mechanisms activated during the processes of synaptic strengthening and memory formation, as CREB phosphorylation leads to transcription of memory-assocd. genes.  Disruption of these mechanisms in AD results in a redn. of CREB activation with accompanying memory impairment.  Thus, it is likely that strategies aimed at these mechanisms will lead to future therapies for AD.  In this review, we will summarize literature that investigates 5 possible therapeutic pathways for rescuing synaptic dysfunction in AD: 4 enzymic pathways that lead to CREB phosphorylation (the cyclic adenosine monophosphate cascade, the serine/threonine kinases extracellular regulated kinases 1 and 2, the nitric oxide cascade, and the calpains), as well as histone acetyltransferases and histone deacetylases (2 enzymes that regulate the histone acetylation necessary for gene transcription).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtuWRTEQW78bVg90H21EOLACvtfcHk0lgZN5GpA3ia5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvVSlt78%253D&md5=1b1cd3d1f31fa90e6bc317e10af44be2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs13311-014-0327-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-014-0327-5%26sid%3Dliteratum%253Aachs%26aulast%3DTeich%26aufirst%3DA.%2BF.%26aulast%3DNicholls%26aufirst%3DR.%2BE.%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DFiorito%26aufirst%3DJ.%26aulast%3DPurgatorio%26aufirst%3DR.%26aulast%3DFa%26aufirst%3DM.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DSynaptic%2520therapy%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520CREB-centric%2520approach%26jtitle%3DNeurotherapeutics%26date%3D2015%26volume%3D12%26issue%3D1%26spage%3D29%26epage%3D41%26doi%3D10.1007%2Fs13311-014-0327-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puzzo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span> <span> </span><span class="NLM_article-title">Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer’s disease</span>. <i>Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">523</span>, <span class="refDoi"> DOI: 10.1515/REVNEURO.2006.17.5.497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1515%2FREVNEURO.2006.17.5.497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=17180876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlentbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=497-523&issue=5&author=D.+Puzzoauthor=A.+Palmeriauthor=O.+Arancio&title=Involvement+of+the+nitric+oxide+pathway+in+synaptic+dysfunction+following+amyloid+elevation+in+Alzheimer%E2%80%99s+disease&doi=10.1515%2FREVNEURO.2006.17.5.497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer's disease</span></div><div class="casAuthors">Puzzo, Daniela; Palmeri, Agostino; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in the Neurosciences (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">497-523</span>CODEN:
                <span class="NLM_cas:coden">RNEUEO</span>;
        ISSN:<span class="NLM_cas:issn">0334-1763</span>.
    
            (<span class="NLM_cas:orgname">Freund & Pettman</span>)
        </div><div class="casAbstract">A review.  Amyloid-beta (Aβ), a peptide thought to play a crucial role in Alzheimer's disease (AD), has attracted scientific interest with the aim of characterizing the mechanisms by which it is involved in AD pathogenesis.  Aβ has been found to markedly impair hippocampal long-term potentiation (LTP), a widely studied cellular model of synaptic plasticity that is thought to underlie learning and memory.  The overall purpose of this review is to define the role of the nitric oxide (NO)/cGMP/cAMP-regulatory element binding (CREB) pathway in beta-amyloid-induced changes of basal neurotransmission and synaptic plasticity in the hippocampus, a structure within the temporal lobe of the brain crit. for memory storage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzLKNBiiakNLVg90H21EOLACvtfcHk0lgZN5GpA3ia5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlentbzJ&md5=faa3271286d20c9cd431f9b001476089</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1515%2FREVNEURO.2006.17.5.497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FREVNEURO.2006.17.5.497%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DInvolvement%2520of%2520the%2520nitric%2520oxide%2520pathway%2520in%2520synaptic%2520dysfunction%2520following%2520amyloid%2520elevation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DRev.%2520Neurosci.%26date%3D2006%26volume%3D17%26issue%3D5%26spage%3D497%26epage%3D523%26doi%3D10.1515%2FREVNEURO.2006.17.5.497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saura, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valero, J.</span></span> <span> </span><span class="NLM_article-title">The role of CREB signaling in Alzheimer’s disease and other cognitive disorders</span>. <i>Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1515/rns.2011.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1515%2Frns.2011.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=21476939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlWktrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=153-169&issue=2&author=C.+A.+Sauraauthor=J.+Valero&title=The+role+of+CREB+signaling+in+Alzheimer%E2%80%99s+disease+and+other+cognitive+disorders&doi=10.1515%2Frns.2011.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The role of CREB signaling in Alzheimer's disease and other cognitive disorders</span></div><div class="casAuthors">Saura, Carlos A.; Valero, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in the Neurosciences (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-169</span>CODEN:
                <span class="NLM_cas:coden">RNEUEO</span>;
        ISSN:<span class="NLM_cas:issn">0334-1763</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review.  Gene expression changes in the brain affect cognition during normal and pathol. aging.  Progress in understanding the cellular processes regulating gene expression networks in cognition is relevant to develop therapeutic interventions for age-related cognitive disorders.  Synaptic efficacy mediating memory storage requires the activation of specific gene expression programs regulated, among others, by the transcription factor cAMP-response element binding protein (CREB).  CREB signaling is essential for long-lasting changes in synaptic plasticity that mediates the conversion of short-term memory to long-term memory.  CREB signaling has been recently involved in several brain pathol. conditions including cognitive and neurodegenerative disorders.  The β-amyloid (Aβ) peptide, which plays a crucial role in the pathogenesis of Alzheimer's disease, alters hippocampal-dependent synaptic plasticity and memory and mediates synapse loss through the CREB signaling pathway.  The fact that altered CREB signaling has been implicated in other cognitive disorders including Huntington's disease and Rubinstein-Taybi and Coffin-Lowry syndromes suggests a crucial role of CREB signaling in cognitive dysfunction.  In this review paper, we summarize recent findings indicating a role of CREB and its coactivators CREB binding protein and CREB-regulated transcription coactivator in cognition during normal and pathol. aging.  We also discuss the development of novel therapeutic strategies based on CREB targeting to ameliorate cognitive decline in aging and cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTvPO2NdVSi7Vg90H21EOLACvtfcHk0lgZN5GpA3ia5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlWktrzI&md5=64b6b432822be2ae925b5f58e279d0a9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1515%2Frns.2011.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Frns.2011.018%26sid%3Dliteratum%253Aachs%26aulast%3DSaura%26aufirst%3DC.%2BA.%26aulast%3DValero%26aufirst%3DJ.%26atitle%3DThe%2520role%2520of%2520CREB%2520signaling%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520other%2520cognitive%2520disorders%26jtitle%3DRev.%2520Neurosci.%26date%3D2011%26volume%3D22%26issue%3D2%26spage%3D153%26epage%3D169%26doi%3D10.1515%2Frns.2011.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pugazhenthi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sze, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckman, C. B.</span></span> <span> </span><span class="NLM_article-title">Downregulation of CREB expression in Alzheimer’s brain and in Abeta-treated rat hippocampal neurons</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">60</span>, <span class="refDoi"> DOI: 10.1186/1750-1326-6-60</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1186%2F1750-1326-6-60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=21854604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1SqtLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=60&author=S.+Pugazhenthiauthor=M.+Wangauthor=S.+Phamauthor=C.+I.+Szeauthor=C.+B.+Eckman&title=Downregulation+of+CREB+expression+in+Alzheimer%E2%80%99s+brain+and+in+Abeta-treated+rat+hippocampal+neurons&doi=10.1186%2F1750-1326-6-60"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Downregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons</span></div><div class="casAuthors">Pugazhenthi, Subbiah; Wang, Maorong; Pham, Serena; Sze, Chun-I.; Eckman, Christopher B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">60</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Oxidative stress plays an important role in neuronal dysfunction and neuron loss in Alzheimer's brain.  Previous studies have reported downregulation of CREB-mediated transcription by oxidative stress and Aβ.  The promoter for CREB itself contains cAMP response elements.  Therefore, we examd. the expression of CREB in the hippocampal neurons of Tg2576 mice, AD post-mortem brain and in cultured rat hippocampal neurons exposed to Aβ aggregates.  Results: Laser Capture Microdissection of hippocampal neurons from Tg2576 mouse brain revealed decreases in the mRNA levels of CREB and its target, BDNF.  Immunohistochem. anal. of Tg2576 mouse brain showed decreases in CREB levels in hippocampus and cortex.  Markers of oxidative stress were detected in transgenic mouse brain and decreased CREB staining was obsd. in regions showing abundance of astrocytes.  There was also an inverse correlation between SDS-extd. Aβ and CREB protein levels in Alzheimer's post-mortem hippocampal samples.  The levels of CREB-regulated BDNF and BIRC3, a caspase inhibitor, decreased and the active cleaved form of caspase-9, a marker for the intrinsic pathway of apoptosis, was elevated in these samples.  Exposure of rat primary hippocampal neurons to Aβ fibrils decreased CREB promoter activity.  Decrease in CREB mRNA levels in Aβ-treated neurons was reversed by the antioxidant, N-acetyl cysteine.  Overexpression of CREB by adenoviral transduction led to significant protection against Aβ-induced neuronal apoptosis.  Conclusions: Our findings suggest that chronic downregulation of CREB-mediated transcription results in decrease of CREB content in the hippocampal neurons of AD brain which may contribute to exacerbation of disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-Jy8qMsXYa7Vg90H21EOLACvtfcHk0lgZN5GpA3ia5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1SqtLrM&md5=d844676fb6b7ce36eca53a5438528665</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-6-60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-6-60%26sid%3Dliteratum%253Aachs%26aulast%3DPugazhenthi%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DPham%26aufirst%3DS.%26aulast%3DSze%26aufirst%3DC.%2BI.%26aulast%3DEckman%26aufirst%3DC.%2BB.%26atitle%3DDownregulation%2520of%2520CREB%2520expression%2520in%2520Alzheimer%25E2%2580%2599s%2520brain%2520and%2520in%2520Abeta-treated%2520rat%2520hippocampal%2520neurons%26jtitle%3DMol.%2520Neurodegener.%26date%3D2011%26volume%3D6%26spage%3D60%26doi%3D10.1186%2F1750-1326-6-60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puzzo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitolo, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinchese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span> <span> </span><span class="NLM_article-title">Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">29</span>),  <span class="NLM_fpage">6887</span>– <span class="NLM_lpage">6897</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.5291-04.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1523%2FJNEUROSCI.5291-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=16033898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmslClt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=6887-6897&issue=29&author=D.+Puzzoauthor=O.+Vitoloauthor=F.+Trincheseauthor=J.+P.+Jacobauthor=A.+Palmeriauthor=O.+Arancio&title=Amyloid-beta+peptide+inhibits+activation+of+the+nitric+oxide%2FcGMP%2FcAMP-responsive+element-binding+protein+pathway+during+hippocampal+synaptic+plasticity&doi=10.1523%2FJNEUROSCI.5291-04.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity</span></div><div class="casAuthors">Puzzo, Daniela; Vitolo, Ottavio; Trinchese, Fabrizio; Jacob, Joel P.; Palmeri, Agostino; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">6887-6897</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Amyloid-β (Aβ), a peptide thought to play a crucial role in Alzheimer's disease (AD), has many targets that, in turn, activate different 2nd-messenger cascades.  Interestingly, Aβ was found to markedly impair hippocampal long-term potentiation (LTP).  To identify a new pathway that might be responsible for such impairment, the authors analyzed the role of the NO/sol. guanylyl cyclase (sGC)/cGMP/cGMP-dependent protein kinase (cGK)/cAMP-responsive element-binding protein (CREB) cascade because of its involvement in LTP.  The use of the NO donor 2-(N,N-dethylamino)-diazenolate-2-oxide diethylammonium salt (DEA/NO), the sGC stimulator 3-(4-amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine, or the cGMP-analogs 8-bromo-cGMP and 8-(4-chlorophenylthio)-cGMP reversed the Aβ-induced impairment of CA1-LTP through cGK activation.  Furthermore, these compds. reestablished the enhancement of CREB phosphorylation occurring during LTP in slices exposed to Aβ.  We also found that Aβ blocks the increase in cGMP immunoreactivity occurring immediately after LTP and that DEA/NO counteracts the effect of Aβ.  These results strongly suggest that, when modulating hippocampal synaptic plasticity, Aβ downregulates the NO/cGMP/cGK/CREB pathway; thus, enhancement of the NO/cGMP signaling may provide a novel approach to the treatment of AD and other neurodegenerative diseases with elevated prodn. of Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT_M3WUlYelLVg90H21EOLACvtfcHk0lgbj7jVLbFtfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmslClt78%253D&md5=448717d56147ceb9665d8c1ce8136c98</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5291-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5291-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DVitolo%26aufirst%3DO.%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DJacob%26aufirst%3DJ.%2BP.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DAmyloid-beta%2520peptide%2520inhibits%2520activation%2520of%2520the%2520nitric%2520oxide%252FcGMP%252FcAMP-responsive%2520element-binding%2520protein%2520pathway%2520during%2520hippocampal%2520synaptic%2520plasticity%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26issue%3D29%26spage%3D6887%26epage%3D6897%26doi%3D10.1523%2FJNEUROSCI.5291-04.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusky, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatcher, G. R.</span></span> <span> </span><span class="NLM_article-title">Cognitive deficits in rats after forebrain cholinergic depletion are reversed by a novel NO mimetic nitrate ester</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">505</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1038/sj.npp.1301054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1038%2Fsj.npp.1301054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=505-513&issue=3&author=B.+M.+Bennettauthor=J.+N.+Reynoldsauthor=G.+T.+Pruskyauthor=R.+M.+Douglasauthor=R.+J.+Sutherlandauthor=G.+R.+Thatcher&title=Cognitive+deficits+in+rats+after+forebrain+cholinergic+depletion+are+reversed+by+a+novel+NO+mimetic+nitrate+ester&doi=10.1038%2Fsj.npp.1301054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1301054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1301054%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DB.%2BM.%26aulast%3DReynolds%26aufirst%3DJ.%2BN.%26aulast%3DPrusky%26aufirst%3DG.%2BT.%26aulast%3DDouglas%26aufirst%3DR.%2BM.%26aulast%3DSutherland%26aufirst%3DR.%2BJ.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%26atitle%3DCognitive%2520deficits%2520in%2520rats%2520after%2520forebrain%2520cholinergic%2520depletion%2520are%2520reversed%2520by%2520a%2520novel%2520NO%2520mimetic%2520nitrate%2520ester%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D32%26issue%3D3%26spage%3D505%26epage%3D513%26doi%3D10.1038%2Fsj.npp.1301054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VandeVrede, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Aissa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teich, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Souza, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elharram, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koster, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaDu, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatcher, G. R. J.</span></span> <span> </span><span class="NLM_article-title">A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer’s disease</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">35</span>, <span class="refDoi"> DOI: 10.1186/s13024-016-0103-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1186%2Fs13024-016-0103-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=27129593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsFGgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=35&issue=1&author=J.+Luoauthor=S.+H.+Leeauthor=L.+VandeVredeauthor=Z.+Qinauthor=M.+Ben+Aissaauthor=J.+Larsonauthor=A.+F.+Teichauthor=O.+Arancioauthor=Y.+D%E2%80%99Souzaauthor=A.+Elharramauthor=K.+Kosterauthor=L.+M.+Taiauthor=M.+J.+LaDuauthor=B.+M.+Bennettauthor=G.+R.+J.+Thatcher&title=A+multifunctional+therapeutic+approach+to+disease+modification+in+multiple+familial+mouse+models+and+a+novel+sporadic+model+of+Alzheimer%E2%80%99s+disease&doi=10.1186%2Fs13024-016-0103-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease</span></div><div class="casAuthors">Luo, Jia; Lee, Sue H.; Vande Vrede, Lawren; Qin, Zhihui; Ben Aissa, Manel; Larson, John; Teich, Andrew F.; Arancio, Ottavio; D'Souza, Yohan; Elharram, Ahmed; Koster, Kevin; Tai, Leon M.; LaDu, Mary Jo; Bennett, Brian M.; Thatcher, Gregory R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35/1-35/14</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Clin. failures singularly targeting amyloid-β pathol. indicate a crit. need for alternative Alzheimer's disease (AD) therapeutic strategies.  The mixed pathol. reported in a large population of AD patients demands a multifunctional drug approach.  Since activation of cAMP response element binding protein (CREB) plays a crucial role in synaptic strengthening and memory formation, we retooled a clin. drug with known neuroprotective and anti-inflammatory activity to activate CREB, and validated this novel multifunctional drug, NMZ, in 4 different mouse models of AD.  Results: NMZ was tested in three mouse models of familial AD and one model of sporadic AD.  In 3 × Tg hippocampal slices, NMZ restored LTP.  In vivo, memory was improved with NMZ in all animal models with robust cognitive deficits.  NMZ treatment lowered neurotoxic forms of Aβ in both APP/PS1 and 3 × Tg transgenic mice while also restoring neuronal plasticity biomarkers in the 3 × Tg mice.  In EFAD mice, incorporation of the major genetic AD risk factor, hAPOE4, did not mute the beneficial drug effects.  In a novel sporadic mouse model that manifests AD-like pathol. caused by accelerated oxidative stress in the absence of any familial AD mutation, oral administration of NMZ attenuated hallmark AD pathol. and restored biomarkers of synaptic and neuronal function.  Conclusions: The multifunctional approach, embodied by NMZ, was successful in mouse models of AD incorporating Aβ pathol. (APP/PS1), tau pathol. (3 × Tg), and APOE4, the major human genetic risk factor for AD (EFAD).  The efficacy obsd. in a novel model of sporadic AD (Aldh2-/-) demonstrates that the therapeutic approach is not limited to rare, familial AD genetic mutations.  The multifunctional drug, NMZ, was not designed directly to target Aβ and tau pathol.; however, the attenuation of this hallmark pathol. suggests the approach to be a highly promising, disease-modifying strategy for AD and mixed pathol. dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_wPT-pA9Iz7Vg90H21EOLACvtfcHk0lgbj7jVLbFtfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsFGgur4%253D&md5=92dc7fdc5709d681f46997c1407f5396</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1186%2Fs13024-016-0103-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13024-016-0103-6%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DVandeVrede%26aufirst%3DL.%26aulast%3DQin%26aufirst%3DZ.%26aulast%3DBen%2BAissa%26aufirst%3DM.%26aulast%3DLarson%26aufirst%3DJ.%26aulast%3DTeich%26aufirst%3DA.%2BF.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DY.%26aulast%3DElharram%26aufirst%3DA.%26aulast%3DKoster%26aufirst%3DK.%26aulast%3DTai%26aufirst%3DL.%2BM.%26aulast%3DLaDu%26aufirst%3DM.%2BJ.%26aulast%3DBennett%26aufirst%3DB.%2BM.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26atitle%3DA%2520multifunctional%2520therapeutic%2520approach%2520to%2520disease%2520modification%2520in%2520multiple%2520familial%2520mouse%2520models%2520and%2520a%2520novel%2520sporadic%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Neurodegener.%26date%3D2016%26volume%3D11%26issue%3D1%26spage%3D35%26doi%3D10.1186%2Fs13024-016-0103-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chien, W.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, K.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, F.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W.-M.</span></span> <span> </span><span class="NLM_article-title">Enhancement of long-term potentiation by a potent nitric oxide-guanylyl cyclase activator, 3-(5-hydroxymethyl-2-furyl)-1-benzyl-indazole</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1322</span>– <span class="NLM_lpage">1328</span>, <span class="refDoi"> DOI: 10.1124/mol.63.6.1322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1124%2Fmol.63.6.1322" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=1322-1328&issue=6&author=W.-L.+Chienauthor=K.-C.+Liangauthor=C.-M.+Tengauthor=S.-C.+Kuoauthor=F.-Y.+Leeauthor=W.-M.+Fu&title=Enhancement+of+long-term+potentiation+by+a+potent+nitric+oxide-guanylyl+cyclase+activator%2C+3-%285-hydroxymethyl-2-furyl%29-1-benzyl-indazole&doi=10.1124%2Fmol.63.6.1322"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1124%2Fmol.63.6.1322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.63.6.1322%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DW.-L.%26aulast%3DLiang%26aufirst%3DK.-C.%26aulast%3DTeng%26aufirst%3DC.-M.%26aulast%3DKuo%26aufirst%3DS.-C.%26aulast%3DLee%26aufirst%3DF.-Y.%26aulast%3DFu%26aufirst%3DW.-M.%26atitle%3DEnhancement%2520of%2520long-term%2520potentiation%2520by%2520a%2520potent%2520nitric%2520oxide-guanylyl%2520cyclase%2520activator%252C%25203-%25285-hydroxymethyl-2-furyl%2529-1-benzyl-indazole%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D63%26issue%3D6%26spage%3D1322%26epage%3D1328%26doi%3D10.1124%2Fmol.63.6.1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Privitera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giunta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loreto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzzo, D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of phosphodiesterase-5 rescues age-related impairment of synaptic plasticity and memory</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>240</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2012.10.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.bbr.2012.10.060" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=240&publication_year=2013&pages=11-20&author=A.+Palmeriauthor=L.+Priviteraauthor=S.+Giuntaauthor=C.+Loretoauthor=D.+Puzzo&title=Inhibition+of+phosphodiesterase-5+rescues+age-related+impairment+of+synaptic+plasticity+and+memory&doi=10.1016%2Fj.bbr.2012.10.060"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2012.10.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2012.10.060%26sid%3Dliteratum%253Aachs%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DPrivitera%26aufirst%3DL.%26aulast%3DGiunta%26aufirst%3DS.%26aulast%3DLoreto%26aufirst%3DC.%26aulast%3DPuzzo%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520phosphodiesterase-5%2520rescues%2520age-related%2520impairment%2520of%2520synaptic%2520plasticity%2520and%2520memory%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2013%26volume%3D240%26spage%3D11%26epage%3D20%26doi%3D10.1016%2Fj.bbr.2012.10.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puzzo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loreto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giunta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musumeci, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frasca, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podda, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmeri, A.</span></span> <span> </span><span class="NLM_article-title">Effect of phosphodiesterase-5 inhibition on apoptosis and beta amyloid load in aged mice</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">520</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2013.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.neurobiolaging.2013.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=24112792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFykur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=520-531&issue=3&author=D.+Puzzoauthor=C.+Loretoauthor=S.+Giuntaauthor=G.+Musumeciauthor=G.+Frascaauthor=M.+V.+Poddaauthor=O.+Arancioauthor=A.+Palmeri&title=Effect+of+phosphodiesterase-5+inhibition+on+apoptosis+and+beta+amyloid+load+in+aged+mice&doi=10.1016%2Fj.neurobiolaging.2013.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of phosphodiesterase-5 inhibition on apoptosis and beta amyloid load in aged mice</span></div><div class="casAuthors">Puzzo, Daniela; Loreto, Carla; Giunta, Salvatore; Musumeci, Giuseppe; Frasca, Giuseppina; Podda, Maria Vittoria; Arancio, Ottavio; Palmeri, Agostino</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">520-531</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Age-related cognitive decline is accompanied by an increase of neuronal apoptosis and a dysregulation of neuroplasticity-related mols. such as brain-derived neurotrophic factor and neurotoxic factors including beta amyloid (Aβ) peptide.  Because it has been previously demonstrated that phosphodiesterase-5 inhibitors (PDE5-Is) protect against hippocampal synaptic dysfunction and memory deficits in mouse models of Alzheimer's disease and physiol. aging, we investigated the effect of a treatment with the PDE5-I, sildenafil, on cell death, pro- and antiapoptotic mols., and Aβ prodn.  We demonstrated that chronic i.p. injection of sildenafil (3 mg/kg for 3 wk) decreased terminal deoxyuridine triphosphate nick end labeling-pos. cells in the CA1 hippocampal area of 26-30-mo-old mice, downregulating the proapoptotic proteins, caspase-3 and B-cell lymphoma 2-assocd. X, and increasing antiapoptotic mols. such as B-cell lymphoma protein-2 and brain-derived neurotrophic factor.  Also, sildenafil reverted the shifting of amyloid precursor protein processing toward Aβ42 prodn. and the increase of the Aβ42:Aβ40 ratio in aged mice.  Our data suggest that PDE5-I might be beneficial to treat age-related detrimental features in a physiol. mouse model of aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQfx5_aPXHqbVg90H21EOLACvtfcHk0lirAHs_cdTddA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFykur%252FI&md5=4f8f5b69a3340d0e6fa552052d194940</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2013.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2013.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DLoreto%26aufirst%3DC.%26aulast%3DGiunta%26aufirst%3DS.%26aulast%3DMusumeci%26aufirst%3DG.%26aulast%3DFrasca%26aufirst%3DG.%26aulast%3DPodda%26aufirst%3DM.%2BV.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DPalmeri%26aufirst%3DA.%26atitle%3DEffect%2520of%2520phosphodiesterase-5%2520inhibition%2520on%2520apoptosis%2520and%2520beta%2520amyloid%2520load%2520in%2520aged%2520mice%26jtitle%3DNeurobiol.%2520Aging%26date%3D2014%26volume%3D35%26issue%3D3%26spage%3D520%26epage%3D531%26doi%3D10.1016%2Fj.neurobiolaging.2013.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, H.</span></span> <span> </span><span class="NLM_article-title">Anticancer efficacy of a nitric oxide-modified derivative of bifendate against multidrug-resistant cancer cells</span>. <i>J. Cell Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1095</span>– <span class="NLM_lpage">1105</span>, <span class="refDoi"> DOI: 10.1111/jcmm.12796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1111%2Fjcmm.12796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=26864945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos1Srt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=1095-1105&issue=6&author=Z.+Renauthor=X.+Guauthor=B.+Luauthor=Y.+Chenauthor=G.+Chenauthor=J.+Fengauthor=J.+Linauthor=Y.+Zhangauthor=H.+Peng&title=Anticancer+efficacy+of+a+nitric+oxide-modified+derivative+of+bifendate+against+multidrug-resistant+cancer+cells&doi=10.1111%2Fjcmm.12796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer efficacy of a nitric oxide-modified derivative of bifendate against multidrug-resistant cancer cells</span></div><div class="casAuthors">Ren, Zhiguang; Gu, Xiaoke; Lu, Bin; Chen, Yaqiong; Chen, Guojiang; Feng, Jiannan; Lin, Jizhen; Zhang, Yihua; Peng, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1095-1105</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-4934</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The development of multidrug resistance (MDR) not only actively transports a wide range of cytotoxic drugs across drug transporters but is also a complex interaction between a no. of important cellular signalling pathways.  Nitric oxide donors appear to be a new class of anticancer therapeutics for satisfying all the above conditions.  Previously, we reported furoxan-based nitric oxide-releasing compds. that exhibited selective antitumor activity in vitro and in vivo.  Herein, we demonstrate that bifendate (DDB)-nitric oxide, a synthetic furoxan-based nitric oxide-releasing deriv. of bifendate, effectively inhibits the both sensitive and MDR tumor cell viability at a comparatively low concn.  Interestingly, the potency of DDB-nitric oxide is the independent of inhibition of the functions and expressions of three major ABC transporters.  The mechanism of DDB-nitric oxide appears to be in two modes of actions by inducing mitochondrial tyrosine nitration and apoptosis, as well as by down-regulating HIF-1α expression and protein kinase B (AKT), extracellular signal-regulated kinases (ERK), nuclear factor κB (NF-κB) activation in MDR cells.  Moreover, the addn. of a typical nitric oxide scavenger significantly attenuated all the effects of DDB-nitric oxide, indicating that the cytotoxicity of DDB-nitric oxide is as a result of higher levels of nitric oxide release in MDR cancer cells.  Given that acquired MDR to nitric oxide donors is reportedly difficult to achieve and genetically unstable, compd. like DDB-nitric oxide may be a new type of therapeutic agent for the treatment of MDR tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplHi8uVSb7J7Vg90H21EOLACvtfcHk0lirAHs_cdTddA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos1Srt78%253D&md5=b0bbc08e2f956075b8adf5759ca47c46</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fjcmm.12796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjcmm.12796%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DZ.%26aulast%3DGu%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DH.%26atitle%3DAnticancer%2520efficacy%2520of%2520a%2520nitric%2520oxide-modified%2520derivative%2520of%2520bifendate%2520against%2520multidrug-resistant%2520cancer%2520cells%26jtitle%3DJ.%2520Cell%2520Mol.%2520Med.%26date%3D2016%26volume%3D20%26issue%3D6%26spage%3D1095%26epage%3D1105%26doi%3D10.1111%2Fjcmm.12796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Almeida, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passalacqua, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, F. A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peccinini, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chegaev, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guglielmo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruttero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graminha, M. A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">dos
Santos, J. L.</span></span> <span> </span><span class="NLM_article-title">Leishmanicidal activities of novel synthetic furoxan and benzofuroxan derivatives</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4837</span>– <span class="NLM_lpage">4847</span>, <span class="refDoi"> DOI: 10.1128/AAC.00052-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1128%2FAAC.00052-14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=4837-4847&issue=8&author=L.+A.+Dutraauthor=L.+de+Almeidaauthor=T.+G.+Passalacquaauthor=J.+S.+Reisauthor=F.+A.+E.+Torresauthor=I.+Martinezauthor=R.+G.+Peccininiauthor=C.+M.+Chinauthor=K.+Chegaevauthor=S.+Guglielmoauthor=R.+Frutteroauthor=M.+A.+S.+Graminhaauthor=J.+L.+dos%0ASantos&title=Leishmanicidal+activities+of+novel+synthetic+furoxan+and+benzofuroxan+derivatives&doi=10.1128%2FAAC.00052-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FAAC.00052-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00052-14%26sid%3Dliteratum%253Aachs%26aulast%3DDutra%26aufirst%3DL.%2BA.%26aulast%3Dde%2BAlmeida%26aufirst%3DL.%26aulast%3DPassalacqua%26aufirst%3DT.%2BG.%26aulast%3DReis%26aufirst%3DJ.%2BS.%26aulast%3DTorres%26aufirst%3DF.%2BA.%2BE.%26aulast%3DMartinez%26aufirst%3DI.%26aulast%3DPeccinini%26aufirst%3DR.%2BG.%26aulast%3DChin%26aufirst%3DC.%2BM.%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DGuglielmo%26aufirst%3DS.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DGraminha%26aufirst%3DM.%2BA.%2BS.%26aulast%3Ddos%2BSantos%26aufirst%3DJ.%2BL.%26atitle%3DLeishmanicidal%2520activities%2520of%2520novel%2520synthetic%2520furoxan%2520and%2520benzofuroxan%2520derivatives%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26issue%3D8%26spage%3D4837%26epage%3D4847%26doi%3D10.1128%2FAAC.00052-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tosco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertinaria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Stilo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cena, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorba, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruttero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasco, A.</span></span> <span> </span><span class="NLM_article-title">Furoxan analogues of the histamine H3-receptor antagonist imoproxifan and related furazan derivatives</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">4750</span>– <span class="NLM_lpage">4759</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.bmc.2005.05.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=4750-4759&issue=15&author=P.+Toscoauthor=M.+Bertinariaauthor=A.+Di+Stiloauthor=C.+Cenaauthor=G.+Sorbaauthor=R.+Frutteroauthor=A.+Gasco&title=Furoxan+analogues+of+the+histamine+H3-receptor+antagonist+imoproxifan+and+related+furazan+derivatives&doi=10.1016%2Fj.bmc.2005.05.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DTosco%26aufirst%3DP.%26aulast%3DBertinaria%26aufirst%3DM.%26aulast%3DDi%2BStilo%26aufirst%3DA.%26aulast%3DCena%26aufirst%3DC.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DGasco%26aufirst%3DA.%26atitle%3DFuroxan%2520analogues%2520of%2520the%2520histamine%2520H3-receptor%2520antagonist%2520imoproxifan%2520and%2520related%2520furazan%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26issue%3D15%26spage%3D4750%26epage%3D4759%26doi%3D10.1016%2Fj.bmc.2005.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chegaev, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cena, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolando, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertinaria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruttero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrupt, P.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasco, A.</span></span> <span> </span><span class="NLM_article-title">Edaravone derivatives containing NO-donor functions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">574</span>– <span class="NLM_lpage">578</span>, <span class="refDoi"> DOI: 10.1021/jm8007008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8007008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=574-578&issue=2&author=K.+Chegaevauthor=C.+Cenaauthor=M.+Giorgisauthor=B.+Rolandoauthor=P.+Toscoauthor=M.+Bertinariaauthor=R.+Frutteroauthor=P.-A.+Carruptauthor=A.+Gasco&title=Edaravone+derivatives+containing+NO-donor+functions&doi=10.1021%2Fjm8007008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm8007008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8007008%26sid%3Dliteratum%253Aachs%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DCena%26aufirst%3DC.%26aulast%3DGiorgis%26aufirst%3DM.%26aulast%3DRolando%26aufirst%3DB.%26aulast%3DTosco%26aufirst%3DP.%26aulast%3DBertinaria%26aufirst%3DM.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26aulast%3DGasco%26aufirst%3DA.%26atitle%3DEdaravone%2520derivatives%2520containing%2520NO-donor%2520functions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D2%26spage%3D574%26epage%3D578%26doi%3D10.1021%2Fjm8007008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waseem, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sana, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somakala, K.</span></span> <span> </span><span class="NLM_article-title">Furoxan derivatives as nitric oxide donors and their therapeutic potential</span>. <i>Int. Res. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">599</span>, <span class="refDoi"> DOI: 10.7897/2230-8407.069115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.7897%2F2230-8407.069115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFemu7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=585-599&issue=9&author=M.+Amirauthor=A.+M.+Waseemauthor=T.+Sanaauthor=K.+Somakala&title=Furoxan+derivatives+as+nitric+oxide+donors+and+their+therapeutic+potential&doi=10.7897%2F2230-8407.069115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Furoxan derivatives as nitric oxide donors and their therapeutic potential</span></div><div class="casAuthors">Amir, Mohammad; Waseem, Akhter Mohammad; Sana, Tariq; Somakala, Kanagasabai</div><div class="citationInfo"><span class="NLM_cas:title">International Research Journal of Pharmacy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">585-599</span>CODEN:
                <span class="NLM_cas:coden">IRJPBS</span>;
        ISSN:<span class="NLM_cas:issn">2230-8407</span>.
    
            (<span class="NLM_cas:orgname">Moksha Publishing House</span>)
        </div><div class="casAbstract">Nitric oxide synthesized in endothelial cells that line blood vessels, was first described in 1980 as an endothelium derived vascular relaxing factor.  It is an important signalling mol. in various pathol. and physiol. processes.  Dysfunction of NO formation has been implicated in the pathogenesis of a no. of disorders.  Exogenous NO sources constitute a powerful way to supplement NO when the body cannot generate enough for normal biol. functions.  Furoxan, 1,2,5-oxadiazole 2-oxide, has been a very important scaffold in Medicinal Chem. as nitric oxide (NO) donor.  This article explores some of the most promising recent advances in NO donor drug development.  Major focus is placed on recently developed Furoxan derivs. as NO donors and their pharmacol. actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoanFomb-2pPrVg90H21EOLACvtfcHk0li723eZiltiSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFemu7vL&md5=f77e1eefed3e5001931edacbcfe76940</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.7897%2F2230-8407.069115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7897%252F2230-8407.069115%26sid%3Dliteratum%253Aachs%26aulast%3DAmir%26aufirst%3DM.%26aulast%3DWaseem%26aufirst%3DA.%2BM.%26aulast%3DSana%26aufirst%3DT.%26aulast%3DSomakala%26aufirst%3DK.%26atitle%3DFuroxan%2520derivatives%2520as%2520nitric%2520oxide%2520donors%2520and%2520their%2520therapeutic%2520potential%26jtitle%3DInt.%2520Res.%2520J.%2520Pharm.%26date%3D2015%26volume%3D6%26issue%3D9%26spage%3D585%26epage%3D599%26doi%3D10.7897%2F2230-8407.069115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velazquez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, P. N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaus, E. E.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2749</span>– <span class="NLM_lpage">2757</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.02.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.bmc.2005.02.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=2749-2757&issue=8&author=C.+Velazquezauthor=P.+N.+P.+Raoauthor=R.+McDonaldauthor=E.+E.+Knaus&title=Synthesis+and+biological+evaluation+of+3%2C4-diphenyl-1%2C2%2C5-oxadiazole-2-oxides+and+3%2C4-diphenyl-1%2C2%2C5-oxadiazoles+as+potential+hybrid+COX-2+inhibitor%2Fnitric+oxide+donor+agents&doi=10.1016%2Fj.bmc.2005.02.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.02.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.02.034%26sid%3Dliteratum%253Aachs%26aulast%3DVelazquez%26aufirst%3DC.%26aulast%3DRao%26aufirst%3DP.%2BN.%2BP.%26aulast%3DMcDonald%26aufirst%3DR.%26aulast%3DKnaus%26aufirst%3DE.%2BE.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25203%252C4-diphenyl-1%252C2%252C5-oxadiazole-2-oxides%2520and%25203%252C4-diphenyl-1%252C2%252C5-oxadiazoles%2520as%2520potential%2520hybrid%2520COX-2%2520inhibitor%252Fnitric%2520oxide%2520donor%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26issue%3D8%26spage%3D2749%26epage%3D2757%26doi%3D10.1016%2Fj.bmc.2005.02.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schiefer, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VandeVrede, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatcher, G. R. J.</span></span> <span> </span><span class="NLM_article-title">Furoxans (1,2,5-oxadiazole-N-oxides) as novel NO mimetic neuroprotective and procognitive agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3076</span>– <span class="NLM_lpage">3087</span>, <span class="refDoi"> DOI: 10.1021/jm201504s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201504s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3076-3087&issue=7&author=I.+T.+Schieferauthor=L.+VandeVredeauthor=M.+Faauthor=O.+Arancioauthor=G.+R.+J.+Thatcher&title=Furoxans+%281%2C2%2C5-oxadiazole-N-oxides%29+as+novel+NO+mimetic+neuroprotective+and+procognitive+agents&doi=10.1021%2Fjm201504s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm201504s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201504s%26sid%3Dliteratum%253Aachs%26aulast%3DSchiefer%26aufirst%3DI.%2BT.%26aulast%3DVandeVrede%26aufirst%3DL.%26aulast%3DFa%26aufirst%3DM.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26atitle%3DFuroxans%2520%25281%252C2%252C5-oxadiazole-N-oxides%2529%2520as%2520novel%2520NO%2520mimetic%2520neuroprotective%2520and%2520procognitive%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D7%26spage%3D3076%26epage%3D3087%26doi%3D10.1021%2Fjm201504s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chegaev, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolando, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruttero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morbin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fugnanesi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badiola, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasparini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripoli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grassi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasco, A.</span></span> <span> </span><span class="NLM_article-title">NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">4688</span>– <span class="NLM_lpage">4698</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.05.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.bmc.2015.05.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=4688-4698&issue=15&author=K.+Chegaevauthor=A.+Federicoauthor=E.+Mariniauthor=B.+Rolandoauthor=R.+Frutteroauthor=M.+Morbinauthor=G.+Rossiauthor=V.+Fugnanesiauthor=A.+Bastoneauthor=M.+Salmonaauthor=N.+B.+Badiolaauthor=L.+Gaspariniauthor=S.+Coccoauthor=C.+Ripoliauthor=C.+Grassiauthor=A.+Gasco&title=NO-donor+thiacarbocyanines+as+multifunctional+agents+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2015.05.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.05.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.05.050%26sid%3Dliteratum%253Aachs%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DFederico%26aufirst%3DA.%26aulast%3DMarini%26aufirst%3DE.%26aulast%3DRolando%26aufirst%3DB.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DMorbin%26aufirst%3DM.%26aulast%3DRossi%26aufirst%3DG.%26aulast%3DFugnanesi%26aufirst%3DV.%26aulast%3DBastone%26aufirst%3DA.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DBadiola%26aufirst%3DN.%2BB.%26aulast%3DGasparini%26aufirst%3DL.%26aulast%3DCocco%26aufirst%3DS.%26aulast%3DRipoli%26aufirst%3DC.%26aulast%3DGrassi%26aufirst%3DC.%26aulast%3DGasco%26aufirst%3DA.%26atitle%3DNO-donor%2520thiacarbocyanines%2520as%2520multifunctional%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26issue%3D15%26spage%3D4688%26epage%3D4698%26doi%3D10.1016%2Fj.bmc.2015.05.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gleeson, M. P.</span></span> <span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">817</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1021/jm701122q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&issue=4&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb&doi=10.1021%2Fjm701122q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0liqFAA3NK2M1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D4%26spage%3D817%26epage%3D834%26doi%3D10.1021%2Fjm701122q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rankovic, Z.</span></span> <span> </span><span class="NLM_article-title">CNS drug design: balancing physicochemical properties for optimal brain exposure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2584</span>– <span class="NLM_lpage">2608</span>, <span class="refDoi"> DOI: 10.1021/jm501535r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501535r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2584-2608&issue=6&author=Z.+Rankovic&title=CNS+drug+design%3A+balancing+physicochemical+properties+for+optimal+brain+exposure&doi=10.1021%2Fjm501535r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure</span></div><div class="casAuthors">Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2584-2608</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins.  Designing mols. that can overcome this protection system and achieve optimal concn. at the desired therapeutic target in the brain is a specific and major challenge for medicinal chemists working in CNS drug discovery.  Analogous to the now widely accepted rule of 5 in the design of oral drugs, the physicochem. properties required for optimal brain exposure have been extensively studied in an attempt to similarly define the attributes of successful CNS drugs and drug candidates.  This body of work is systematically reviewed here, with a particular emphasis on the interplay between the most crit. physicochem. and pharmacokinetic parameters of CNS drugs as well as their impact on medicinal chem. strategies toward mols. with optimal brain exposure.  A summary of modern CNS pharmacokinetic concepts and methods is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8V0N1j49uuLVg90H21EOLACvtfcHk0liqFAA3NK2M1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP&md5=f01e3f2dc4e2eff7b0618124277a5cf8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm501535r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501535r%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DCNS%2520drug%2520design%253A%2520balancing%2520physicochemical%2520properties%2520for%2520optimal%2520brain%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D6%26spage%3D2584%26epage%3D2608%26doi%3D10.1021%2Fjm501535r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cecchelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berezowski, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundquist, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renftel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehouck, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenart, L.</span></span> <span> </span><span class="NLM_article-title">Modelling of the blood-brain barrier in drug discovery and development</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1038/nrd2368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1038%2Fnrd2368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=17667956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotl2qtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=650-661&issue=8&author=R.+Cecchelliauthor=V.+Berezowskiauthor=S.+Lundquistauthor=M.+Culotauthor=M.+Renftelauthor=M.-P.+Dehouckauthor=L.+Fenart&title=Modelling+of+the+blood-brain+barrier+in+drug+discovery+and+development&doi=10.1038%2Fnrd2368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Modelling of the blood-brain barrier in drug discovery and development</span></div><div class="casAuthors">Cecchelli, Romeo; Berezowski, Vincent; Lundquist, Stefan; Culot, Maxime; Renftel, Mila; Dehouck, Marie-Pierre; Fenart, Laurence</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">650-661</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The market for neuropharmaceuticals is potentially one of the largest sectors of the global pharmaceutical market owing to the increase in av. life expectancy and the fact that many neurol. disorders have been largely refractory to pharmacotherapy.  The brain is a delicate organ that can efficiently protect itself from harmful compds. and precisely regulate its microenvironment.  Unfortunately, the same mechanisms can also prove to be formidable hurdles in drug development.  An improved understanding of the regulatory interfaces that exist between blood and brain may provide novel and more effective strategies to treat neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2naeQVJt75bVg90H21EOLACvtfcHk0liqFAA3NK2M1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotl2qtLc%253D&md5=94e3cea28faa1ba4e9ad98123a3fa4bd</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnrd2368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2368%26sid%3Dliteratum%253Aachs%26aulast%3DCecchelli%26aufirst%3DR.%26aulast%3DBerezowski%26aufirst%3DV.%26aulast%3DLundquist%26aufirst%3DS.%26aulast%3DCulot%26aufirst%3DM.%26aulast%3DRenftel%26aufirst%3DM.%26aulast%3DDehouck%26aufirst%3DM.-P.%26aulast%3DFenart%26aufirst%3DL.%26atitle%3DModelling%2520of%2520the%2520blood-brain%2520barrier%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26issue%3D8%26spage%3D650%26epage%3D661%26doi%3D10.1038%2Fnrd2368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitteringham, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, P. M.</span></span> <span> </span><span class="NLM_article-title">Metabolism of fluorine-containing drugs</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1146/annurev.pharmtox.41.1.443</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1146%2Fannurev.pharmtox.41.1.443" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=443-470&issue=1&author=B.+K.+Parkauthor=N.+R.+Kitteringhamauthor=P.+M.+O%E2%80%99Neill&title=Metabolism+of+fluorine-containing+drugs&doi=10.1146%2Fannurev.pharmtox.41.1.443"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.41.1.443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.41.1.443%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DB.%2BK.%26aulast%3DKitteringham%26aufirst%3DN.%2BR.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26atitle%3DMetabolism%2520of%2520fluorine-containing%2520drugs%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2001%26volume%3D41%26issue%3D1%26spage%3D443%26epage%3D470%26doi%3D10.1146%2Fannurev.pharmtox.41.1.443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruela, A. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueiredo, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, G. R.</span></span> <span> </span><span class="NLM_article-title">LC-PDA and LC-MS studies of donepezil hydrochloride degradation behaviour in forced stress conditions</span>. <i>J. Braz. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2094</span>– <span class="NLM_lpage">2101</span>, <span class="refDoi"> DOI: 10.5935/0103-5053.20140199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.5935%2F0103-5053.20140199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktVyqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=2094-2101&author=A.+L.+M.+Ruelaauthor=M.+G.+Santosauthor=E.+C.+Figueiredoauthor=G.+R.+Pereira&title=LC-PDA+and+LC-MS+studies+of+donepezil+hydrochloride+degradation+behaviour+in+forced+stress+conditions&doi=10.5935%2F0103-5053.20140199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">LC-PDA and LC-MS studies of donepezil hydrochloride degradation behaviour in forced stress conditions</span></div><div class="casAuthors">Ruela, Andre L. M.; Santos, Mariane G.; Figueiredo, Eduardo C.; Pereira, Gislaine R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Brazilian Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2094-2101</span>CODEN:
                <span class="NLM_cas:coden">JOCSET</span>;
        ISSN:<span class="NLM_cas:issn">0103-5053</span>.
    
            (<span class="NLM_cas:orgname">Sociedade Brasileira de Quimica</span>)
        </div><div class="casAbstract">The aim of this work was to study the intrinsic stability of donepezil hydrochloride in conditions of forced degrdn. (acid stress, alk. stress, oxidant stress, light exposure and dry heat).  The degrdn. profile of donepezil was characterized by liq. chromatog.-mass spectrometry (LC-MS) and high-performance liq. chromatog. coupled with photodiode array detection (LC-PDA).  According to the results, the degrdn. products were sepd. and detected in acid and alk. solns.  After seven days at room temp., the recovery of donepezil in alk. soln. (0.1 mol L-1 NaOH) was about 42%, and three degrdn. products were detected.  In acid soln. (0.1 mol L-1 HCl), the drug recovery was about 86%, and three degrdn. products were detected.  Thus, it was possible to propose a rapid and selective stability-indicating assay method using reversed-phase liq. chromatog. for anal. of donepezil and their degrdn. products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzbov7GB9BZLVg90H21EOLACvtfcHk0liGQ5mDHPfqgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktVyqsQ%253D%253D&md5=1eba03d5c7257f7620de2a4c7b72d5c7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.5935%2F0103-5053.20140199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5935%252F0103-5053.20140199%26sid%3Dliteratum%253Aachs%26aulast%3DRuela%26aufirst%3DA.%2BL.%2BM.%26aulast%3DSantos%26aufirst%3DM.%2BG.%26aulast%3DFigueiredo%26aufirst%3DE.%2BC.%26aulast%3DPereira%26aufirst%3DG.%2BR.%26atitle%3DLC-PDA%2520and%2520LC-MS%2520studies%2520of%2520donepezil%2520hydrochloride%2520degradation%2520behaviour%2520in%2520forced%2520stress%2520conditions%26jtitle%3DJ.%2520Braz.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D25%26spage%3D2094%26epage%3D2101%26doi%3D10.5935%2F0103-5053.20140199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugan, L. L.</span></span> <span> </span><span class="NLM_article-title">Techniques for assessing neuroprotective drugs in vitro</span>. <i>Int. Rev. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/S0074-7742(08)60716-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2FS0074-7742%2808%2960716-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1996&pages=69-93&author=M.+P.+Goldbergauthor=U.+Strasserauthor=L.+L.+Dugan&title=Techniques+for+assessing+neuroprotective+drugs+in+vitro&doi=10.1016%2FS0074-7742%2808%2960716-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0074-7742%2808%2960716-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0074-7742%252808%252960716-3%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DM.%2BP.%26aulast%3DStrasser%26aufirst%3DU.%26aulast%3DDugan%26aufirst%3DL.%2BL.%26atitle%3DTechniques%2520for%2520assessing%2520neuroprotective%2520drugs%2520in%2520vitro%26jtitle%3DInt.%2520Rev.%2520Neurobiol.%26date%3D1996%26volume%3D40%26spage%3D69%26epage%3D93%26doi%3D10.1016%2FS0074-7742%2808%2960716-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shineman, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basi, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bizon, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colton, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollister, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lincecum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morse, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Refolo, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scearce-Levie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yrjanheikki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillit, H. M.</span></span> <span> </span><span class="NLM_article-title">Accelerating drug discovery for Alzheimer’s disease: best practices for preclinical animal studies</span>. <i>Alzheimer's Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">28</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1186/alzrt90</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1186%2Falzrt90" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=1-13&issue=28&author=D.+W.+Shinemanauthor=G.+S.+Basiauthor=J.+L.+Bizonauthor=C.+A.+Coltonauthor=B.+D.+Greenbergauthor=B.+A.+Hollisterauthor=J.+Lincecumauthor=G.+G.+Leblancauthor=L.+B.+Leeauthor=F.+Luoauthor=D.+Morganauthor=I.+Morseauthor=L.+M.+Refoloauthor=D.+R.+Riddellauthor=K.+Scearce-Levieauthor=P.+Sweeneyauthor=J.+Yrjanheikkiauthor=H.+M.+Fillit&title=Accelerating+drug+discovery+for+Alzheimer%E2%80%99s+disease%3A+best+practices+for+preclinical+animal+studies&doi=10.1186%2Falzrt90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1186%2Falzrt90&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt90%26sid%3Dliteratum%253Aachs%26aulast%3DShineman%26aufirst%3DD.%2BW.%26aulast%3DBasi%26aufirst%3DG.%2BS.%26aulast%3DBizon%26aufirst%3DJ.%2BL.%26aulast%3DColton%26aufirst%3DC.%2BA.%26aulast%3DGreenberg%26aufirst%3DB.%2BD.%26aulast%3DHollister%26aufirst%3DB.%2BA.%26aulast%3DLincecum%26aufirst%3DJ.%26aulast%3DLeblanc%26aufirst%3DG.%2BG.%26aulast%3DLee%26aufirst%3DL.%2BB.%26aulast%3DLuo%26aufirst%3DF.%26aulast%3DMorgan%26aufirst%3DD.%26aulast%3DMorse%26aufirst%3DI.%26aulast%3DRefolo%26aufirst%3DL.%2BM.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSweeney%26aufirst%3DP.%26aulast%3DYrjanheikki%26aufirst%3DJ.%26aulast%3DFillit%26aufirst%3DH.%2BM.%26atitle%3DAccelerating%2520drug%2520discovery%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520best%2520practices%2520for%2520preclinical%2520animal%2520studies%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2011%26volume%3D3%26issue%3D28%26spage%3D1%26epage%3D13%26doi%3D10.1186%2Falzrt90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glicksman, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hull-Ryde, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span> <span> </span><span class="NLM_article-title">Tackling reproducibility in academic preclinical drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">733</span>– <span class="NLM_lpage">734</span>, <span class="refDoi"> DOI: 10.1038/nrd4737</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1038%2Fnrd4737" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=733-734&issue=11&author=S.+V.+Fryeauthor=M.+R.+Arkinauthor=C.+H.+Arrowsmithauthor=P.+J.+Connauthor=M.+A.+Glicksmanauthor=E.+A.+Hull-Rydeauthor=B.+S.+Slusher&title=Tackling+reproducibility+in+academic+preclinical+drug+discovery&doi=10.1038%2Fnrd4737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnrd4737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4737%26sid%3Dliteratum%253Aachs%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DGlicksman%26aufirst%3DM.%2BA.%26aulast%3DHull-Ryde%26aufirst%3DE.%2BA.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26atitle%3DTackling%2520reproducibility%2520in%2520academic%2520preclinical%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26issue%3D11%26spage%3D733%26epage%3D734%26doi%3D10.1038%2Fnrd4737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferriero, D.</span></span> <span> </span><span class="NLM_article-title">Signaling pathway involved in hypoxia-inducible factor-1alpha regulation in hypoxic-ischemic cortical neurons in vitro</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>461</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.1016/j.neulet.2009.03.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.neulet.2009.03.091" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=1-6&issue=1&author=L.+Zhangauthor=Y.+Quauthor=C.+Yangauthor=J.+Tangauthor=X.+Zhangauthor=M.+Maoauthor=D.+Muauthor=D.+Ferriero&title=Signaling+pathway+involved+in+hypoxia-inducible+factor-1alpha+regulation+in+hypoxic-ischemic+cortical+neurons+in+vitro&doi=10.1016%2Fj.neulet.2009.03.091"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2009.03.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2009.03.091%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DQu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DM.%26aulast%3DMu%26aufirst%3DD.%26aulast%3DFerriero%26aufirst%3DD.%26atitle%3DSignaling%2520pathway%2520involved%2520in%2520hypoxia-inducible%2520factor-1alpha%2520regulation%2520in%2520hypoxic-ischemic%2520cortical%2520neurons%2520in%2520vitro%26jtitle%3DNeurosci.%2520Lett.%26date%3D2009%26volume%3D461%26issue%3D1%26spage%3D1%26epage%3D6%26doi%3D10.1016%2Fj.neulet.2009.03.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chung, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span> <span> </span><span class="NLM_article-title">Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells</span>. <i>J. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>198</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.1677/JOE-08-0160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1677%2FJOE-08-0160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=18541646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Clt7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2008&pages=511-521&issue=3&author=H.+Chungauthor=S.+Seoauthor=M.+Moonauthor=S.+Park&title=Phosphatidylinositol-3-kinase%2FAkt%2Fglycogen+synthase+kinase-3+beta+and+ERK1%2F2+pathways+mediate+protective+effects+of+acylated+and+unacylated+ghrelin+against+oxygen-glucose+deprivation-induced+apoptosis+in+primary+rat+cortical+neuronal+cells&doi=10.1677%2FJOE-08-0160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3β and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells</span></div><div class="casAuthors">Chung, Hyunju; Seo, Sanghee; Moon, Minho; Park, Seungjoon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endocrinology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">511-521</span>CODEN:
                <span class="NLM_cas:coden">JOENAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-0795</span>.
    
            (<span class="NLM_cas:orgname">Society for Endocrinology</span>)
        </div><div class="casAbstract">Only acylated ghrelin (AG) binds GH secretagog receptor 1a (GHS-R1a) and has central endocrine activities.  An anti-apoptotic effect of AG in neuronal cells has recently been reported.  However, whether there is a neuroprotective effect of unacylated ghrelin (UAG), the most abundant form of ghrelin in plasma, is still unknown.  Therefore, we investigated whether UAG was neuroprotective against ischemic neuronal injury using primary cultured rat cortical neurons exposed to oxygen and glucose deprivation (OGD).  Both AG and UAG inhibited OGD-induced apoptosis.  Exposure of cells to the receptor-specific antagonist D-Lys-3-GHRH-6 abolished the protective effects of AG against OGD, whereas those of UAG were preserved, suggesting the involvement of a receptor that is distinct from GHS-R1a.  Chem. inhibition of MAPK and phosphatidylinositol-3-kinase (PI3K) blocked the anti-apoptotic effects of AG and UAG.  Ghrelin siRNA enhanced apoptosis either during OGD or even in normoxic conditions.  The protective effects of AG and UAG were accompanied by an increased phosphorylation of extracellular signal-regulated kinase (ERK)1/2, Akt, and glycogen synthase kinase-3β (GSK-3β).  Furthermore, treatment of cells with AG or UAG resulted in nuclear translocation of β-catenin.  In addn., both AG and UAG increased the Bcl-2/Bax ratio, prevented cytochrome c release, and inhibited caspase-3 activation.  The data indicate that, independent of acylation, ghrelin can function as a neuroprotective agent that inhibits apoptotic pathways.  These effects may be mediated via activation of the MAPK and PI3K/Akt pathways.  Our data also suggest that PI3K/Akt-mediated inactivation of GSK-3β and stabilization of β-catenin contribute to the anti-apoptotic effects of ghrelin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptcvd5hjOsm7Vg90H21EOLACvtfcHk0lg0moclCkDqLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Clt7zE&md5=c5cc644ff57e49325df2a7db7b802934</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1677%2FJOE-08-0160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252FJOE-08-0160%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DH.%26aulast%3DSeo%26aufirst%3DS.%26aulast%3DMoon%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DS.%26atitle%3DPhosphatidylinositol-3-kinase%252FAkt%252Fglycogen%2520synthase%2520kinase-3%2520beta%2520and%2520ERK1%252F2%2520pathways%2520mediate%2520protective%2520effects%2520of%2520acylated%2520and%2520unacylated%2520ghrelin%2520against%2520oxygen-glucose%2520deprivation-induced%2520apoptosis%2520in%2520primary%2520rat%2520cortical%2520neuronal%2520cells%26jtitle%3DJ.%2520Endocrinol.%26date%3D2008%26volume%3D198%26issue%3D3%26spage%3D511%26epage%3D521%26doi%3D10.1677%2FJOE-08-0160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span> <span> </span><span class="NLM_article-title">Demystifying brain penetration in central nervous system drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1021/jm301297f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301297f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2-12&issue=1&author=L.+Diauthor=H.+Rongauthor=B.+Feng&title=Demystifying+brain+penetration+in+central+nervous+system+drug+discovery&doi=10.1021%2Fjm301297f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Demystifying Brain Penetration in Central Nervous System Drug Discovery</span></div><div class="casAuthors">Di, Li; Rong, Haojing; Feng, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-12</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This Perspective provides important concepts about the blood-brain barrier (BBB) in drug discovery and how they should be applied effectively in designing successful CNS drugs.  Key parameters for brain penetration are discussed, including unbound brain concn., unbound brain-to-plasma ratio, BBB permeability, fraction unbound in brain and plasma, and transporters.  Results from a retrospective anal. of 32 Pfizer CNS clin. drug candidates are described.  Frequently encountered misconceptions about brain penetration in drug discovery programs are clarified.  Strategies and guidance are provided to enhance or minimize brain exposure for CNS or peripheral targets, resp.  Recommendations for screening methodologies and a cascade in assessing brain penetration potential are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmurs7cfju37Vg90H21EOLACvtfcHk0lg0moclCkDqLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrJ&md5=8b88e2044bf41898ab40c45e18f2a20d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm301297f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301297f%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DB.%26atitle%3DDemystifying%2520brain%2520penetration%2520in%2520central%2520nervous%2520system%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D1%26spage%3D2%26epage%3D12%26doi%3D10.1021%2Fjm301297f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vandevrede, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavassoli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pepperberg, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatcher, G. R.</span></span> <span> </span><span class="NLM_article-title">Novel analogues of chlormethiazole are neuroprotective in four cellular models of neurodegeneration by a mechanism with variable dependence on GABAA receptor potentiation</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1111/bph.12454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1111%2Fbph.12454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=24116891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FktFyrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=389-402&issue=2&author=L.+Vandevredeauthor=E.+Tavassoliauthor=J.+Luoauthor=Z.+Qinauthor=L.+Yueauthor=D.+R.+Pepperbergauthor=G.+R.+Thatcher&title=Novel+analogues+of+chlormethiazole+are+neuroprotective+in+four+cellular+models+of+neurodegeneration+by+a+mechanism+with+variable+dependence+on+GABAA+receptor+potentiation&doi=10.1111%2Fbph.12454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel analogues of chlormethiazole are neuroprotective in four cellular models of neurodegeneration by a mechanism with variable dependence on GABA(A) receptor potentiation</span></div><div class="casAuthors">Vandevrede Lawren; Tavassoli Ehsan; Luo Jia; Qin Zhihui; Yue Lan; Pepperberg David R; Thatcher Gregory R</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">389-402</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Chlormethiazole (CMZ), a clinical sedative/anxiolytic agent, did not reach clinical efficacy in stroke trials despite neuroprotection demonstrated in numerous animal models.  Using CMZ as a lead compound, neuroprotective methiazole (MZ) analogues were developed, and neuroprotection and GABA(A) receptor dependence were studied.  EXPERIMENTAL APPROACH:  Eight MZs were selected from a novel library, of which two were studied in detail.  Neuroprotection, glutamate release, intracellular calcium and response to GABA blockade by picrotoxin were measured in rat primary cortical cultures using four cellular models of neurodegeneration.  GABA potentiation was assayed in oocytes expressing the α1β2γ2 GABA(A) receptor.  KEY RESULTS:  Neuroprotection against a range of insults was retained even with substantial chemical modification.  Dependence on GABAA receptor activity was variable: at the extremes, neuroprotection by GN-28 was universally sensitive to picrotoxin, while GN-38 was largely insensitive.  In parallel, effects on extracellular glutamate and intracellular calcium were associated with GABA(A) dependence.  Consistent with these findings, GN-28 potentiated α1β2γ2 GABA(A) function, whereas GN-38 had a weak inhibitory effect.  Neuroprotection against moderate dose oligomeric Aβ1 42 was also tolerant to structural changes.  CONCLUSIONS AND IMPLICATIONS:  The results support the concept that CMZ does not contain a single pharmacophore, rather that broad-spectrum neuroprotection results from a GABA(A)-dependent mechanism represented by GN-28, combined with a mechanism represented in GN-38 that shows the least dependence on GABA(A) receptors.  These findings allow further refinement of the neuroprotective pharmacophore and investigation into secondary mechanisms that will assist in identifying MZ-based compounds of use in treating neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR2QiW_eraOHRwLZxei1HN8fW6udTcc2ebDdt-FY8tXsLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FktFyrsQ%253D%253D&md5=da31587008978a7c5aee468fe69635d8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fbph.12454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12454%26sid%3Dliteratum%253Aachs%26aulast%3DVandevrede%26aufirst%3DL.%26aulast%3DTavassoli%26aufirst%3DE.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DQin%26aufirst%3DZ.%26aulast%3DYue%26aufirst%3DL.%26aulast%3DPepperberg%26aufirst%3DD.%2BR.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%26atitle%3DNovel%2520analogues%2520of%2520chlormethiazole%2520are%2520neuroprotective%2520in%2520four%2520cellular%2520models%2520of%2520neurodegeneration%2520by%2520a%2520mechanism%2520with%2520variable%2520dependence%2520on%2520GABAA%2520receptor%2520potentiation%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26issue%3D2%26spage%3D389%26epage%3D402%26doi%3D10.1111%2Fbph.12454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Besnard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruda, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abecassis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguiz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidah, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constam, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bickerton, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span> <span> </span><span class="NLM_article-title">Automated design of ligands to polypharmacological profiles</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>492</i></span> (<span class="NLM_issue">7428</span>),  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1038/nature11691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1038%2Fnature11691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=23235874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=215-220&issue=7428&author=J.+Besnardauthor=G.+F.+Rudaauthor=V.+Setolaauthor=K.+Abecassisauthor=R.+M.+Rodriguizauthor=X.+P.+Huangauthor=S.+Norvalauthor=M.+F.+Sassanoauthor=A.+I.+Shinauthor=L.+A.+Websterauthor=F.+R.+Simeonsauthor=L.+Stojanovskiauthor=A.+Pratauthor=N.+G.+Seidahauthor=D.+B.+Constamauthor=G.+R.+Bickertonauthor=K.+D.+Readauthor=W.+C.+Wetselauthor=I.+H.+Gilbertauthor=B.+L.+Rothauthor=A.+L.+Hopkins&title=Automated+design+of+ligands+to+polypharmacological+profiles&doi=10.1038%2Fnature11691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Automated design of ligands to polypharmacological profiles</span></div><div class="casAuthors">Besnard, Jeremy; Ruda, Gian Filippo; Setola, Vincent; Abecassis, Keren; Rodriguiz, Ramona M.; Huang, Xi-Ping; Norval, Suzanne; Sassano, Maria F.; Shin, Antony I.; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Prat, Annik; Seidah, Nabil G.; Constam, Daniel B.; Bickerton, G. Richard; Read, Kevin D.; Wetsel, William C.; Gilbert, Ian H.; Roth, Bryan L.; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">492</span>
        (<span class="NLM_cas:issue">7428</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy and safety of a drug is detd. by its activity profile across many proteins in the proteome.  However, designing drugs with a specific multi-target profile is both complex and difficult.  Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery.  Here is described a new approach for the automated design of ligands against profiles of multiple drug targets.  The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug donepezil (I) into brain-penetrable ligands with either specific polypharmacol. or exquisite selectivity profiles for G-protein-coupled receptors.  Overall, 800 ligand-target predictions of prospectively designed ligands were tested exptl., of which 75% were confirmed to be correct.  Target engagement in vivo is also demonstrated.  The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNu5bwrBD3tbVg90H21EOLACvtfcHk0lhO0StscOhSCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN&md5=ace6cced250cf968d327b482a5bf1798</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnature11691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11691%26sid%3Dliteratum%253Aachs%26aulast%3DBesnard%26aufirst%3DJ.%26aulast%3DRuda%26aufirst%3DG.%2BF.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DAbecassis%26aufirst%3DK.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DShin%26aufirst%3DA.%2BI.%26aulast%3DWebster%26aufirst%3DL.%2BA.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DConstam%26aufirst%3DD.%2BB.%26aulast%3DBickerton%26aufirst%3DG.%2BR.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DAutomated%2520design%2520of%2520ligands%2520to%2520polypharmacological%2520profiles%26jtitle%3DNature%26date%3D2012%26volume%3D492%26issue%3D7428%26spage%3D215%26epage%3D220%26doi%3D10.1038%2Fnature11691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hufeisen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Identification of human Ether-a-go-go related gene modulators by three screening platforms in an academic drug-discovery setting</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">742</span>, <span class="refDoi"> DOI: 10.1089/adt.2010.0331</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1089%2Fadt.2010.0331" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=727-742&issue=6&author=X.+P.+Huangauthor=T.+Manganoauthor=S.+Hufeisenauthor=V.+Setolaauthor=B.+L.+Roth&title=Identification+of+human+Ether-a-go-go+related+gene+modulators+by+three+screening+platforms+in+an+academic+drug-discovery+setting&doi=10.1089%2Fadt.2010.0331"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1089%2Fadt.2010.0331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2010.0331%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DMangano%26aufirst%3DT.%26aulast%3DHufeisen%26aufirst%3DS.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DIdentification%2520of%2520human%2520Ether-a-go-go%2520related%2520gene%2520modulators%2520by%2520three%2520screening%2520platforms%2520in%2520an%2520academic%2520drug-discovery%2520setting%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2010%26volume%3D8%26issue%3D6%26spage%3D727%26epage%3D742%26doi%3D10.1089%2Fadt.2010.0331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angelucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvisi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosentino, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozzolino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Witt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghirardi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannessi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuliani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guaraldi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramacci, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scolastico, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinti, M. O.</span></span> <span> </span><span class="NLM_article-title">Synthesis and amnesia-reversal activity of a series of 7- and 5-membered 3-acylamino lactams</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1511</span>– <span class="NLM_lpage">1519</span>, <span class="refDoi"> DOI: 10.1021/jm00063a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00063a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=1511-1519&issue=11&author=L.+Angelucciauthor=P.+Calvisiauthor=R.+Catiniauthor=U.+Cosentinoauthor=R.+Cozzolinoauthor=P.+De+Wittauthor=O.+Ghirardiauthor=F.+Giannessiauthor=A.+Giulianiauthor=D.+Guaraldiauthor=D.+Misitiauthor=M.+T.+Ramacciauthor=C.+Scolasticoauthor=M.+O.+Tinti&title=Synthesis+and+amnesia-reversal+activity+of+a+series+of+7-+and+5-membered+3-acylamino+lactams&doi=10.1021%2Fjm00063a001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm00063a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00063a001%26sid%3Dliteratum%253Aachs%26aulast%3DAngelucci%26aufirst%3DL.%26aulast%3DCalvisi%26aufirst%3DP.%26aulast%3DCatini%26aufirst%3DR.%26aulast%3DCosentino%26aufirst%3DU.%26aulast%3DCozzolino%26aufirst%3DR.%26aulast%3DDe%2BWitt%26aufirst%3DP.%26aulast%3DGhirardi%26aufirst%3DO.%26aulast%3DGiannessi%26aufirst%3DF.%26aulast%3DGiuliani%26aufirst%3DA.%26aulast%3DGuaraldi%26aufirst%3DD.%26aulast%3DMisiti%26aufirst%3DD.%26aulast%3DRamacci%26aufirst%3DM.%2BT.%26aulast%3DScolastico%26aufirst%3DC.%26aulast%3DTinti%26aufirst%3DM.%2BO.%26atitle%3DSynthesis%2520and%2520amnesia-reversal%2520activity%2520of%2520a%2520series%2520of%25207-%2520and%25205-membered%25203-acylamino%2520lactams%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26issue%3D11%26spage%3D1511%26epage%3D1519%26doi%3D10.1021%2Fjm00063a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeiffer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccaboni, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banfi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagetti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorigotti, L.</span></span> <span> </span><span class="NLM_article-title">Synthesis and pharmacological activity of a series of dihydro-1H-pyrrolo[1,2-a]imidazole-2,5(3H,6H)-diones, a novel class of potent cognition enhancers</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">4214</span>– <span class="NLM_lpage">4220</span>, <span class="refDoi"> DOI: 10.1021/jm00078a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00078a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=4214-4220&issue=26&author=M.+Pinzaauthor=C.+Farinaauthor=A.+Cerriauthor=U.+Pfeifferauthor=M.+T.+Riccaboniauthor=S.+Banfiauthor=R.+Biagettiauthor=O.+Pozziauthor=M.+Magnaniauthor=L.+Dorigotti&title=Synthesis+and+pharmacological+activity+of+a+series+of+dihydro-1H-pyrrolo%5B1%2C2-a%5Dimidazole-2%2C5%283H%2C6H%29-diones%2C+a+novel+class+of+potent+cognition+enhancers&doi=10.1021%2Fjm00078a011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm00078a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00078a011%26sid%3Dliteratum%253Aachs%26aulast%3DPinza%26aufirst%3DM.%26aulast%3DFarina%26aufirst%3DC.%26aulast%3DCerri%26aufirst%3DA.%26aulast%3DPfeiffer%26aufirst%3DU.%26aulast%3DRiccaboni%26aufirst%3DM.%2BT.%26aulast%3DBanfi%26aufirst%3DS.%26aulast%3DBiagetti%26aufirst%3DR.%26aulast%3DPozzi%26aufirst%3DO.%26aulast%3DMagnani%26aufirst%3DM.%26aulast%3DDorigotti%26aufirst%3DL.%26atitle%3DSynthesis%2520and%2520pharmacological%2520activity%2520of%2520a%2520series%2520of%2520dihydro-1H-pyrrolo%255B1%252C2-a%255Dimidazole-2%252C5%25283H%252C6H%2529-diones%252C%2520a%2520novel%2520class%2520of%2520potent%2520cognition%2520enhancers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26issue%3D26%26spage%3D4214%26epage%3D4220%26doi%3D10.1021%2Fjm00078a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regan, C. M.</span></span> <span> </span><span class="NLM_article-title">Repetitive and transient increases in hippocampal neural cell adhesion molecule polysialylation state following multitrial spatial training</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1268</span>– <span class="NLM_lpage">1274</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.1996.67031268.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1046%2Fj.1471-4159.1996.67031268.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=8752135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADyaK28XltlKkurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1996&pages=1268-1274&issue=3&author=K.+J.+Murphyauthor=A.+W.+O%E2%80%99Connellauthor=C.+M.+Regan&title=Repetitive+and+transient+increases+in+hippocampal+neural+cell+adhesion+molecule+polysialylation+state+following+multitrial+spatial+training&doi=10.1046%2Fj.1471-4159.1996.67031268.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Repetitive and transient increases in hippocampal neural cell adhesion molecule polysialylation state following multitrial spatial training</span></div><div class="casAuthors">Murphy, Keith J.; O'Connell, Alan W.; Regan, Ciaran M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1268-1274</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">Polysialylated neurons, located at the inner border of the dentate granule cell layer, have been demonstrated to exhibit time-dependent change in their frequency at 10-12 h following training in the Morris water maze, a spatial learning paradigm.  Such a change was not obsd. in animals required to locate a visible platform or in those rendered amnesic with scopolamine.  This frequency response was capable of rapid reactivation following further training stimuli in a manner that was independent of circadian influence.  These learning-assocd. modulations in neural cell adhesion mol. (NCAM) polysialylation state did not increase in magnitude despite improved performance suggesting their activation is required for processing information rather than contributing to previously stored, task-assocd. memory.  An increase in NCAM polysialylation appears to be a universal learning response to both spatial and nonspatial paradigms as similar time-dependent changes occurred following training in a one-trial, step-through, passive avoidance response subsequent to water maze training.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriKES1JLCGNrVg90H21EOLACvtfcHk0lhO0StscOhSCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltlKkurs%253D&md5=849485cd7883dca55bbc3b7e9778204d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1996.67031268.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1996.67031268.x%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DK.%2BJ.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DA.%2BW.%26aulast%3DRegan%26aufirst%3DC.%2BM.%26atitle%3DRepetitive%2520and%2520transient%2520increases%2520in%2520hippocampal%2520neural%2520cell%2520adhesion%2520molecule%2520polysialylation%2520state%2520following%2520multitrial%2520spatial%2520training%26jtitle%3DJ.%2520Neurochem.%26date%3D1996%26volume%3D67%26issue%3D3%26spage%3D1268%26epage%3D1274%26doi%3D10.1046%2Fj.1471-4159.1996.67031268.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, J. H.</span></span> <span> </span><span class="NLM_article-title">The ameliorating effects of stigmasterol on scopolamine-induced memory impairments in mice</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>676</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2011.11.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.ejphar.2011.11.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=22173129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1GlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=676&publication_year=2012&pages=64-70&issue=1&author=S.+J.+Parkauthor=D.+H.+Kimauthor=J.+M.+Jungauthor=J.+M.+Kimauthor=M.+Caiauthor=X.+Liuauthor=J.+G.+Hongauthor=C.+H.+Leeauthor=K.+R.+Leeauthor=J.+H.+Ryu&title=The+ameliorating+effects+of+stigmasterol+on+scopolamine-induced+memory+impairments+in+mice&doi=10.1016%2Fj.ejphar.2011.11.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The ameliorating effects of stigmasterol on scopolamine-induced memory impairments in mice</span></div><div class="casAuthors">Park, Se Jin; Kim, Dong Hyun; Jung, Jun Man; Kim, Jong Min; Cai, Mudan; Liu, Xiaotong; Hong, Jin Gyu; Lee, Chang Hwan; Lee, Kang Ro; Ryu, Jong Hoon</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">676</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">64-70</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Stigmasterol, a kind of phytosterol, is present in small amts. in various foods.  In the present study, we investigated the effects of stigmasterol on scopolamine-induced memory impairments using the passive avoidance and the Morris water maze tasks in mice.  In addn., changes in memory-related mols., including extracellular signal-regulated kinase (ERK) and cAMP response element-binding protein (CREB), were examd. following the administration of stigmasterol.  Scopolamine-induced memory impairments were significantly attenuated by the administration of stigmasterol (10 mg/kg) in the passive avoidance task.  In the Morris water maze task, the escape latencies were significantly decreased in the stigmasterol-treated group compared to the scopolamine-treated group during the training phase.  The swimming times within the target zone during the probe trial were significantly increased as compared to scopolamine-treated mice.  Furthermore, the ameliorating effect of stigmasterol on scopolamine-induced memory dysfunction was blocked by a sub-ED of dizocilpine (MK-801), an NMDA receptor antagonist, and tamoxifen, an estrogen receptor antagonist, in the passive avoidance task.  In addn., the expression levels of phosphorylated ERK and CREB in the hippocampus were significantly increased by stigmasterol, which was blocked by tamoxifen or MK-801 with scopolamine.  These results suggest that stigmasterol-induced cognitive ameliorative effects are mediated by the enhancement of cholinergic neurotransmission system via the activation of estrogen or NMDA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRNdp0qIyRVLVg90H21EOLACvtfcHk0lgdke8kVx43Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1GlsA%253D%253D&md5=fc3cbb4f86b23379d666160955812685</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2011.11.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2011.11.050%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DJung%26aufirst%3DJ.%2BM.%26aulast%3DKim%26aufirst%3DJ.%2BM.%26aulast%3DCai%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DHong%26aufirst%3DJ.%2BG.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DLee%26aufirst%3DK.%2BR.%26aulast%3DRyu%26aufirst%3DJ.%2BH.%26atitle%3DThe%2520ameliorating%2520effects%2520of%2520stigmasterol%2520on%2520scopolamine-induced%2520memory%2520impairments%2520in%2520mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D676%26issue%3D1%26spage%3D64%26epage%3D70%26doi%3D10.1016%2Fj.ejphar.2011.11.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, R.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span> <span> </span><span class="NLM_article-title">Neuropeptide S enhances memory and mitigates memory impairment induced by MK801, scopolamine or Aβ1–42 in mice novel object and object location recognition tasks</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2013.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.neuropharm.2013.02.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=261-267&author=R.-W.+Hanauthor=R.-S.+Zhangauthor=H.-J.+Xuauthor=M.+Changauthor=Y.-L.+Pengauthor=R.+Wang&title=Neuropeptide+S+enhances+memory+and+mitigates+memory+impairment+induced+by+MK801%2C+scopolamine+or+A%CE%B21%E2%80%9342+in+mice+novel+object+and+object+location+recognition+tasks&doi=10.1016%2Fj.neuropharm.2013.02.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2013.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2013.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DR.-W.%26aulast%3DZhang%26aufirst%3DR.-S.%26aulast%3DXu%26aufirst%3DH.-J.%26aulast%3DChang%26aufirst%3DM.%26aulast%3DPeng%26aufirst%3DY.-L.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DNeuropeptide%2520S%2520enhances%2520memory%2520and%2520mitigates%2520memory%2520impairment%2520induced%2520by%2520MK801%252C%2520scopolamine%2520or%2520A%25CE%25B21%25E2%2580%259342%2520in%2520mice%2520novel%2520object%2520and%2520object%2520location%2520recognition%2520tasks%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D70%26spage%3D261%26epage%3D267%26doi%3D10.1016%2Fj.neuropharm.2013.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Detrait, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dardenne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamberty, Y.</span></span> <span> </span><span class="NLM_article-title">The inhibitory avoidance test optimized for discovery of cognitive enhancers</span>. <i>Behav Res. Meth</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">811</span>, <span class="refDoi"> DOI: 10.3758/BRM.41.3.805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.3758%2FBRM.41.3.805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=19587195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A280%3ADC%252BD1MvntlKhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=805-811&issue=3&author=E.+R.+Detraitauthor=E.+Hanonauthor=B.+Dardenneauthor=Y.+Lamberty&title=The+inhibitory+avoidance+test+optimized+for+discovery+of+cognitive+enhancers&doi=10.3758%2FBRM.41.3.805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The inhibitory avoidance test optimized for discovery of cognitive enhancers</span></div><div class="casAuthors">Detrait Eric R A Y; Hanon Etienne; Dardenne Bertrand; Lamberty Yves</div><div class="citationInfo"><span class="NLM_cas:title">Behavior research methods</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">805-11</span>
        ISSN:<span class="NLM_cas:issn">1554-351X</span>.
    </div><div class="casAbstract">In the present article, we describe a new protocol for the inhibitory avoidance test, with a dual purpose: (1) to provide a less variable and more reliable assessment of the efficacy of potential cognitive enhancers in antagonizing scopolamine-induced long-term-memory deficits, and (2) to secure a high throughput for pharmacological screening of cognitive enhancers.  The new protocol consists of two acquisition trials that are followed 24 h later by a single retention trial.  In the present study, this protocol clearly dissociated the frequency distributions of retention latencies between scopolamine- and vehicle-treated groups and allowed validation by means of two acetylcholinesterase inhibitors-tacrine and donepezil-that proved to be active in counteracting the scopolamine-induced memory deficit.  This protocol also produced stability of the behavioral response to pharmacological agents over a 3-year period.  A statistical power analysis indicated that, depending on the efficacy of the drug/dose, a sample size of 5-12 mice was required in order to show a reversal of the scopolamine-induced memory deficit.  The double-trial acquisition protocol is suitable for testing cognitive enhancers, while also providing a clearly enhanced throughput.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-il4nnhF7lMkU0YCbOU3EfW6udTcc2eZIBq9sK78W67ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvntlKhsw%253D%253D&md5=eccc0b8ade233eca6b90dc7d782b97c6</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.3758%2FBRM.41.3.805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3758%252FBRM.41.3.805%26sid%3Dliteratum%253Aachs%26aulast%3DDetrait%26aufirst%3DE.%2BR.%26aulast%3DHanon%26aufirst%3DE.%26aulast%3DDardenne%26aufirst%3DB.%26aulast%3DLamberty%26aufirst%3DY.%26atitle%3DThe%2520inhibitory%2520avoidance%2520test%2520optimized%2520for%2520discovery%2520of%2520cognitive%2520enhancers%26jtitle%3DBehav%2520Res.%2520Meth%26date%3D2009%26volume%3D41%26issue%3D3%26spage%3D805%26epage%3D811%26doi%3D10.3758%2FBRM.41.3.805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ota, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploski, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Queen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafe, G. E.</span></span> <span> </span><span class="NLM_article-title">The NO-cGMP-PKG signaling pathway regulates synaptic plasticity and fear memory consolidation in the lateral amygdala via activation of ERK/MAP kinase</span>. <i>Learn. Mem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">792</span>– <span class="NLM_lpage">805</span>, <span class="refDoi"> DOI: 10.1101/lm.1114808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1101%2Flm.1114808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=18832566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsV2nsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=792-805&issue=10&author=K.+T.+Otaauthor=V.+J.+Pierreauthor=J.+E.+Ploskiauthor=K.+Queenauthor=G.+E.+Schafe&title=The+NO-cGMP-PKG+signaling+pathway+regulates+synaptic+plasticity+and+fear+memory+consolidation+in+the+lateral+amygdala+via+activation+of+ERK%2FMAP+kinase&doi=10.1101%2Flm.1114808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The NO-cGMP-PKG signaling pathway regulates synaptic plasticity and fear memory consolidation in the lateral amygdala via activation of ERK/MAP kinase</span></div><div class="casAuthors">Ota, Kristie T.; Pierre, Vicki J.; Ploski, Jonathan E.; Queen, Kaila; Schafe, Glenn E.</div><div class="citationInfo"><span class="NLM_cas:title">Learning & Memory</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7-12</span>),
    <span class="NLM_cas:pages">792-805</span>CODEN:
                <span class="NLM_cas:coden">LEMEFO</span>;
        ISSN:<span class="NLM_cas:issn">1072-0502</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Recent studies have shown that nitric oxide (NO) signaling plays a crucial role in memory consolidation of Pavlovian fear conditioning and in synaptic plasticity in the lateral amygdala (LA).  In the present expts., we examd. the role of the cGMP-dependent protein kinase (PKG), a downstream effector of NO, in fear memory consolidation and long-term potentiation (LTP) at thalamic and cortical input pathways to the LA.  In behavioral expts., rats given intra-LA infusions of either the PKG inhibitor Rp-8-Br-PET-cGMPS or the PKG activator 8-Br-cGMP exhibited dose-dependent impairments or enhancements of fear memory consolidation, resp.  In slice electrophysiol. expts., bath application of Rp-8-Br-PET-cGMPS or the guanylyl cyclase inhibitor LY83583 impaired LTP at thalamic, but not cortical inputs to the LA, while bath application of 8-Br-cGMP or the guanylyl cyclase activator YC-1 resulted in enhanced LTP at thalamic inputs to the LA.  Interestingly, YC-1-induced enhancement of LTP in the LA was reversed by concurrent application of the MEK inhibitor U0126, suggesting that the NO-cGMP-PKG signaling pathway may promote synaptic plasticity and fear memory formation in the LA, in part by activating the ERK/MAPK signaling cascade.  As a test of this hypothesis, we next showed that rats given intra-LA infusion of the PKG inhibitor Rp-8-Br-PET-cGMPS or the PKG activator 8-Br-cGMP exhibit impaired or enhanced activation, resp., of ERK/MAPK in the LA after fear conditioning.  Collectively, our findings suggest that an NO-cGMP-PKG-dependent form of synaptic plasticity at thalamic input synapses to the LA may underlie memory consolidation of Pavlovian fear conditioning, in part, via activation of the ERK/MAPK signaling cascade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvU68ba_ZL5LVg90H21EOLACvtfcHk0lgdke8kVx43Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2nsLw%253D&md5=a59ff3eb4bce97a42173cb13ff1f77ae</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1101%2Flm.1114808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Flm.1114808%26sid%3Dliteratum%253Aachs%26aulast%3DOta%26aufirst%3DK.%2BT.%26aulast%3DPierre%26aufirst%3DV.%2BJ.%26aulast%3DPloski%26aufirst%3DJ.%2BE.%26aulast%3DQueen%26aufirst%3DK.%26aulast%3DSchafe%26aufirst%3DG.%2BE.%26atitle%3DThe%2520NO-cGMP-PKG%2520signaling%2520pathway%2520regulates%2520synaptic%2520plasticity%2520and%2520fear%2520memory%2520consolidation%2520in%2520the%2520lateral%2520amygdala%2520via%2520activation%2520of%2520ERK%252FMAP%2520kinase%26jtitle%3DLearn.%2520Mem.%26date%3D2008%26volume%3D15%26issue%3D10%26spage%3D792%26epage%3D805%26doi%3D10.1101%2Flm.1114808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vanmierlo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creemers, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkerman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Duinen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambeth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span> <span> </span><span class="NLM_article-title">The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2016.01.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.bbr.2016.01.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2016&pages=26-33&author=T.+Vanmierloauthor=P.+Creemersauthor=S.+Akkermanauthor=M.+van+Duinenauthor=A.+Sambethauthor=J.+De+Vryauthor=T.+Uzauthor=A.+Bloklandauthor=J.+Prickaerts&title=The+PDE4+inhibitor+roflumilast+improves+memory+in+rodents+at+non-emetic+doses&doi=10.1016%2Fj.bbr.2016.01.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2016.01.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2016.01.031%26sid%3Dliteratum%253Aachs%26aulast%3DVanmierlo%26aufirst%3DT.%26aulast%3DCreemers%26aufirst%3DP.%26aulast%3DAkkerman%26aufirst%3DS.%26aulast%3Dvan%2BDuinen%26aufirst%3DM.%26aulast%3DSambeth%26aufirst%3DA.%26aulast%3DDe%2BVry%26aufirst%3DJ.%26aulast%3DUz%26aufirst%3DT.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DThe%2520PDE4%2520inhibitor%2520roflumilast%2520improves%2520memory%2520in%2520rodents%2520at%2520non-emetic%2520doses%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2016%26volume%3D303%26spage%3D26%26epage%3D33%26doi%3D10.1016%2Fj.bbr.2016.01.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proulx-Lafrance, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claffey, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuttle, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleiman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menniti, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span> <span> </span><span class="NLM_article-title">Design and discovery of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one(PF-04447943), a selective brain penetrant PDE9A inhibitor for the treatment of cognitive disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">9045</span>– <span class="NLM_lpage">9054</span>, <span class="refDoi"> DOI: 10.1021/jm3007799</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3007799" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9045-9054&issue=21&author=P.+R.+Verhoestauthor=K.+R.+Fonsecaauthor=X.+Houauthor=C.+Proulx-Lafranceauthor=M.+Cormanauthor=C.+J.+Helalauthor=M.+M.+Claffeyauthor=J.+B.+Tuttleauthor=K.+J.+Coffmanauthor=S.+Liuauthor=F.+Nelsonauthor=R.+J.+Kleimanauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=M.+Vanase-Frawleyauthor=S.+Liras&title=Design+and+discovery+of+6-%5B%283S%2C4S%29-4-methyl-1-%28pyrimidin-2-ylmethyl%29pyrrolidin-3-yl%5D-1-%28tetrahydro-2H-pyran-4-yl%29-1%2C5-dihydro-4H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-one%28PF-04447943%29%2C+a+selective+brain+penetrant+PDE9A+inhibitor+for+the+treatment+of+cognitive+disorders&doi=10.1021%2Fjm3007799"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm3007799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007799%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DProulx-Lafrance%26aufirst%3DC.%26aulast%3DCorman%26aufirst%3DM.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26aulast%3DTuttle%26aufirst%3DJ.%2BB.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DDesign%2520and%2520discovery%2520of%25206-%255B%25283S%252C4S%2529-4-methyl-1-%2528pyrimidin-2-ylmethyl%2529pyrrolidin-3-yl%255D-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C5-dihydro-4H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2528PF-04447943%2529%252C%2520a%2520selective%2520brain%2520penetrant%2520PDE9A%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D21%26spage%3D9045%26epage%3D9054%26doi%3D10.1021%2Fjm3007799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
der Staay, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barfacker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erb, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckroth, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karthaus, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tersteegen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kampen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymann, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, M.</span></span> <span> </span><span class="NLM_article-title">The novel selective PDE9 inhibitor BAY 73–6691 improves learning and memory in rodents</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">918</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.neuropharm.2008.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=18674549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFajurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=908-918&issue=5&author=F.+J.+Van%0Ader+Staayauthor=K.+Ruttenauthor=L.+Barfackerauthor=J.+Devryauthor=C.+Erbauthor=H.+Heckrothauthor=D.+Karthausauthor=A.+Tersteegenauthor=M.+van+Kampenauthor=A.+Bloklandauthor=J.+Prickaertsauthor=K.+G.+Reymannauthor=U.+H.+Schroderauthor=M.+Hendrix&title=The+novel+selective+PDE9+inhibitor+BAY+73%E2%80%936691+improves+learning+and+memory+in+rodents&doi=10.1016%2Fj.neuropharm.2008.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents</span></div><div class="casAuthors">van der Staay, F. Josef; Rutten, Kris; Baerfacker, Lars; DeVry, Jean; Erb, Christina; Heckroth, Heike; Karthaus, Dagmar; Tersteegen, Adrian; van Kampen, Marja; Blokland, Arjan; Prickaerts, Jos; Reymann, Klaus G.; Schroeder, Ulrich H.; Hendrix, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">908-918</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study investigated the putative pro-cognitive effects of the novel selective PDE9 inhibitor BAY 73-6691.  The effects on basal synaptic transmission and long-term potentiation (LTP) were investigated in rat hippocampal slices.  Pro-cognitive effects were assessed in a series of learning and memory tasks using rodents as subjects.  BAY 73-6691 had no effect on basal synaptic transmission in hippocampal slices prepd. from young adult (7- to 8-wk-old) Wistar rats.  A dose of 10 μM, but not 30 μM, BAY 73-6691 enhanced early LTP after weak tetanic stimulation.  The dose effective in young adult Wistar rats did not affect LTP in hippocampal slices prepd. from young (7- to 8-wk-old) Fischer 344 X Brown Norway (FBNF1) rats, probably reflecting strain differences.  However, it increased basal synaptic transmission and enhanced early LTP after weak tetanic stimulation in hippocampal slices prepd. from very old (31- to 35-mo-old) FBNF1 rats.  BAY 73-6691 enhanced acquisition, consolidation, and retention of long-term memory (LTM) in a social recognition task and tended to enhance LTM in an object recognition task.  Bay 73-6691 attenuated the scopolamine-induced retention deficit in a passive avoidance task, and the MK-801-induced short-term memory deficits in a T-maze alternation task.  The mechanism of action, possibly through modulation of the NO/cGMP-PKG/CREB pathway, is discussed.  Our findings support the notion that PDE9 inhibition may be a novel target for treating memory deficits that are assocd. with aging and neurodegenerative disorders such as Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8HiWHIitIm7Vg90H21EOLACvtfcHk0lhzm1LzhJG_rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFajurzP&md5=627896c9c5f4b8526c50b9c1814c1647</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BStaay%26aufirst%3DF.%2BJ.%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DBarfacker%26aufirst%3DL.%26aulast%3DDevry%26aufirst%3DJ.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DHeckroth%26aufirst%3DH.%26aulast%3DKarthaus%26aufirst%3DD.%26aulast%3DTersteegen%26aufirst%3DA.%26aulast%3Dvan%2BKampen%26aufirst%3DM.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DReymann%26aufirst%3DK.%2BG.%26aulast%3DSchroder%26aufirst%3DU.%2BH.%26aulast%3DHendrix%26aufirst%3DM.%26atitle%3DThe%2520novel%2520selective%2520PDE9%2520inhibitor%2520BAY%252073%25E2%2580%25936691%2520improves%2520learning%2520and%2520memory%2520in%2520rodents%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26issue%3D5%26spage%3D908%26epage%3D918%26doi%3D10.1016%2Fj.neuropharm.2008.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vardigan, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Converso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutson, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uslaner, J. M.</span></span> <span> </span><span class="NLM_article-title">The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 attenuates a scopolamine-induced deficit in a novel rodent attention task</span>. <i>J. Neurogenet.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.3109/01677063.2011.630494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.3109%2F01677063.2011.630494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=22070409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=120-126&issue=4&author=J.+D.+Vardiganauthor=A.+Conversoauthor=P.+H.+Hutsonauthor=J.+M.+Uslaner&title=The+selective+phosphodiesterase+9+%28PDE9%29+inhibitor+PF-04447943+attenuates+a+scopolamine-induced+deficit+in+a+novel+rodent+attention+task&doi=10.3109%2F01677063.2011.630494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The Selective Phosphodiesterase 9 (PDE9) Inhibitor PF-04447943 Attenuates a Scopolamine-Induced Deficit in a Novel Rodent Attention Task</span></div><div class="casAuthors">Vardigan, Joshua D.; Converso, Antonella; Hutson, Pete H.; Uslaner, Jason M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurogenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">120-126</span>CODEN:
                <span class="NLM_cas:coden">JLNEDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-7063</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Numerous changes occur during aging and Alzheimer's disease (AD) progression, including a decline in cholinergic functioning and cognition, as well as alterations in gene expression and activity in the nitric oxide/cyclic guanosine monophosphate (NO/cGMP) pathway.  Donepezil, the current std. of care for Alzheimer's disease, improves cholinergic functioning and has demonstrated effects on multiple domains of cognition, including memory and attention in both preclin. species and patients.  We previously found that increasing activation of the NO/cGMP pathway via phosphodiesterase 9 (PDE9) inhibition also improves memory in rodents and suggested that PDE9 might be a promising target for novel treatments for AD.  Here we investigated whether PDE9 inhibition also enhances attention using a novel attention task in rats.  We validated this task using several pharmacol. manipulations and showed that the selective PDE9 inhibitor PF-04447943 produced effects similar to those of donepezil.  These data confirm and extend the hypothesis that PDE9 inhibition might serve as a novel treatment for AD and age-related cognitive decline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJa-1clww9LrVg90H21EOLACvtfcHk0lhzm1LzhJG_rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bF&md5=1d03e024134e690d1765bd4ee8576aad</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3109%2F01677063.2011.630494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01677063.2011.630494%26sid%3Dliteratum%253Aachs%26aulast%3DVardigan%26aufirst%3DJ.%2BD.%26aulast%3DConverso%26aufirst%3DA.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520selective%2520phosphodiesterase%25209%2520%2528PDE9%2529%2520inhibitor%2520PF-04447943%2520attenuates%2520a%2520scopolamine-induced%2520deficit%2520in%2520a%2520novel%2520rodent%2520attention%2520task%26jtitle%3DJ.%2520Neurogenet.%26date%3D2011%26volume%3D25%26issue%3D4%26spage%3D120%26epage%3D126%26doi%3D10.3109%2F01677063.2011.630494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>250</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2013.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.bbr.2013.05.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=2013&pages=230-237&author=J.+Zhangauthor=J.+Guoauthor=X.+Zhaoauthor=Z.+Chenauthor=G.+Wangauthor=A.+Liuauthor=Q.+Wangauthor=W.+Zhouauthor=Y.+Xuauthor=C.+Wang&title=Phosphodiesterase-5+inhibitor+sildenafil+prevents+neuroinflammation%2C+lowers+beta-amyloid+levels+and+improves+cognitive+performance+in+APP%2FPS1+transgenic+mice&doi=10.1016%2Fj.bbr.2013.05.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2013.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2013.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DPhosphodiesterase-5%2520inhibitor%2520sildenafil%2520prevents%2520neuroinflammation%252C%2520lowers%2520beta-amyloid%2520levels%2520and%2520improves%2520cognitive%2520performance%2520in%2520APP%252FPS1%2520transgenic%2520mice%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2013%26volume%3D250%26spage%3D230%26epage%3D237%26doi%3D10.1016%2Fj.bbr.2013.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Summerfield, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Carmen
Osuna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spalding, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P.</span></span> <span> </span><span class="NLM_article-title">Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, p-glycoprotein efflux, and free fractions in blood and brain</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>316</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1282</span>– <span class="NLM_lpage">1290</span>, <span class="refDoi"> DOI: 10.1124/jpet.105.092916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1124%2Fjpet.105.092916" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=16330496" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2005&pages=1282-1290&issue=3&author=S.+G.+Summerfieldauthor=A.+J.+Stevensauthor=L.+Cutlerauthor=M.+del+Carmen%0AOsunaauthor=B.+Hammondauthor=S.-P.+Tangauthor=A.+Herseyauthor=D.+J.+Spaldingauthor=P.+Jeffrey&title=Improving+the+in+vitro+prediction+of+in+vivo+central+nervous+system+penetration%3A+integrating+permeability%2C+p-glycoprotein+efflux%2C+and+free+fractions+in+blood+and+brain&doi=10.1124%2Fjpet.105.092916"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.092916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.092916%26sid%3Dliteratum%253Aachs%26aulast%3DSummerfield%26aufirst%3DS.%2BG.%26aulast%3DStevens%26aufirst%3DA.%2BJ.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3Ddel%2BCarmen%2BOsuna%26aufirst%3DM.%26aulast%3DHammond%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DS.-P.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DSpalding%26aufirst%3DD.%2BJ.%26aulast%3DJeffrey%26aufirst%3DP.%26atitle%3DImproving%2520the%2520in%2520vitro%2520prediction%2520of%2520in%2520vivo%2520central%2520nervous%2520system%2520penetration%253A%2520integrating%2520permeability%252C%2520p-glycoprotein%2520efflux%252C%2520and%2520free%2520fractions%2520in%2520blood%2520and%2520brain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D316%26issue%3D3%26spage%3D1282%26epage%3D1290%26doi%3D10.1124%2Fjpet.105.092916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of orally available first-generation dual-target selective inhibitors of acetylcholinesterase (ache) and phosphodiesterase 5 (pde5) for the treatment of Alzheimer’s disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">345</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00345</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00345" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWrs7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=328-345&issue=2&author=F.+Maoauthor=H.+Wangauthor=W.+Niauthor=X.+Zhengauthor=M.+Wangauthor=K.+Baoauthor=D.+Lingauthor=X.+Liauthor=Y.+Xuauthor=H.+Zhangauthor=J.+Li&title=Design%2C+synthesis%2C+and+biological+evaluation+of+orally+available+first-generation+dual-target+selective+inhibitors+of+acetylcholinesterase+%28ache%29+and+phosphodiesterase+5+%28pde5%29+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facschemneuro.7b00345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Orally Available First-Generation Dual-Target Selective Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Mao, Fei; Wang, Huan; Ni, Wei; Zheng, Xinyu; Wang, Manjiong; Bao, Keting; Ling, Dazheng; Li, Xiaokang; Xu, Yixiang; Zhang, Haiyan; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">328-345</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Through drug discovery strategies of repurposing and redeveloping existing drugs, a series of novel tadalafil derivs. were rationally designed, synthesized, and evaluated to seek dual-target AChE/PDE5 inhibitors as good candidate drugs for Alzheimer's disease (AD).  Among these derivs., (6R,12aR)-6-(benzo[d][1,3]dioxol-5-yl)-2-(2-(1-benzylpiperidin-4yl)ethyl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione (1p, I) and (6R,12aS)-6-(benzo[d][1,3]dioxol-5-yl)-2-(2-(1-benzylpiperidin-4yl)ethyl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione (1w, II) exhibited excellent selective dual-target AChE/PDE5 inhibitory activities and improved blood-brain barrier (BBB) penetrability.  Importantly, II·Cit (citrate of II) could reverse the cognitive dysfunction of scopolamine-induced AD mice and exhibited an excellent effect on enhancing cAMP response element-binding protein (CREB) phosphorylation in vivo, a crucial factor in memory formation and synaptic plasticity.  Moreover, the mol. docking simulations of II with hAChE and hPDE5A confirmed that the design strategy was rational.  In summary, the research provides a potential selective dual-target AChE/PDE5 inhibitor as a good candidate drug for the treatment of AD, and it could also be regarded as a small mol. probe to validate the novel AD therapeutic approach in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoThEyISqB-vrVg90H21EOLACvtfcHk0lheS4fySyOkcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWrs7rF&md5=f681ad7b8ce0bf011d30d36a869eedd0</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00345%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DNi%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DBao%26aufirst%3DK.%26aulast%3DLing%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520orally%2520available%2520first-generation%2520dual-target%2520selective%2520inhibitors%2520of%2520acetylcholinesterase%2520%2528ache%2529%2520and%2520phosphodiesterase%25205%2520%2528pde5%2529%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26issue%3D2%26spage%3D328%26epage%3D345%26doi%3D10.1021%2Facschemneuro.7b00345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fiorito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vendome, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeed, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staniszewski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, D. W.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel 1,2,3,4-tetrahydrobenzo[b][1,6]naphthyridine analogue as a potent phosphodiesterase 5 inhibitor with improved aqueous solubility for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">8858</span>– <span class="NLM_lpage">8875</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00979</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00979" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8858-8875&issue=21&author=J.+Fioritoauthor=J.+Vendomeauthor=F.+Saeedauthor=A.+Staniszewskiauthor=H.+Zhangauthor=S.+Yanauthor=S.+X.+Dengauthor=O.+Arancioauthor=D.+W.+Landry&title=Identification+of+a+novel+1%2C2%2C3%2C4-tetrahydrobenzo%5Bb%5D%5B1%2C6%5Dnaphthyridine+analogue+as+a+potent+phosphodiesterase+5+inhibitor+with+improved+aqueous+solubility+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.7b00979"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00979%26sid%3Dliteratum%253Aachs%26aulast%3DFiorito%26aufirst%3DJ.%26aulast%3DVendome%26aufirst%3DJ.%26aulast%3DSaeed%26aufirst%3DF.%26aulast%3DStaniszewski%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DS.%2BX.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26atitle%3DIdentification%2520of%2520a%2520novel%25201%252C2%252C3%252C4-tetrahydrobenzo%255Bb%255D%255B1%252C6%255Dnaphthyridine%2520analogue%2520as%2520a%2520potent%2520phosphodiesterase%25205%2520inhibitor%2520with%2520improved%2520aqueous%2520solubility%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D21%26spage%3D8858%26epage%3D8875%26doi%3D10.1021%2Facs.jmedchem.7b00979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puzzo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staniszewski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Privitera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leznik, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-β load in an Alzheimer’s disease mouse model</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">8075</span>– <span class="NLM_lpage">8086</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0864-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1523%2FJNEUROSCI.0864-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=19553447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFKgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=8075-8086&issue=25&author=D.+Puzzoauthor=A.+Staniszewskiauthor=S.+X.+Dengauthor=L.+Priviteraauthor=E.+Leznikauthor=S.+Liuauthor=H.+Zhangauthor=Y.+Fengauthor=A.+Palmeriauthor=D.+W.+Landryauthor=O.+Arancio&title=Phosphodiesterase+5+inhibition+improves+synaptic+function%2C+memory%2C+and+amyloid-%CE%B2+load+in+an+Alzheimer%E2%80%99s+disease+mouse+model&doi=10.1523%2FJNEUROSCI.0864-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-β load in an Alzheimer's disease mouse model</span></div><div class="casAuthors">Puzzo, Daniela; Staniszewski, Agnieszka; Deng, Shi Xian; Privitera, Lucia; Leznik, Elena; Liu, Shumin; Zhang, Hong; Feng, Yan; Palmeri, Agostino; Landry, Donald W.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">8075-8086</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Memory loss, synaptic dysfunction, and accumulation of amyloid β-peptides (Aβ) are major hallmarks of Alzheimer's disease (AD).  Downregulation of the nitric oxide/cGMP/cGMP-dependent protein kinase/c-AMP responsive element-binding protein (CREB) cascade has been linked to the synaptic deficits after Aβ elevation.  Here, we report that the phosphodiesterase 5 inhibitor (PDE5) sildenafil (Viagra), a mol. that enhances phosphorylation of CREB, a mol. involved in memory, through elevation of cGMP levels, is beneficial against the AD phenotype in a mouse model of amyloid deposition.  We demonstrate that the inhibitor produces an immediate and long-lasting amelioration of synaptic function, CREB phosphorylation, and memory.  This effect is also assocd. with a long-lasting redn. of Aβ levels.  Given that side effects of PDE5 inhibitors are widely known and do not preclude their administration to a senile population, these drugs have potential for the treatment of AD and other diseases assocd. with elevated Aβ levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq69pOrzfjxY7Vg90H21EOLACvtfcHk0licVWjyWiLxOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFKgtbw%253D&md5=5aead1f7c92b6166b8591c3e7951f78d</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0864-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0864-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DStaniszewski%26aufirst%3DA.%26aulast%3DDeng%26aufirst%3DS.%2BX.%26aulast%3DPrivitera%26aufirst%3DL.%26aulast%3DLeznik%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DPhosphodiesterase%25205%2520inhibition%2520improves%2520synaptic%2520function%252C%2520memory%252C%2520and%2520amyloid-%25CE%25B2%2520load%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26issue%3D25%26spage%3D8075%26epage%3D8086%26doi%3D10.1523%2FJNEUROSCI.0864-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madineni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhadidi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, Z. A.</span></span> <span> </span><span class="NLM_article-title">Cofilin inhibition restores neuronal cell death in oxygen-glucose deprivation model of ischemia</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">867</span>– <span class="NLM_lpage">878</span>, <span class="refDoi"> DOI: 10.1007/s12035-014-9056-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1007%2Fs12035-014-9056-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=25526862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKmtbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2016&pages=867-878&issue=2&author=A.+Madineniauthor=Q.+Alhadidiauthor=Z.+A.+Shah&title=Cofilin+inhibition+restores+neuronal+cell+death+in+oxygen-glucose+deprivation+model+of+ischemia&doi=10.1007%2Fs12035-014-9056-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Cofilin Inhibition Restores Neuronal Cell Death in Oxygen-Glucose Deprivation Model of Ischemia</span></div><div class="casAuthors">Madineni, Anusha; Alhadidi, Qasim; Shah, Zahoor A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">867-878</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Ischemia is a condition assocd. with decreased blood supply to the brain, eventually leading to death of neurons.  It is assocd. with a diverse cascade of responses involving both degenerative and regenerative mechanisms.  At the cellular level, the changes are initiated prominently in the neuronal cytoskeleton.  Cofilin, a cytoskeletal actin severing protein, is known to be involved in the early stages of apoptotic cell death.  Evidence supports its intervention in the progression of disease states like Alzheimer's and ischemic kidney disease.  In the present study, we have hypothesized the possible involvement of cofilin in ischemia.  Using PC12 cells and mouse primary cultures of cortical neurons, we investigated the potential role of cofilin in ischemia in two different in vitro ischemic models: chem. induced oxidative stress and oxygen-glucose deprivation/reperfusion (OGD/R).  The expression profile studies demonstrated a decrease in phosphocofilin levels in all models of ischemia, implying stress-induced cofilin activation.  Furthermore, calcineurin and slingshot 1L (SSH) phosphatases were found to be the signaling mediators of the cofilin activation.  In primary cultures of cortical neurons, cofilin was found to be significantly activated after 1 h of OGD.  To delineate the role of activated cofilin in ischemia, we knocked down cofilin by small interfering RNA (siRNA) technique and tested the impact of cofilin silencing on neuronal viability.  Cofilin siRNA-treated neurons showed a significant redn. of cofilin levels in all treatment groups (control, OGD, and OGD/R).  Addnl., cofilin siRNA-reduced cofilin mitochondrial translocation and caspase 3 cleavage, with a concomitant increase in neuronal viability.  These results strongly support the active role of cofilin in ischemia-induced neuronal degeneration and apoptosis.  We believe that targeting this protein mediator has a potential for therapeutic intervention in ischemic brain injury and stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMYvX1eRDjbLVg90H21EOLACvtfcHk0licVWjyWiLxOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKmtbzF&md5=f327945197a460db783f6efce84bfb1a</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2Fs12035-014-9056-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-014-9056-3%26sid%3Dliteratum%253Aachs%26aulast%3DMadineni%26aufirst%3DA.%26aulast%3DAlhadidi%26aufirst%3DQ.%26aulast%3DShah%26aufirst%3DZ.%2BA.%26atitle%3DCofilin%2520inhibition%2520restores%2520neuronal%2520cell%2520death%2520in%2520oxygen-glucose%2520deprivation%2520model%2520of%2520ischemia%26jtitle%3DMol.%2520Neurobiol.%26date%3D2016%26volume%3D53%26issue%3D2%26spage%3D867%26epage%3D878%26doi%3D10.1007%2Fs12035-014-9056-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suneja, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potashner, S. J.</span></span> <span> </span><span class="NLM_article-title">Phospho-CREB and other phospho-proteins: improved recovery from brain tissue</span>. <i>J. Neurosci. Methods</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>150</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1016/j.jneumeth.2005.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=10.1016%2Fj.jneumeth.2005.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=16087244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnslyksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2006&pages=238-241&issue=2&author=S.+K.+Sunejaauthor=Z.+Moauthor=S.+J.+Potashner&title=Phospho-CREB+and+other+phospho-proteins%3A+improved+recovery+from+brain+tissue&doi=10.1016%2Fj.jneumeth.2005.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Phospho-CREB and other phospho-proteins: improved recovery from brain tissue</span></div><div class="casAuthors">Suneja, Sanoj K.; Mo, Zhicheng; Potashner, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">238-241</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">During attempts to quantify levels of phosphorylated cAMP response element binding protein (CREB-P) in guinea pig brain stem auditory nuclei by Western blotting, we compared the decay of CREB-P levels when tissues were homogenized in traditional Lysis buffer contg. detergents or in 50 mM Tris-HCl buffer contg. 0.32 M sucrose.  The decay of CREB-P levels was retarded considerably in the Tris-Sucrose medium as compared to the Lysis buffer.  Similarly, the levels of two other phospho-proteins, extracellular regulated kinases (ERK1/2-P) and stress activated protein/Jun-N-terminal kinase (SAP/JNK-P), were better preserved by the Tris-Sucrose medium.  These findings imply that the detergents typically present in the Lysis buffer may disrupt organelles and increase the exposure of sol. phospho-proteins to hydrolyzing enzymes.  In contrast, such exposure was probably minimized in the Tris-Sucrose medium, which is thought to preserve organelle integrity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIbAHmb2kPhbVg90H21EOLACvtfcHk0licVWjyWiLxOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnslyksg%253D%253D&md5=e0fac667029e37b5f50f93bec3739f64</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2005.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2005.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DSuneja%26aufirst%3DS.%2BK.%26aulast%3DMo%26aufirst%3DZ.%26aulast%3DPotashner%26aufirst%3DS.%2BJ.%26atitle%3DPhospho-CREB%2520and%2520other%2520phospho-proteins%253A%2520improved%2520recovery%2520from%2520brain%2520tissue%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2006%26volume%3D150%26issue%3D2%26spage%3D238%26epage%3D241%26doi%3D10.1016%2Fj.jneumeth.2005.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i76"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00389">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_60300"></div></div></div></div></div><hr /></hr><p class="last">.doc .pdf .pdf .pdf .csv The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00389">10.1021/acs.jmedchem.8b00389</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_001.csv">CSV</a>)</p></li><li><p class="inline">Supporting information (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Supplemental characterization (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_003.pdf">PDF</a>)</p></li><li><p class="inline">Supplemental crystal structure report (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_004.pdf">PDF</a>)</p></li><li><p class="inline">Supplemental pharmacokinetic data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_005.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_001.csv">jm8b00389_si_001.csv (1.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_002.pdf">jm8b00389_si_002.pdf (1.27 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_003.pdf">jm8b00389_si_003.pdf (4.84 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_004.pdf">jm8b00389_si_004.pdf (1.03 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00389/suppl_file/jm8b00389_si_005.pdf">jm8b00389_si_005.pdf (1.42 MB)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The X-ray crystal structure of <b>5a</b> has been deposited into the Cambridge Crystallographic Data Centre, ID code: CCDC 1838464.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00389&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-10%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00389%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00389" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a9e31fe223dd7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
